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 Foreword 
It gives me great pleasure to introduce the 36th report from the Better the Evaluation and 
Care of Health (BEACH) program, General practice activity in Australia 2013–14. It is a further 
credit to The Family Medicine Research Centre who undertake this research, and who are 
responsible for the most comprehensive and objective measure of general practitioner 
activity undertaken anywhere in the world.  
General practice and primary care represent the interface between complex (and expensive) 
health care services and the wider community. Australian general practice can reasonably 
claim to represent world best practice in terms of both cost and patient outcomes. The 
general practitioner’s role is described by the RACGP as the provision of “person centred, 
continuing, comprehensive and coordinated whole person health care to individuals and 
families in their communities”. There is ample evidence that preventive and primary care 
services that are patient-focussed rather than disease-focussed provide the most cost 
effective health outcomes for those individuals and communities.  
However we live in an era when decisions relating to the allocation of health care funds are 
fiercely contested and subject to intense scrutiny from many sectors, including the research 
community and the general media. It has been difficult to move away from a disease 
focussed funding model, with funding often linked to one of the nationally adopted health 
priority domains, such as cardiovascular disease or diabetes, or directed to conditions that 
achieve a high media profile such as childhood or breast cancers. While all diseases are 
worthy, this funding model does not reflect the scope of services needed in our community. 
GPs are expected to undertake ‘evidence-based practice’, but the quality and utility of the 
evidence presented to GPs is variable, with insufficient time and resources allocated to 
determining the perceived discrepancy between ‘evidence’ and ‘practice’. The common 
model for clinical research is to focus on a particular disease subset or narrowly defined 
patient cohort, because it is easier to define research hypotheses and obtain funding for 
focussed research projects. However, the reported results often fail to take into account 
associated comorbidities, or environmental and psychosocial factors that may influence 
patient and doctor adoption of guidelines that derive from the research. The BEACH data 
measures what we actually do in our practices, and provides the data template for a broader 
discussion around any gap between research and actual clinical practice. 
By more clearly defining the relativities and complexities of the work that GPs undertake in 
their practices, the information contained in the current BEACH report assists in challenging 
some of these traditional disease focussed approaches to health service delivery. While 
individual diseases are coded and prevalence can be assessed from the database, “all 
variables can be directly related to the encounter, the GP and the patient characteristics”, 
allowing for a patient centred approach to data interpretation. For example the report 
indicates a high frequency of musculoskeletal problems presenting to general practitioners 
(18 per 100 patient encounters, compared to 19 and 17 for respiratory and circulatory 
disorders respectively), and yet chronic arthritis, which attracts significant attention as a 
national health priority, accounts for a minority of these presentations. The data contained in 
the report indicates that GPs see many different musculoskeletal problems in general 
practice, indicating the need for better understanding of the complexity and diversity of such 
conditions and their management. 
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The companion publication, A decade of Australian general practice activity 2004–05 to 2013–14 
can be used to evaluate trends in the rate of ordering investigations, prescribing medications 
or referral to consultants. The steady increase in test ordering and referrals to specialist 
consultants and allied health professionals may result from multiple factors including: an 
increased incidence of patients with diagnosed chronic and complex comorbidities 
secondary to age and risk factors such as obesity; better therapeutic options and a lower 
tolerance of adverse outcomes from patients and communities. The BEACH report provides 
a foundation for exploring these hypotheses. 
There are of course potential limitations to any data set. One limitation that may need to be 
considered in the future is the restriction of recruitment to GPs who undertake a minimum 
of 375 Medicare rebated services in a 3 month period. It is likely that many GP clinicians who 
have a fractional clinical role in general practice, or who undertake significantly longer and 
fewer consultations, are thereby excluded from the study. This group has recently been 
recognised as providing a significant workforce contribution to Australian general practice 
and may have a somewhat different activity profile to those included in the BEACH study.  
It is essential that we have reliable information that provides a detailed and unbiased picture 
of the full scope of health issues affecting the Australian community, and an opportunity to 
triangulate these data with other national data sets including the MBS, PBS and the 
Australian Health Survey. The BEACH reports provide a key longitudinal resource whose 
value can only increase over time, particularly as we move closer to achieving an integrated 
electronic health record. As stated in the report “BEACH is the only continuous randomised 
study of general practice activity in the world, and the only national program that provides 
direct linkage of management actions (such as prescriptions, referrals, investigations) to the 
problem under management. Medicare statistics provide information about frequency and 
cost of visits claimed from Medicare for GP service items, (but) they cannot tell us about the 
content of these visits. The BEACH program fills this gap.” 
 
Simon M Willcock MBBS (Hons1), PhD, FRACGP 
Professor of General Practice 
University of Sydney Medical Program 
Chair: Avant Mutual Insurance Group. 
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 Summary 
This report describes clinical activity at, or associated with, general practitioner (GP) 
encounters, from April 2013 to March 2014, inclusive. It summarises results from the 
16th year of the Bettering the Evaluation and Care of Health (BEACH) program, using a 
nationally representative sample of 95,900 patient encounters with 959 randomly selected 
GPs. After post-stratification weighting, 95,879 encounters were analysed in this report. 
BEACH is a continuous cross-sectional national study that began in April 1998. Every year 
about 1,000 randomly selected GPs, each record details of 100 consecutive encounters on 
structured paper recording forms, and provide information about themselves and their 
practice. BEACH is the only continuous randomised study of general practice activity in the 
world, and the only national program that provides direct linkage of management (such as 
prescriptions, referrals, investigations) to the problem under management.  
The BEACH database now includes information for almost 1.6 million encounters from 
15,759 participants representing 9,950 individual GPs.  
In subsamples of the BEACH encounters, smaller patient-based (rather than encounter-
based) studies are conducted. This publication includes results for patient body mass index, 
smoking status and alcohol consumption, and abstracts (with the research tools) are 
provided for each of the other substudies conducted in 2013–14.  
The companion report highlighting major change over the most recent 10 years of BEACH,  
A decade of Australian general practice activity 2004–05 to 2013–14,1 is available at 
<purl.library.usyd.edu.au/sup/9781743324233>. 
The general practitioners (Chapter 4) 
Of the 959 participating GPs in 2013–14: 
• 57% were male, 48% were aged 55 years and over, 71% had graduated in Australia 
• spent an average of 36.8 hours per week (median 37 hours) in direct patient care  
• 56% were Fellows of the Royal Australian College of General Practitioners (RACGP), 
and 6.3% were Fellows of the Australian College of Rural and Remote Medicine 
(ACRRM) 
• 54% had provided care in a residential aged care facility in the previous month 
• 69% practised in Major cities (using the Australian Standard Geographical Classification) 
• 74% worked at only one practice location in a regular week; 21% worked in two 
• 52% were in practices of fewer than five full-time equivalent (FTE) GPs (a mean of 5.2 
FTE GPs per practice and a median of 4.5 FTE GPs) 
• 83% worked in a practice employing practice nursing staff 
• nearly three-quarters (74%) had a co-located pathology laboratory or collection centre in, 
or within 50 metres of the practice, and more than half (56%) had a co-located 
psychologist  
• 43% worked in a practice that provided their own or cooperative after-hours care and 
56% in a practice that used a deputising service (multiple responses allowed)  
• 70% of GPs reported using electronic medical records exclusively (i.e. were paperless). 
There were no significant differences in the characteristics of the final sample of BEACH 
participants and all GPs in the sample frame in terms of sex or practice location by the 
Australian Standard Geographical Classification. However, in the final BEACH GP sample 
xii 
 there was a slight under-representation of GPs in the <35 year and 35–44 year age groups, 
and a slight over-representation in the 55+ years age group; GPs who had graduated from 
their primary medical degree in Australia, and some slight variations in state representation. 
Comparison of the mean number of Medicare Benefits Schedule (MBS) claims over the 
previous year by participating GPs showed a difference on only six consultations per week, 
compared with those in the GP sample frame. 
The encounters (Chapter 5) 
After weighting the data for the minor differences in GP activity and the age–sex 
distribution of the GP participants, the age–sex distribution of patients at BEACH 
encounters had an excellent fit (precision ratios 0.91–1.09), with that of patients at all GP 
services claimed through the MBS.  
• On average, patients gave 155 reasons for encounter (RFEs), and GPs managed about 
158 problems per 100 encounters. 
• Chronic problems accounted for 36%, and new problems for 37% of all problems. 
• Work-related problems were managed at a rate of 2.4 per 100 encounters. 
• At an ‘average’ 100 encounters, problem management involved: 103 medications 
[prescribed, supplied or advised for over-the-counter (OTC) purchase], 49 pathology 
tests/batteries of tests; 38 clinical treatments; 19 procedures; 15 referrals (including 10 to 
medical specialists and 5 to allied health services); and 11 imaging tests. 
• Direct encounters (patient seen) accounted for 98% of encounters at which a payment 
source was recorded. Of these: 95% were claimable either through the MBS or the 
Department of Veterans’ Affairs (DVA), 2% through workers compensation, and 1% 
through other sources. 
In a subsample of 31,816 BEACH MBS/DVA-claimable encounters at which start and finish 
times were recorded, mean consultation length was 14.8 minutes, median 13.0 minutes. 
Who were the patients and why did they see the GP? (Chapter 6)  
• Females accounted for 57% of encounters, and the greater proportion of encounters in 
all adult age groups. 
• Children (aged <15 years) accounted for 11% of encounters; 15–24 years 8%; 25–44 years 
22%; 45–64 years 27%; and patients aged 65 years and over accounted for 32%. 
• The patient was new to the practice at 7% of encounters, held a Commonwealth 
concession card at 44%, held a Repatriation health card at 2% and was from a 
non-English-speaking background at 10%. 
• At 1.7% of encounters, the patient identified themselves as an Aboriginal and/or Torres 
Strait Islander person. 
For every 100 encounters, patients gave 155 reasons for encounters (RFEs) including: 
63 symptom and complaint RFEs, 30 diagnosis/disease RFEs, 63 requests for processes of 
care (e.g. procedures, referrals). 
What problems do GPs manage at patient encounters? (Chapter 7) 
There were 151,675 problems managed, an average 158 per 100 encounters: one problem was 
managed at 60% of encounters, two or three managed at 37%, and four at 4%. More 
problems were managed at encounters with female patients, than with male patients. 
xiii 
 Nearly two-thirds (65%) of problems were described as diagnoses or diseases, 19% in terms 
of symptoms or complaints, and 10% as diagnostic or preventive procedures (e.g. check-
ups). 
• The most commonly managed were: problems of a general and unspecified nature 
(20 per 100 encounters), respiratory problems (19 per 100 encounters), musculoskeletal 
problems (18), skin (18), and circulatory (17). 
• Individual problems managed most often were hypertension (8.7 per 100 encounters), 
check-ups (7.0), immunisation/vaccination (5.8), upper respiratory tract infection (URTI) 
(4.9), and depression (4.3). 
• At least one chronic problem was managed at 42% of encounters and 56 chronic 
problems were managed per 100 encounters.  
• Over half of all chronic problems managed were accounted for by: non-gestational 
hypertension (15.3% of chronic conditions), depressive disorder (7.6%), non-gestational 
diabetes (7.4%), chronic arthritis (7.1%), lipid disorder (5.5%), oesophageal disease 
(4.6%), and asthma (3.5%). Extrapolation of these results to the 133.4 million Medicare 
GP consultation items claimed in 2013–14 suggests there were 11.5 million encounters 
involving non-gestational hypertension, 5.7 million involving depression and 5.6 million 
involving non-gestational diabetes. 
Management actions recorded for problems managed? (Chapter 8) 
On average, for every 100 problems they managed, GPs provided 53 prescriptions and 
24 clinical treatments, undertook 12 procedures, made 6 referrals to medical specialists and 
3 to allied health services, and placed 31 pathology test orders and 7 imaging test orders. 
Medications (Chapter 9) 
There were 98,394 medications recorded, 103 per 100 encounters but only 65 per 100 
problems managed: 84% were prescribed, 10% supplied by the GP and 9% recommended 
for OTC purchase. Extrapolation of these results suggests that, across Australia in 2013–14, 
GPs wrote 111 million prescriptions, supplied 14 million medications directly to the patient, 
and advised medications for OTC purchase 12 million times. 
• At least one medication (most prescribed) was given for 51% of problems managed. 
• No repeats were given for 34% of prescriptions, and five repeats were ordered for 38%. 
The ordering of one repeat was also quite common (15%).  
• Medication types most often prescribed were those acting on: the nervous system  
(24% of scripts), particularly opioids (7%) and antidepressants (5%); and the 
cardiovascular system (19%), particularly anti-hypertensives and lipid lowering agents. 
The most commonly prescribed individual medications were: the antibiotics cephalexin 
(3% of all prescriptions), amoxycillin (3%) and amoxycillin/potassium clavulanate (2%); 
the nervous system drugs paracetamol (3%) and oxycodone (2%); and the proton pump 
inhibitor esomeprazole (2%). 
• Medications were GP-supplied at a rate of 7 per 100 problems managed and vaccines 
accounted for the vast majority of these. The influenza virus vaccine accounted for 
one-third of GP-supplied medications. 
• Medications were advised for OTC purchase at a rate of 6 per 100 problems managed. 
Paracetamol accounted for 25% of these and ibuprofen made up 7%.  
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 Other treatments (Chapter 10) 
At least one other treatment was provided at 43% of encounters and 54,104 other treatments 
were recorded, two-thirds (67%) being clinical treatments (such as advice and counselling).  
Clinical treatments: 36,024 clinical treatments were recorded, 38 per 100 encounters, or 
24 per 100 problems managed. General advice and education (17% of clinical treatments), 
and counselling about the problem being managed (12%) were most common. Preventive 
counselling/advice about nutrition and weight, exercise, smoking, lifestyle, prevention, 
and/or alcohol, was also frequently provided by GPs (together at a rate of 7.1 per 
100 encounters). 
Of all problems for which clinical treatments were provided, the top 10 accounted for 30%. 
The most common were depression (6% of problems with clinical treatments), URTI (5%), 
diabetes (4%) and anxiety (3%). 
Procedural treatments: 18,081 procedural treatments were recorded, 19 per 100 encounters, 
or 12 per 100 problems. The most common were: excision (17% of procedural treatments), 
dressing (15%), local injection (14%) and rehabilitation (7%). 
The most common problem for which a procedure was performed was solar keratosis/ 
sunburn (5% of problems with a procedure). 
Practice nurse/Aboriginal health worker activity  
These results are limited to practice nurse (PN) and/or Aboriginal health worker (AHW) 
activities associated with recorded GP–patient encounters.  
There were 7,690 GP–patient encounters (8.0% of all encounters) at which at least one 
PN/AHW activity was recorded. However, for 75 of these, their activity was not described. 
At the remaining 7,615 encounters a PN/AHW was involved in the management of 8,041 
problems (5.3% of all problems managed at all encounters. Extrapolation of this result 
suggests that in 2013–14, PNs/AHWs were involved in about 10.7 million GP–patient 
consultations across Australia. A PN/AHW Medicare item was recorded at only 0.4% of all 
encounters: 5% of encounters involving a PN/AHW. 
The problems most often involving the PN/AHWs at GP–patient encounters were: 
immunisation/vaccination, check-up, laceration/cut, atrial fibrillation/flutter, diabetes and 
chronic skin ulcer. Together they accounted for more than 40% of all the problems involving 
PN/AHWs.  
The vast majority (87.5%) of the PN/AHW recorded activity was procedural, and these 
procedures represented 33.6% of all procedures recorded. In contrast, clinical treatments 
accounted for 12.5% of PN/AHW recorded activity at encounters, but PNs/AHWs provided 
only 3.0% of all recorded clinical treatments. PNs/AHWs did 39.7% of the recorded 
immunisation injections at GPs encounters. 
Referrals and admissions (Chapter 11) 
There were 16 referrals recorded per 100 encounters or 10 per 100 problems managed.  
The most frequent were to medical specialists (10 per 100 encounters, 6 per 100 problems 
managed), followed by those to allied health services (5 per 100 encounters, 3 per 100 
problems). Very few patients were referred to hospitals or emergency departments (0.7 per 
100 encounters, 0.4 per 100 problems).  
Referrals to specialists were most often to orthopaedic surgeons (9% of specialist referrals), 
surgeons (8%), cardiologists (8%) and dermatologists (8%). Malignant skin neoplasms, 
osteoarthritis, pregnancy and diabetes were the problems most often referred to specialists. 
The five problems most frequently referred to each of the 10 most common medical 
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 specialties are described. They may represent a small or large proportion of all problems 
referred to a particular specialty. For example, the top five problems accounted for 25.4% of 
all referrals to ear, nose and throat specialists (indicative of the broad range of conditions 
referred to them), and for 58.1% of referrals to orthopaedic surgeons, suggesting a more 
defined range of problems referred. 
Referrals to allied health services were most often to physiotherapists (27% of allied health 
referrals), psychologists (22%), podiatrists/chiropodists (11%) and dietitians/nutritionists 
(8%). Problems most likely to be referred were depression, diabetes and anxiety.  
Tests and investigations (Chapter 12) 
Pathology tests ordered: GPs recorded 47,035 orders for pathology tests/batteries, at a rate 
of 49 per 100 encounters (31 per 100 problems managed). At least one pathology test was 
recorded at 19% of encounters (for 14% of problems managed). 
• Chemistry tests accounted for 58% of pathology test orders, the most common being: 
lipid tests (2.6 per 100 problems managed); multi-biochemical analysis (2.2); thyroid 
function tests (2.0); and electrolytes, urea and creatinine (1.9).  
• Haematology tests accounted for 17% of pathology and included full blood count, the 
most frequently ordered individual test (14% of all pathology), 4.3 being ordered per 
100 problems managed. 
• Microbiology accounted for 14% of pathology orders. Urine microscopy, culture and 
sensitivity was the most frequent test ordered within the group.  
• Almost 40% of all pathology tests were generated by orders for 10 problems, led by 
diabetes, general check-ups, hypertension, and weakness/tiredness.  
Imaging ordered: There were 10,460 imaging test orders recorded, 11 per 100 encounters 
and 7 per 100 problems managed. At least one imaging test was ordered at 9% of encounters 
(for 6% of problems managed). Diagnostic radiology accounted for 42%, ultrasound 41%, 
and computerised tomography for 12% of all imaging orders.  
Patient risk factors (Chapter 13) 
Overweight and obesity in adults (18 years and over): Of 31,371 adults, 63% (69% of males 
and 59% of females) were overweight or obese: 35% being overweight and 28% obese. After 
adjustment for attendance patterns by age–sex, prevalence in adults who attended general 
practice at least once in 2013–14 was estimated as 35% overweight and 27% obese. 
Overweight and obesity in children (2–17 years): Of 2,536 children, 28% were overweight 
(19%) or obese (10%). Prevalence and age pattern did not differ between the sexes. 
Smoking status (adults 18 years and over): Of 32,166 adults, 14% (17% of men and 12% of 
women) were daily smokers and this was most prevalent among 25–44 year olds (20%). 
Adjusted to the attending population, prevalence of daily smoking was 17%. 
Alcohol consumption in adults (18 years and over): Of 31,369 adult patients, 23% (28% of 
men and 20% of women) reported drinking at-risk levels of alcohol. This was most prevalent 
among 18–24 year olds. Adjusted to the attending population, 26% reported at-risk alcohol 
consumption. 
Adult risk profile (18 years and over): Of the 30,250 patients for whom all three risk factor 
data were available: 25% had no risk factors, 53% had one, 18% had two, and 3% had three. 
Adjusted to the attending population, one in four patients (25%) had at least two risk factors. 
xvi 
 1 Introduction 
This is the 16th annual report and the 36th book in the General Practice Series from the BEACH 
(Bettering the Evaluation and Care of Health) program, a continuous national study of 
general practice activity in Australia. It provides the annual results for the period April 2013 
to March 2014 inclusive, using details of 959,000 encounters between general practitioners 
(GPs) and patients (almost a 0.1% sample of all general practice encounters) from a random 
sample of 959 practising GPs across the country.  
Released in parallel with this report is a summary of results from the most recent 10 years of 
the BEACH program, A decade of Australian general practice activity 2004–05 to 2013–14,1 
available at <purl.library.usyd.edu.au/sup/9781743324233>.  
The BEACH program began in April 1998 and was the culmination of about 20 years research 
and development work at the University of Sydney. BEACH is currently supported 
financially by government and private industry (see Acknowledgments). 
BEACH is the only continuous randomised study of general practice activity in the world, 
and the only national program that provides direct linkage of management actions (such as 
prescriptions, referrals, investigations) to the problem under management. The BEACH 
database now includes information for almost 1.6 million encounters from 15,759 
participants representing 9,950 individual GPs. 
1.1 Background 
In December 2013, the estimated resident Australian population was 23.3 million people.2  
Australia’s health expenditure in 2011–12 was $140.2 billion, an average $6,230 per head of 
population, and accounted for 9.5% of gross domestic product (GDP). Governments funded 
69.7%, with the remainder (30.3%) being paid by the non-government sector and by 
individuals.3 In the 2013–14 financial year, government expenditure on general practice 
services (including those of practice nurses) was almost $6.4 billion dollars.4 
GPs are usually the first port of call in the Australian healthcare system. Payment for GP 
visits is largely on a fee-for-service system, there being no compulsory patient lists or 
registration. People are free to see multiple practitioners and visit multiple practices of their 
choice. There is a universal medical insurance scheme (managed by Medicare Australia), 
which covers all or some of an individual’s cost for a GP visit.  
In Australia in 2012, there were 25,958 practising GPs (medical practitioners self-identifying 
as GPs), making up 25,063 full-time equivalents (FTE, based on a 40-hour week), or 111.8 
FTE GPs per 100,000 people.5  
In the April 2013 to March 2014 year, about 85.2% of the Australian population claimed at 
least one GP service from Medicare (personal communication, Department of Health [DoH], 
August 2014). In the same period, Medicare paid rebates for about 133.4 million claimed 
general practice service items (excluding practice nurse items),6 at an average of about 5.8 
GP visits per head of population or 6.8 visits per person who visited at least once. This 
equates to about 2.57 million GP–patient encounters per week.  
While Medicare statistics provide information about frequency and cost of visits claimed 
from Medicare for GP service items, they cannot tell us about the content of these visits. The 
BEACH program fills this gap. 
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 1.2 The BEACH program 
In summary, the BEACH program is a continuous national study of general practice activity 
in Australia. Each year an ever-changing random sample of about 1,000 practising GPs 
participate, each recording details of 100 patient encounters on structured paper-based 
recording sheets (Appendix 1). This provides details of about 100,000 GP–patient encounters 
per year. They also provide information about themselves and their major practice 
(Appendix 2). The BEACH methods are described in Chapter 2 of this report. 
Aims 
The three main aims of the BEACH program are to: 
• provide a reliable and valid data collection process for general practice that is 
responsive to the ever-changing needs of information users, and provides insight into 
the evolving character of GP–patient encounters in Australia 
• provide an ongoing database of GP–patient encounter information 
• assess patient risk factors and health states, and the relationship these factors have with 
health service activity. 
Current status of BEACH 
BEACH began in April 1998 and is now in its 17th year. The BEACH database now includes 
records for 1,585,179 GP–patient encounters from 15,752 participating GPs. Each year we 
publish an annual report of BEACH results collected in the previous 12 months. This 
publication reports results from April 2013 to March 2014. The companion publication  
A decade of Australian general practice activity 2004–05 to 2013–14,1 provides summaries of 
changes in the most frequent events over the decade.  
The strengths of the BEACH program 
• BEACH is the only national study of general practice activity in the world that is 
continuous, relying on a random ever-changing sample of GPs. The ever-changing 
nature of the sample (where each GP can participate only once per triennium) ensures 
reliable representation of what is happening in general practice across the country.  
• The sheer size of the GP sample (1,000 per year) and the relatively small cluster of 
encounters around each GP, provide more reliable estimates than a smaller number of 
GPs with large clusters of patients and/or encounters.7 Our access to a regular random 
sample of recognised GPs in active practice, through DoH, ensures that the GP sample is 
drawn from a very reliable sample frame of currently active GPs. 
• The sampling methods ensure that new entrants to the profession are available for 
selection because the sample frame is based on the most recent Medicare data. Where 
data collection programs use a fixed set of GPs over a long period, they are measuring 
what that group is doing at any one time, or how that group has changed over time, and 
there may well be a ‘training effect’ inherent in longer-term participation. Such 
measures cannot be generalised to the whole of general practice. Further, where GPs in 
the group have a particular characteristic in common (for example, all belong to a 
professional organisation to which not all GPs belong; all use a selected software system 
which is not used by all GPs), the group is biased and cannot represent all GPs. 
• We have sufficient details about the characteristics of all GPs in the sample frame to test 
the representativeness of the final BEACH GP sample, and to apply post-stratification 
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 weighting to correct for any under or over-representation in the sample when compared 
with the sample frame.  
• Each GP records for a set number of encounters (100), but there is wide variance among 
them in the number of patient consultations they conduct in any one year. DoH 
therefore provides an individual count of activity level (that is, number of Medicare GP 
service items claimed in the previous period) for all randomly sampled GPs, allowing us 
to give a weighting to each GP’s set of encounters commensurate with his or her 
contribution to total general practice encounters. This ensures that the final encounters 
represent encounters with all GPs. 
• BEACH includes all patient encounters and management activities provided at these 
encounters, not just those encounters and activities funded by Medicare.  
• The structured paper encounter form leads the GP through each step in the encounter, 
encouraging entry of data for each element (see Appendix 1), with instructions and an 
example of a completed form. The structure itself forces linkage of actions to the 
problem being managed. In contrast, systems such as electronic health records rely on 
the GP to complete fields of interest without guidance. 
• BEACH is the only continuous national study in the world in which management 
actions at encounter are directly linked by the GP to the problems under management. 
This provides a measure of the ‘quality’ of care rather than just a count of the number of 
times an action has occurred (for example, how often a specific drug has been 
prescribed). 
• The medication data include all prescriptions, rather than being limited to those 
prescribed medications covered by the Pharmaceutical Benefits Scheme (PBS). BEACH 
is the only source of information on medications supplied directly to the patient by the 
GP, and about the medications GPs advised for OTC purchase, the patients to whom 
they provide such advice and the problems managed in this way.  
• The inclusion of other (non-pharmacological) treatments such as clinical counselling and 
procedural treatments provides a broader view of the interventions used by GPs in the 
care of their patients than other data sources. 
• The use of an internationally standard well-structured classification system (ICPC-2)8 
designed specifically for general practice, together with the use of a clinical interface 
terminology, facilitates reliable classification of the data by trained secondary coders, 
and removes the guesswork often applied in word searches of available records (in free 
text format) and in classification of a concept.  
• The use of the World Health Organization’s (WHO) Anatomical Therapeutic Chemical 
(ATC) classification for pharmaceuticals at the generic level ensures reporting of 
medications data is in terms of the international standard. 
• The analytical techniques applied to the BEACH data ensure that the clustering inherent 
in the sampling methods is dealt with. Results are reported with 95% confidence 
intervals. Users are therefore aware of how reliable any estimate might be. 
• Reliability of the methods is demonstrated by the consistency of results over time where 
change is not expected, and by the measurement of change when it might be expected.  
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 1.3 Using BEACH data with other national data 
Users of the BEACH data might wish to integrate information from multiple national data 
sources, to gain a more comprehensive picture of the health and health care of the 
Australian community. It is therefore important that readers are aware of how the BEACH 
data differ from those drawn from other sources. This section summarises differences 
between BEACH and other national sources of data about general practice in Australia. 
The Pharmaceutical Benefits Scheme  
Prescribed medications for which a PBS subsidy has been paid when they are dispensed, are 
recorded by Medicare Australia.  
The PBS data: 
• count the prescription each time it crosses the pharmacist’s counter (so that one by the 
GP prescription written with five repeats in BEACH would be counted by the PBS six 
times if the patient filled all repeats) 
• count only prescribed medications that cost 
– more than the minimum PBS subsidy for those holding a Commonwealth 
concession card or and/or who have reached the safety net threshold (and therefore 
covered by the PBS for all patients), or medications prescribed 
– more than a far higher PBS threshold for non-concession card holders.  
• will change with each change in the PBS co-payment level for non-Commonwealth 
concession cardholders – when the co-payment level increases, those medications  
that then fall under the new level will no longer be counted in the PBS for  
non-Commonwealth concession cardholders9 
• hold no record of the problem being managed (with the exception of authority 
prescriptions, which require an indication and account for a small proportion of PBS 
data). Morbidity cannot be reliably assumed on the basis of medication prescribed.10,11 
In BEACH: 
• total medications include those prescribed (whether covered by the PBS or not), those 
supplied to the patient directly by the GP, and those advised for OTC purchase 
• each prescription recorded, reflects the GP’s intent that the patient receives the 
prescribed medication, and the specified number of repeats; the prescription, 
irrespective of the number of repeats ordered, is counted only once  
• the medication is directly linked to the problem being managed by the GP 
• there is no information on the number of patients who do not present their prescription 
to be filled (this also applies to the PBS). 
These differences have a major impact on the numbers of prescriptions counted and also 
affect their distribution. For example, the majority of broad spectrum antibiotics such as 
amoxycillin fall under the non-concessional card holders‘ minimum subsidy level and 
would not be counted in the PBS data. The PBS data only include those filled under the PBS 
by a Commonwealth concession card holder or by people who had reached the annual 
safety net threshold.9 
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 Medicare Benefits Schedule 
Consultations with GPs that are paid for in-part, or in-full, through the Medicare Benefits 
Schedule (MBS) are recorded by Medicare Australia. 
• Publicly available MBS claims data do not include data about patients and encounters 
funded through the Department of Veterans’ Affairs (DVA).  
• The MBS data include GP services that have been billed to Medicare. BEACH includes 
all consultations, irrespective of whether a charge is made or who pays for it.  
• The MBS data reflect the item number charged to Medicare for a service and include 
some patient demographics, but hold no information about the content of the 
consultation. 
• BEACH participants are limited to recording three Medicare item numbers for each 
encounter. In contrast, MBS data include all Medicare item numbers claimed. In the 
BEACH data set this may result in a lower number of ‘other’ Medicare items than would 
be counted in the Medicare data.  
• In activities of relatively low frequency with a skewed distribution across individual 
GPs, the relative frequency of the event in the BEACH data may not reflect that reported 
in the MBS data. Where activity is so skewed across the practising population, a national 
random sample will provide an underestimate of activity because the sample reflects the 
population rather than the minority. 
• One of the advantages of BEACH over the MBS is also the relative consistency over time 
of the data collection form. BEACH is relatively resilient to changes in MBS payment 
policies, such as the inclusion or removal of items from the MBS.  
Pathology data from the MBS 
Pathology tests undertaken by pathologists that are charged to Medicare are recorded by 
Medicare Australia. However, these Medicare data are not comparable with BEACH data. 
• MBS pathology data reflect pathology orders made by GPs and other medical 
specialists. About 70% of the volume of MBS pathology claims are for pathology 
ordered by GPs.12 
• Each pathology company can respond differently to a specific test order label recorded 
by the GP. For example, the tests completed by a pathologist in response to a GP order 
for a full blood count may differ between companies. 
• The pathology companies can charge through the MBS only for the three most expensive 
items undertaken, even when more were actually done. This is called ‘coning’ and is 
part of the DoH pathology payment system. This means that the tests recorded in the 
MBS include only those charged for, not all those that were done. Coning applies only to 
GP pathology orders, not to those generated by medical specialists. 
• Pathology MBS items contain pathology tests that have been grouped on the basis of 
cost (for example, ‘any two of the following … tests’). Therefore an MBS item often does 
not give a clear picture of the precise tests performed. 
• This means that the MBS pathology data reflect those tests billed to the MBS after 
interpretation of the order by the pathologist, and after selection of the three most 
expensive MBS items.  
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 In BEACH, the pathology data: 
• include details of pathology tests ordered by the participating GPs; however, the GP is 
limited to the recording of five tests or battery of tests at each encounter, and as the 
number of tests/batteries ordered on any single occasion is increasing,13 an increasing 
number of additional tests ordered will be lost 
• reflect the terms used by GPs in their orders to pathologists, and for reporting purposes 
these have been grouped by the MBS pathology groups for comparability.  
The distributions of the two data sets will therefore differ, reflecting on the one hand the GP 
order and on the other the MBS-billed services from the pathologist. 
Pathology ordering by GPs is described in Chapter 12 of this report. Those interested in 
pathology test ordering by GPs should also view the following publications: 
• Evaluation of pathology ordering by general practitioners in Australia (Doctoral thesis).14 
• Are rates of pathology test ordering higher in general practices co-located with pathology 
collection centres?15 This publication investigated the independent effect of general 
practice co-location with pathology collection centres on GP pathology test ordering in 
Sydney and Melbourne metropolitan areas.  
• Evidence-practice gap in GP pathology test ordering: a comparison of BEACH pathology data 
and recommended testing.16 
Imaging data from the MBS 
Some of the issues discussed regarding pathology data also apply to imaging data. Although 
coning is not an issue for imaging, radiologists can decide whether the test ordered by the 
GP is the most suitable and whether to undertake other or additional tests of their choosing. 
The MBS data therefore reflect the tests that are actually undertaken by the radiologist, 
whereas the BEACH data reflect those ordered by the GP. Those interested in GP ordering 
of imaging tests should see Evaluation of imaging ordering by general practitioners in Australia.17 
The Australian Health Survey 
The 2011–13 Australian Health Survey, conducted by the Australian Bureau of Statistics 
(ABS), includes the National Health Survey, the National Nutrition and Physical Activity 
Survey and the National Health Measures Survey. The National Health Survey provides 
estimates of population prevalence of some diseases, and a measure of the problems taken to 
the GP by people in the two weeks before the survey. The National Health Measures Survey 
includes biomedical measures related to chronic disease and nutritional biomarkers.18  
• Prevalence estimates from the National Health Survey are based on self-reported 
morbidity from a representative sample of the Australian population, using a structured 
interview to elicit health-related information from participants. Prevalence estimates 
from the National Health Measures Survey are based on biomedical measures of 
diagnosed and undiagnosed disease.  
• Community surveys such as the National Health Survey have the advantage of 
accessing people who do not go to a GP as well as those who do. They can therefore 
provide an estimate of population prevalence of disease and a point estimate of 
incidence of disease. Prevalence estimates based on biomedical measures have the 
advantage of measuring diagnosed and undiagnosed disease. 
• Self-report has been demonstrated to be susceptible to misclassification because of a lack 
of clinical corroboration of diagnoses.19 
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 Management rates of health problems in general practice represent GP workload for a health 
problem. BEACH can be used to estimate the period incidence of diagnosed disease 
presenting in general practice through the number of new cases of that disease. The 
management rates of individual health problems and management actions can be 
extrapolated to national management rates.  
The general practice patient population sits between the more clinical hospital-based 
population and the general population, with about 85.2% of Australians visiting a GP at 
least once in 2013–14 (personal communication, DoH, August 2014). Disease management 
rates are a product of both the prevalence of the disease/health problem in the population, 
and the frequency with which patients visit GPs for the treatment of that problem. Those 
who are older and/or have more chronic disease, are therefore likely to visit more often, and 
have a greater chance of being sampled in the encounter data.  
Prevalence of selected diseases among patients seen in general practice can be investigated 
using the Supplementary Analysis of Nominated Data method (see Section 2.6). Those 
interested in disease prevalence should refer to the following papers: Estimating prevalence of 
common chronic morbidities in Australia,20 Prevalence and patterns of multimorbidity in Australia,21 
and Prevalence of chronic conditions in Australia.22 
1.4 Access to BEACH data 
Different bundles of BEACH data are available to the general public, to BEACH 
participating organisations, and to other organisations and researchers. 
Public domain 
This annual publication provides a comprehensive view of general practice activity in 
Australia. The BEACH program has generated many papers on a wide variety of topics in 
journals and professional magazines. All published material from BEACH is available at 
<sydney.edu.au/medicine/fmrc/publications>. 
Since April 1998, a section at the bottom of each encounter form has been used to investigate 
aspects of patient health or healthcare delivery not covered by general practice 
consultation-based information. These additional substudies are referred to as SAND 
(Supplementary Analysis of Nominated Data). The SAND methods are described in 
Section 2.6. Abstracts of results and the research tools used in all SAND substudies from 
April 1998 to March 2014 have been published. Those from: 
• April 1998 to March 1999 were published in Measures of health and health care delivery in 
general practice in Australia23 
• April 1999 to July 2006 were published in Patient-based substudies from BEACH: abstracts 
and research tools 1999–200624 
• August 2006 to March 2013 were published in each of the BEACH annual reports25-31 
• April 2013 to March 2014 are included in Chapter 14 of this report. 
Abstracts of results for all SAND substudies are also available on the Family Medicine 
Research Centre’s (FMRC) website <sydney.edu.au/medicine/fmrc/publications/sand-
abstracts> where you can search by topic. 
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 Participating organisations 
Organisations providing funding for the BEACH program receive summary reports of the 
encounter data quarterly, and standard reports or specifically designed analyses about their 
subjects of interest. Participating organisations also have direct access to straightforward 
analyses on any selected problem, medication, pathology or imaging test through an 
interactive web server. All data made available to participating organisations have been 
further ‘de-identified’. Patients’ are not identifiable even from the original encounter data 
forms, but are further stripped of date of birth (replaced with age in years and months) and 
postcode of residence (replaced with state and area type). GP characteristics data are 
provided only in the form of grouped output (for example, GPs aged less than 35 years) to 
any organisation. 
External purchasers of reports 
Non-contributing organisations may purchase standard reports or other ad hoc analyses. 
Charges are outlined at <sydney.edu.au/medicine/fmrc/beach/data-reports/for-
purchase>. The FMRC should be contacted for specific quotations. Contact details are 
provided at the front of this publication. 
Analysis of the BEACH data is a complex task. The FMRC has designed standard reports 
that cover most aspects of a subject under investigation. Examples of a problem-based 
standard report (subject: ischaemic heart disease in patients aged 45 years and over), a 
group report (subject: female patients aged 15–24 years) and a pharmacological-based 
standard report (subject: allopurinol) for a single year’s data are available at 
<sydney.edu.au/medicine/fmrc/beach/data-reports/for-purchase>. 
Customised data analyses can be done where the specific research question is not 
adequately answered through standard reports.  
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 2 Methods  
In summary: 
• each year, BEACH involves a new random sample of about 1,000 GPs 
• each GP records details of about 100 doctor–patient encounters of all types  
• the GP sample is a rolling (ever-changing) sample, with about 20 GPs participating in 
any one week, 50 weeks a year (with 2 weeks break over Christmas) 
• each GP can be selected only once per Quality Improvement & Continuing Professional 
Development (QI & CPD) Program triennium (that is, once in each 3-year period) 
• the encounter information is recorded by the GPs on structured paper encounter forms 
(Appendix 1) 
• GP participants also complete a questionnaire about themselves and their practice 
(Appendix 2). 
2.1 Sampling methods 
The source population includes all vocationally registered GPs and all general practice 
registrars who claimed a minimum of 375 Medicare general practice items of service in the 
most recently available 3-month Medicare data period (which equates to 1,500 such claims in 
a year). This ensures inclusion of the majority of part-time GPs, while excluding those who 
are not in private practice but claim for a few consultations a year. 
The Medicare statistics section of the DoH updates the sample frame from the Medicare 
records quarterly, using the Medicare claims data, then removes from the sample frame any 
GPs already randomly sampled in the current triennium, and draws a new sample from 
those remaining in the sample frame. This ensures the timely addition of new entries to the 
profession, and timely exclusion of those GPs who have stopped practising, or have already 
participated or been approached in the current triennium. 
2.2 Recruitment methods 
The randomly selected GPs are approached by letter, posted to the address provided by the 
Australian Government DoH. 
• Over the following 10 days, the telephone numbers generated from the Medicare data 
are checked using the electronic white and yellow pages. This is necessary because 
many of the telephone numbers provided from the Medicare data are incorrect. 
• The GPs are then telephoned in the order they were approached and, referring to the 
approach letter, asked whether they will participate. 
• This initial telephone contact with the practice often indicates that the selected GP has 
moved elsewhere, but is still in practice. Where a new address and/or telephone 
number can be obtained, these GPs are followed up at their new address. 
• GPs who agree to participate are set an agreed recording date several weeks ahead. 
• A research pack is sent to each participant before the planned start date. 
• Each GP receives a telephone reminder early in the agreed recording period – this also 
provides the GP with an opportunity to ask questions about the recording process. 
• GPs can use a ‘freecall’ (1800) number to ring the research team with any questions 
during their recording period. 
• Non-returns are followed up by regular telephone calls for 3 months. 
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 • Participating GPs earn clinical audit points towards their QI & CPD requirements 
through the Royal Australian College of General Practitioners (RACGP) and/or the 
Australian College of Rural and Remote Medicine (ACRRM). As part of this QI process, 
each receives an analysis of his or her results compared with those of nine other de-
identified GPs who recorded at about the same time. Comparisons with the national 
average and with targets relating to the National Health Priority Areas are also 
provided. In addition, GPs receive some educational material related to the 
identification and management of patients who smoke or consume alcohol at hazardous 
levels. Additional points can be earned if the participant chooses to do a follow-up audit 
of smoking and alcohol consumption among a sample of patients about 6 months later. 
2.3 Ethics approval and informed patient consent 
Ethics approval for this study in 2013–14 was obtained from the Human Ethics Committee 
of the University of Sydney.  
Although the data collected by the GPs is not sufficient to identify an individual patient, 
informed consent for GP recording of the encounter details is required from each patient. 
GPs are instructed to ensure that all patients presenting during their recording period are 
provided with a Patient Information Card (Appendix 3), and they ask the patient if they are 
happy for their data to be included in the study. If the patient refuses, details of the 
encounter are not recorded. This is in accordance with the Ethics requirements for the 
BEACH program. 
2.4 Data elements 
BEACH includes three interrelated data collections: GP characteristics, encounter data and 
patient health status. An example of the form used to collect the encounter data and the data 
on patient health status is included in Appendix 1. The GP characteristics questionnaire is 
provided in Appendix 2. The GP characteristics and encounter data collected are 
summarised below. Patient health status data are described in Section 2.6. 
GP profile form (Appendix 2) 
• GP characteristics: age and sex, years in general practice, number of direct patient care 
hours worked per week, intended changes in hours of direct patient care in 5 years, 
country of graduation, general practice registrar status, Fellow of the RACGP status, 
Fellow of the ACRRM status, use of computers at work, work undertaken in other 
clinical settings, number of practice locations worked in a regular week. 
• Practice characteristics: postcode of major practice; number of individual, and number 
of full-time equivalent GPs working in the practice; number of individual and number 
of full-time equivalent practice nurses working in the practice; usual after-hours care 
arrangements, other health services located at the major practice. 
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 Encounter recording form (Appendix 1) 
• Encounter data: date of consultation, type of consultation (direct/indirect) (tick box 
options), up to three MBS/DVA item numbers (where applicable), and other payment 
source (where applicable) (tick boxes). 
• Patient data: date of birth, sex and postcode of residence. Tick boxes (yes/no options) 
are provided for a Commonwealth concession cardholder, holder of a Repatriation 
health card (from DVA), non-English-speaking background (patient reported a language 
other than English is the primary language at home), Aboriginal person (self-
identification), and Torres Strait Islander person (self-identification). Space is provided 
for up to three patient reasons for encounter (RFEs) (see ‘Glossary’). 
• The problems managed at encounter (at least one and up to four). Tick boxes are 
provided to denote the status of each problem as new or continuing for the patient and 
whether the problem is considered by the GP to be work-related. 
• Management of each problem, including: 
– medications prescribed, supplied by the GP and advised for over-the-counter 
purchase including brand name, form (where required), strength, regimen, status 
(new or continuing medication for this problem), number of repeats 
– other treatments provided for each problem, including counselling, advice and 
education, and procedures undertaken, and whether the recorded other treatment 
was provided by practice nurse (tick box) 
– new referrals to medical specialists, allied health services, emergency departments, 
and hospital admissions 
– investigations, including pathology tests, imaging and other investigations ordered.  
2.5 The BEACH relational database 
The BEACH relational database is described diagrammatically in Figure 2.1. Note that:  
• all variables can be directly related to the encounter, the GP and the patient 
characteristics 
• all types of management are directly related to the problem being managed  
• RFEs have only an indirect relationship with problems managed, as a patient may 
describe one RFE (such as ‘repeat prescriptions’) that is related to multiple problems 
managed, or several RFEs (such as ‘runny nose’ and ‘cough’) that relate to a single 
problem (such as upper respiratory tract infection) managed (see Section 6.3). 
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The encounter 
• date 
• direct (face to face) 
— Medicare/DVA item 
number(s) claimable 
— workers compensation 
— other paid 
— no charge 
• indirect (e.g. telephone) 
Patient substudies (SAND) 
• risk factors 
— body mass 
— smoking status 
— alcohol consumption  
• other topics 
Management of each problem 
Medications (up to four per problem) 
• prescribed 
• over-the-counter advised 
• provided by GP 
— drug class 
— drug group 
— generic 
— brand name 
— strength 
— regimen 
— number of repeats  
— drug status (new/continued) 
 
Other treatments (up to two per 
problem) 
• procedural treatments 
• clinical treatments (e.g. advice, 
counselling) 
• practice nurse involvement 
 
Other management 
• referrals (up to two) 
— to specialists 
— to allied health professionals 
— to emergency departments 
— hospital admissions 
• pathology tests ordered (up to five) 
• imaging ordered (up to three) 
GP characteristics 
• age and sex 
• years in general practice 
• country of graduation 
• direct patient care hours/week 
• FRACGP status (yes/no) 
• FACRRM status (yes/no) 
• currently a registrar (yes/no) 
• clinical use of computers  
 
Practice characteristics 
• practice size (no. & FTE GPs) 
• practice nurse(s) (no. & FTE) 
• after-hours arrangements 
• postcode  
• presence of other health services 
Problems managed 
• diagnosis/problem label 
• problem status (new/old) 
• work-related problem status 
The patient 
• age and sex 
• practice status (new/old) 
• Commonwealth concession 
card status 
• Repatriation health card status 
• postcode of residence 
• NESB/Indigenous status 
• reasons for encounter 
Note: FRACGP – Fellow of the Royal Australian College of General 
Practitioners; FACRRM – Fellow of the Australian College of Rural 
and Remote Medicine; FTE – full-time equivalent; DVA – Department 
of Veterans’ Affairs; NESB – non-English-speaking background;  
SAND – Supplementary Analysis of Nominated Data. 
Figure 2.1: The BEACH relational database 
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 2.6 Supplementary Analysis of Nominated Data  
A section at the bottom of each recording form investigates aspects of patient health or 
health care delivery in general practice not covered by the consultation-based data. These 
additional substudies are referred to as SAND, Supplementary Analysis of Nominated Data. 
• Each year the 12-month data period is divided into 10 blocks, each of 5 weeks, with 
three substudies per block. The research team aims to include data from about 100 GPs 
in each block.  
• Each GP’s pack of 100 forms is made up of 40 forms that ask for the start and finish 
times of the encounter, and include questions about patient risk factors: patient height 
and weight (used to calculate body mass index, BMI), alcohol intake and smoking status 
(patient self-report). The methods and results of topics in the SAND substudies for 
alcohol consumption, smoking status and BMI are reported in Chapter 13. The start and 
finish times collected on these encounters are used to calculate the length of 
consultation. The length of consultation for Medicare-claimable encounters is reported 
in Section 5.3. 
• The remaining 60 forms in each pack are divided into two blocks of 30, so each SAND 
block includes about 3,000 records. Some topics are repeated to increase sample size. 
Different questions are asked of the patient in each block and these vary throughout 
the year. 
• The order of SAND sections is rotated in the GP recording pack, so that 40 patient risk 
factor forms may appear first, second or third in the pad. Rotation of ordering ensures 
there was no order effect on the quality of the information collected. 
Abstracts of results and the research tools used in all SAND substudies from April 1998 to 
March 2014 have been published. Those: 
• from April 1998 to March 1999 were published in Measures of health and health care 
delivery in general practice in Australia23 
• from April 1999 to July 2006 were published in Patient-based substudies from BEACH: 
abstracts and research tools 1999–200624 
• conducted between August 2006 and March 2013 have been published in each of the 
general practice activity annual reports25-31 
• conducted in the 2013–14 BEACH year are provided in Chapter 14 of this publication. 
Abstracts of results for all SAND substudies are also available on the FMRC’s website 
<sydney.edu.au/medicine/fmrc/publications/sand-abstracts>. 
2.7 Statistical methods 
The analysis of the 2013–14 BEACH data was conducted with Statistical Analysis System 
(SAS) version 9.3,32 and the encounter is the primary unit of inference. Proportions are used 
only when describing the distribution of an event that can arise only once at a consultation 
(for example, patient or GP age and sex), or to describe the distribution of events within a 
class of events (for example, problem A as a percentage of total problems). Due to rounding, 
proportions may not always add to exactly 100%. 
Rates per 100 encounters are used when an event can occur more than once at the 
consultation (for example, RFEs, problems managed or medications). 
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 Rates per 100 problems are also used when a management event can occur more than once 
per problem managed. In general, the results present the number of observations (n), the 
rate per 100 encounters, and (in the case of management actions) the rate per 100 problems 
managed, and the 95% confidence interval. 
BEACH is a single stage cluster sample study design, each 100 encounters forming a cluster 
around each GP participant. In cluster samples, variance needs to be adjusted to account for 
the correlation between observations within clusters. Procedures in SAS version 9.3 were 
used to calculate intracluster correlation, and adjust the confidence intervals accordingly.32  
Post-stratification weighting of encounter data adjusts for: any difference in the age–sex 
distribution of the participating GPs and those GPs in the sample frame from which the 
samples were drawn; and for the varying activity level of each GP (measured by number of 
claims each has made in the previous 12 months from Medicare Australia) (see Chapter 3). 
Statistical significance is tested by chi-square statistic for GP characteristics. However, where 
changes over time are investigated in the companion report significance of differences in 
rates is judged by non-overlapping confidence intervals (CIs) of the results being compared. 
The magnitude of this difference can be described as at least p < 0.05. Assessment using non-
overlapping confidence intervals is a conservative measure of significance,33-35 particularly 
when differences are assessed by comparing results from independent random samples, as 
is the case when changes over time are investigated using BEACH data. Due to the number 
of comparisons made, we believe this conservative approach is warranted. 
2.8 Classification of data 
The following data elements are classified according to the International Classification of 
Primary Care – Version 2 (ICPC-2), of the World Organization of Family Doctors (Wonca):8 
• patient reasons for encounter (RFEs) 
• problems managed 
• clinical treatments (for example, counselling, advice) 
• procedural treatments 
• referrals 
• investigations ordered (including pathology, imaging and other investigations). 
The ICPC-2 is used in more than 45 countries as the standard for data classification in 
primary care. It is accepted by the WHO in the WHO Family of International 
Classifications,36 and is the declared national standard in Australia for reporting of health 
data from general practice and patient self-reported health information.37  
The ICPC-2 has a biaxial structure, with 17 chapters on one axis (each with an alphabetic 
code) and seven components on the other (numeric codes) (Figure 2.2). Chapters are based 
on body systems, with additional chapters for psychological and social problems. 
Component 1 includes symptoms and complaints. Component 7 covers diagnoses – it can 
also be expanded to provide data about infections, injuries, neoplasms, congenital anomalies 
and ‘other’ diagnoses.  
Component 2 (diagnostic, screening and prevention) is often applied in describing the 
problem managed (for example, check-up, immunisation). Components 3 to 6 cover other 
processes of care, including referrals, other (non-pharmacological) treatments and orders for 
pathology and imaging. The components are standard and independent throughout all 
chapters. The updated component groupings of ICPC-2 codes, released by the Wonca 
International Classification Committee in 200438 have been used in this report. 
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 The ICPC-2 is an excellent epidemiological tool. The diagnostic and symptom rubrics have 
been selected for inclusion on the basis of their relative frequency in primary care settings, 
or because of their relative importance in describing the health of the community. ICPC has 
about 1,370 rubrics and these are sufficient for meaningful analyses. However, reliability of 
data entry, using ICPC-2 alone, requires a thorough knowledge of the classification for 
correct classification of a concept to be ensured. 
In 1995, recognising a need for a coding and classification system for general practice 
electronic health records, the FMRC (then the Family Medicine Research Unit, FMRU) 
developed an extended clinical terminology classified according to the ICPC, now called 
ICPC-2 PLUS.39 This is an interface terminology, developed from all the terms used by GPs 
in studies such as The Australian Morbidity and Treatment Survey 1990–91 (113,468 
encounters),40 A comparison of country and metropolitan general practice 1990–91 
(51,277 encounters),41 The Morbidity and Therapeutic Index 1992–1998 (a clinical audit tool that 
was available to GPs) (approximately 400,000 encounters), and BEACH 1998–2014 (about 
1.5 million encounters). Together, these make up about 2 million encounter records, 
involving about 3 million free text descriptions of problems managed and a further 3 million 
for patient reasons for encounter. These terms are classified according to ICPC-2 to ensure 
data can be compared internationally. Readers interested in seeing how coding works can 
download the ICPC-2 PLUS Demonstrator at <sydney.edu.au/medicine/fmrc/icpc-2-
plus/demonstrator>. 
When the free-text data are received from the GPs, trained secondary coders (who are 
undergraduate students), code the data in specific terms using ICPC-2 PLUS. This ensures 
high coder reliability and automatic classification of the concept, and allows us to ‘ungroup’ 
such ICPC-2 rubrics as ‘other diseases of the circulatory system’ and select a specific disease 
from the terms within it. 
 
                    
 Components A B D F H K L N P R S T U W X Y Z  
 1. Symptoms, complaints                    
 2. Diagnostic, screening, prevention                   
 3. Treatment, procedures, medication                   
 4. Test results                   
 5. Administrative                   
 6. Other                   
 7. Diagnoses, disease                   
 A General and unspecified L Musculoskeletal U Urinary 
 B Blood & blood-forming organs N Neurological W Pregnancy, family planning 
 D Digestive P Psychological X Female genital  
 F Eye R Respiratory Y Male genital  
 H Ear S Skin Z Social  
 K Circulatory T Endocrine, nutritional & metabolic   
 
Figure 2.2: The structure of the International Classification of Primary Care – Version 2 (ICPC-2) 
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 Presentation of data classified in ICPC-2 
Statistical reporting is usually at the level of the ICPC-2 classification (for example, acute 
otitis media/myringitis is ICPC-2 code H71). However, there are some exceptions where 
data are grouped either above the ICPC-2 level or across the ICPC-2 level. These grouped 
morbidity, pathology and imaging codes are defined in Appendix 4 available at: 
<hdl.handle.net/2123/11882>. 
Reporting morbidity with groups of ICPC-2 codes 
When recording problems managed, GPs may not always be very specific. For example, in 
recording the management of hypertension, they may simply record the problem as 
‘hypertension’. In ICPC-2, ‘hypertension, unspecified’ is classified as ‘uncomplicated 
hypertension’ (code K86). There is another code for ‘complicated hypertension’ (K87). In 
some cases the GP may simply have failed to specify that the patient had hypertension with 
complications. The research team therefore feels that for national data reporting, it is more 
reliable to group the codes K86 and K87 and label this ‘Hypertension*’ – the asterisk 
indicating that multiple ICPC-2 codes (as in this example), or ICPC-2 PLUS codes (see 
below), are included. Appendix 4, Table A4.1 lists the codes included in these groups.  
Reporting morbidity with groups of ICPC-2 PLUS codes 
In other cases, a concept can be classified within (but be only part of) multiple ICPC-2 codes. 
For example, osteoarthritis is classified in ICPC-2 in multiple broader codes according to 
site, such as L92 – shoulder syndrome (includes bursitis, frozen shoulder, osteoarthritis of 
shoulder, rotator cuff syndrome). When reporting osteoarthritis in this publication, all the 
more specific osteoarthritis ICPC-2 PLUS terms classified within all the appropriate ICPC-2 
codes are grouped. This group is labelled ‘Osteoarthritis*’ – the asterisk again indicating 
multiple codes, but in this case they are PLUS codes rather than ICPC-2 codes. Appendix 4, 
Table A4.1 lists the codes included in these groups. 
Reporting chronic morbidity 
Chronic conditions are medical conditions characterised by a combination of the following 
characteristics: duration that has lasted or is expected to last 6 months or more, a pattern of 
recurrence or deterioration, a poor prognosis, and consequences or sequelae that affect an 
individual’s quality of life.  
To identify chronic conditions, a chronic condition list42 classified according to ICPC-2 was 
applied to the BEACH data set. Chronic and non-chronic conditions (for example, diabetes 
and gestational diabetes) are often grouped together when reporting (for example, 
diabetes – all*). When reporting chronic morbidity, only problems regarded as chronic have 
been included in the analysis. Where the group used for the chronic analysis differs from 
that used in other analyses in this report, they are marked with a double asterisk. Codes 
included in the chronic groups are provided in Appendix 4, Table A4.2. 
Reporting pathology and imaging test orders 
All the pathology and imaging tests are coded very specifically in ICPC-2 PLUS, but ICPC-2 
classifies pathology and imaging tests very broadly (for example, a test of cardiac enzymes is 
classified in K34 – Blood test associated with the circulatory system; a CT scan of the lumbar 
spine is classified as L41 – Diagnostic radiology/imaging of the musculoskeletal system). In 
Australia, the MBS classifies pathology and imaging tests in groups that are relatively well 
recognised. The team therefore regrouped all pathology and imaging ICPC-2 PLUS codes 
into MBS standard groups. This allows comparison of data between data sources.  
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 The groups are marked with an asterisk, and inclusions are provided in Appendix 4, Tables 
A4.8 and A4.9. 
Classification of pharmaceuticals 
Pharmaceuticals that are prescribed, provided by the GP or advised for over-the-counter 
purchase are coded and classified according to an in-house classification, the Coding Atlas 
for Pharmaceutical Substances (CAPS). 
This is a hierarchical structure that facilitates analysis of data at a variety of levels, such as 
medication class, medication group, generic name/composition, and brand name. 
The generic name of a medication is its non-proprietary name, which describes the 
pharmaceutical substance(s) or active pharmaceutical ingredient(s). 
When strength and regimen are combined with the CAPS code, we can derive the prescribed 
daily dose for any prescribed medication or group of medications. 
CAPS is mapped to the Anatomical Therapeutic Chemical (ATC)43 classification, which is 
the Australian standard for classifying medications at the generic level.37 The ATC has a 
hierarchical structure with five levels. For example: 
• Level 1: C – Cardiovascular system 
• Level 2: C10 – Serum lipid reducing agents 
• Level 3: C10A – Cholesterol and triglyceride reducers 
• Level 4: C10AA – HMG CoA reductase inhibitors 
• Level 5: C10AA01 – Simvastatin (the generic drug). 
Use of the pharmaceutical classifications in reporting 
For pharmaceutical data, there is the choice of reporting in terms of the CAPS coding 
scheme or the ATC. They each have advantages in different circumstances. 
In the CAPS system, a new drug enters at the product and generic level, and is immediately 
allocated a generic code. Therefore, the CAPS classification uses a bottom-up approach. 
In the ATC, a new generic may initially enter the classification at any level (1 to 5), not 
always at the generic level. Reclassification to lower ATC levels may occur later. Therefore, 
the ATC uses a top-down approach. 
When analysing medications across time, a generic medication that is initially classified to a 
higher ATC level will not be identifiable in that data period and may result in 
under-enumeration of that drug during earlier data collection periods. 
There are some differences in the labels applied to generic medications in the two 
classifications. For example, the medication combination of paracetamol and codeine is 
labelled as ‘Paracetamol/codeine’ in CAPS and as ‘Codeine combinations excluding 
psycholeptics’ in the ATC. 
• When reporting annual results for pharmaceutical data, the CAPS database is used in 
tables of the ‘most frequent medications’ (Tables 9.2 to 9.4). 
• When reporting the annual results for pharmaceuticals in terms of the ATC hierarchy 
(Table 9.1), ATC levels 1, 3, and 5 are used. The reader should be aware that the results 
reported at the generic level (Level 5) may differ slightly from those reported in the 
‘most frequent medication’ tables for the reasons described above.  
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 Practice nurse and Aboriginal health worker activities associated with the 
encounter 
The BEACH form was changed in 2005–06 to capture ‘other treatments’ performed by 
practice nurses (PNs) following the introduction of MBS item numbers for defined PN 
activities. GPs were asked to tick the ‘practice nurse’ box if a treatment was provided by the 
PN. If not ticked, it was assumed that the GP provided the ‘other treatment’. 
Over the years, new PN item numbers were added to the MBS and some items were 
broadened to include work done by Aboriginal health workers (AHWs). From 2005–06 to 
2010–11 we reported the results referring to PNs alone. As some GPs indicated (of their own 
accord) that the recorded action was done by an AHW rather than a PN, this information is 
now included. In this report we refer to work undertaken at encounters by PNs and AHWs 
in conjunction with the GPs, though the vast majority will have been done by PNs. There is a 
limitation to this approach. Few GPs specifically indicated that the work was done by an 
AHW. Others may have considered the question referred specifically to PNs, and therefore 
did not record work done by AHWs. These results therefore have the potential to be an 
underestimate of the work undertaken at GP–patient encounters by AHWs. 
2.9 Quality assurance 
All morbidity and therapeutic data elements were secondarily coded by staff entering key 
words or word fragments, and selecting the required term or label from a pick list. This was 
then automatically coded and classified by the computer. To ensure reliability of data entry 
we use computer-aided error checks (‘locks’) at the data entry stage, and a physical check of 
samples of data entered versus those on the original recording form. Further logical data 
checks are conducted through SAS regularly. 
2.10 Validity and reliability 
A discussion of the reliability and validity of the BEACH program has been published 
elsewhere.44 This section touches on some aspects of reliability and validity of active data 
collection from general practice that should be considered by the reader.  
In the development of a database such as BEACH, data gathering moves through specific 
stages: GP sample selection, cluster sampling around each GP, GP data recording, secondary 
coding and data entry. At each stage the data can be invalidated by the application of 
inappropriate methods. The methods adopted to ensure maximum reliability of coding and 
data entry have been described above. The statistical techniques adopted to ensure valid 
analysis and reporting of recorded data are described in Section 2.7. Previous work has 
demonstrated the extent to which a random sample of GPs recording information about a 
cluster of patients represents all GPs and all patients attending GPs,45 the degree to which GP-
reported patient RFEs and problems managed accurately reflect those recalled by the patient,46 
and reliability of secondary coding of RFEs47 and problems managed.40 The validity of ICPC as 
a tool with which to classify the data has also been investigated in earlier work.48 
However, the question of the extent to which the GP-recorded data are a reliable and valid 
reflection of the content of the encounter must also be considered. In many primary care 
consultations, a clear pathophysiological diagnosis is not reached. Bentsen49 and Barsky50 
suggest that a firm and clear diagnosis is not apparent in about half of GPs’ consultations, 
and others suggest the proportion may be even greater.51 
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  Further, studies of general ambulatory medical practice have shown that a large number of 
patients presenting to a primary care practitioner are without a serious physical disorder.52,53 
As a result, it is often necessary for a practitioner to record a problem in terms of symptoms, 
signs, patient concerns, or the service that is requested, such as immunisation. For this 
reason, this report refers to patient ‘problems’ rather than ‘diagnoses’. 
A number of studies have demonstrated wide variance in the way a GP perceives the patient’s 
RFE and the manner in which the GP describes the problem under management. Further, in a 
direct observational study of consultations via a one-way mirror, Bentsen demonstrated that 
practitioners differ in the way they labelled problems, and suggested that clinical experience 
may be an important influence on the identification of problems within the consultation.49 Two 
other factors that might affect GPs’ descriptions of patient RFEs have been identified: 
although individuals may select the same stimuli, some label each stimulus separately, 
whereas others cluster them under one label; and individuals differ in the number of stimuli 
they select (selective perception).54 
The extent to which therapeutic decisions may influence the diagnostic label selected has also 
been discussed. Howie55 and Anderson52 argue that, while it is assumed that the diagnostic 
process used in general practice is one of symptom  diagnosis  management, the 
therapeutic method may well be selected on the basis of the symptom, and the diagnostic label 
chosen last. They suggest that the selection of the diagnostic label is therefore influenced by the 
management decision already made. 
Alderson contends that to many practitioners ‘diagnostic accuracy is only important to the 
extent that it will assist them in helping the patient’. He further suggests that if major 
symptoms are readily treatable, some practitioners may feel no need to define the problem in 
diagnostic terms.56 Crombie identified ‘enormous variability in the rates at which doctors 
perceive and record illnesses’. He was unable to account statistically for this variation by the 
effect of geography, age, sex or class differences in the practice populations.57 Differences in the 
way male and female GPs label problems also appear to be independent of such influences.58 
These problems are inherent in the nature of general practice. Knottnerus argues that the GP 
is confronted with a fundamentally different pattern of problems from the medical 
specialist, and often has to draw up general diagnostic hypotheses related to probability, 
severity and consequences.59 Anderson suggests that morbidity statistics from family practice 
should be seen as ‘a reflection of the physician’s diagnostic opinions about the problems that 
patients bring to them rather than an unarguable statement of the problems managed’.52  
While these findings regarding limitations in the reliability and validity of 
practitioner-recorded morbidity should be kept in mind, they apply equally to data drawn 
from health records, whether paper or electronic, as they do to active data collection 
methods.60,61 There is as yet no more reliable method of gaining detailed data about 
morbidity and its management in general practice. Further, irrespective of the differences 
between individual GPs in labelling problems, morbidity data collected by GPs in active 
data collection methods have been shown to provide a reliable overview of the morbidity 
managed in general practice.62 
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 2.11 Extrapolated national estimates 
A section at the end of each chapter highlights changes that have occurred over the decade 
2004–05 to 2013–14. These sections summarise results published in the companion 
publication, A decade of Australian general practice activity 2004–05 to 2013–14.1 Where the 
results demonstrate a significant change over time, the estimated national change across 
total GP Medicare services from 2004–05 to 2013–14 can be calculated using the method 
detailed below. 
 Note that extrapolations are always based on rate per 100 encounters rather than rate per 
100 problems because there is no independent measure of the total number of problems 
managed in Australian general practice. In contrast, the number of national encounters can 
be drawn from Medicare claims data. 
In this report, we also occasionally extrapolate data for the single year 2013–14 to give the 
reader some feeling of the real size of the issue across Australian general practice. 
When extrapolating from a single time point we: 
• divide the ‘rate per 100 encounters’ of the selected event by 100, and then multiply by 
the total number of GP service items claimed through Medicare in that year, 
133.4 million in 2013–14 (rounded to the nearest 100,000, see Table 2.1), to give the 
estimated number of the selected event across Australia in 2013–14.  
When extrapolating measured change over the decade to national estimates, we: 
• divide the ‘rate per 100 encounters’ of the selected event for 2004–05 by 100, and then 
multiply by the total number of GP service items claimed through Medicare in that year, 
98.2 million (rounded to the nearest 100,000, see Table 2.1), to give the estimated 
national number of events in 2004–05.  
• repeat the process using data for 2013–14.  
The difference between the two estimates gives the estimated national change in the 
frequency of that event over the decade. Estimates are rounded to the nearest 100,000 if 
more than a million, and to the nearest 10,000 if below a million. 
Change is expressed as the estimated increase or decrease over the study period (from 
2004–05 to 2013–14), in the number of general practice contacts for that event (for example, 
an increase or decrease in the number of GP management contacts with problem X); or an 
increase or decrease in the number of times a particular medication type was prescribed in 
Australia in 2013–14, when compared with 2004–05. 
Table 2.1 provides the rounded number of GP service items claimed from Medicare in each 
financial year from 2004–05 to 2013–14.  
Table 2.1: Rounded number of general practice professional services claimed from Medicare 
Australia each financial year, 2004–05 to 2013–14 (million) 
 2004–05 2005–06 2006–07 2007–08 2008–09 2009–10 2010–11 2011–12 2012–13 2013–14(a) 
Rounded number of 
Medicare GP items 
of service claimed 
98.2 101.1 103.4 109.5 113.0 116.6 119.2 123.9 126.8 133.4 
(a) Medicare data for the 2013–14 year included data from the April 2013 to March 2014 quarters because the 2013–14 financial year data 
were not available at the time of preparation of this report. 
Source: Medicare Statistics.6  
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 Examples of extrapolation: 
Example 1: Number of GP encounters at which depression was managed nationally in 
2013–14 
Depression was managed at a rate of 4.3 per 100 GP encounters (95% CI: 4.1–4.5) in  
2013–14 (shown in Table 7.4). How many times does this suggest that depression was 
managed in GP encounters across Australia in 2013–14?  
Our best estimate is: 5.7 million times [(4.3/100) x 133.4 million], but we are 95% confident 
that the true number lies between 5.5 million [(4.1/100) x 133.4 million] and 6.0 million 
[(4.5/100) x 133.4 million]. 
Using the management rate per 100 encounters as the basis for this extrapolation works very 
well when estimating total national GP encounters at which a single concept 
(symptom/complaint, or diagnosis/disease) is managed. However, if you wish to estimate 
how many GP–patient encounters involve management of any psychological problem, you 
need to use a different approach (see point 2 below). 
Example 2: Number of GP encounters which involve management of psychological 
problems 
The concept ’psychological problems’ includes many different individual concepts (e.g. 
depression; dementia; anorexia nervosa etc). In BEACH, GPs record at least one and up to 
four problems managed, per encounter. It is therefore possible that at a single encounter a 
GP can manage more than one of the many problems classified as ‘psychological problems’ 
in the International Classification of Primary Care.  
If you use the management rate per 100 encounters to estimate the national number of 
encounters at which one or more psychological problems was managed in 2013–14, you will 
overestimate the true number of encounters, because more than one of these problems can 
be managed at a single encounter.  
This year we have provided new analyses to allow you to make such extrapolations more 
accurately. In Table 6.4 (Patient reasons for encounter by ICPC-2 chapter and most frequent 
individual reasons for encounter within chapter) and Table 7.3 (Problems managed by ICPC-2 
chapter and frequent individual problems within chapter), we have added a new column on the 
right side, which gives you the proportion of all BEACH encounters, at which at least one 
problem of each chapter type, was managed.  
In the examples provided, we use this column to answer the question: At how many 
encounters across Australia, did GPs manage one or more psychological problems in  
2013–14? 
Using the far right column of Table 7.3: our best estimate is: 17.1 million times (12.8% of 
133.4 million), but we are 95% confident that the true number lies between 16.4 million 
(12.3% of 133.4 million) and 17.9 million (13.4% of 133.4 million). 
Example 3: National increase in the number of problems managed from 2004–05 to 
2013–14 
There was a statistically significant increase in the number of problems managed at 
encounter, from 145.5 per 100 encounters in 2004–05 to 158.2 in 2013–14 (see Table 7.2 in 
A decade of Australian general practice activity 2004–05 to 2013–14).1 The calculation used to 
extrapolate the effect of this change across Australia is:  
 (145.5/100) x 98.2 million = 142.9 million problems managed nationally in 2004–05, and 
(158.2/100) x 133.4 million = 211.0 million problems managed nationally in 2013–14.  
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 This suggests there were 68 million (211.0 million minus 142.9 million) more problems 
managed at GP–patient encounters in Australia in 2013–14 than in 2004–05. This is the result 
of the compound effect of the increase in the number of problems managed by GPs at 
encounters plus the increased number of visits over the decade across Australia. 
Considerations and limitations in extrapolations 
The extrapolations to the total events occurring nationally in any one year are only 
estimates. They may provide: 
• an underestimate of the true ‘GP workload’ of a condition/treatment because the 
extrapolations are made to GP Medicare items claimed, not to the total number of GP 
encounters per year – an additional 5% or so of BEACH encounters annually include 
encounters paid by sources other than Medicare, such as DVA, state governments, 
workers compensation insurance, and employers, or not charged to anyone. 
• an underestimate of activities of relatively low frequency with a skewed distribution 
across individual GPs. Where activity is so skewed across the practising population, a 
national random sample will provide an underestimate of activity because the sample 
reflects the population rather than the minority. 
Further, the base numbers used in the extrapolations are rounded to the nearest 100,000, and 
extrapolation estimates are rounded to the nearest 100,000 if more than a million, and to the 
nearest 10,000 if below a million, so can only be regarded as approximations. However, the 
rounding has been applied to all years, so the effect on measures of change will be very 
small. Therefore, the extrapolation still provides an indication of the size of the effect of 
measured change nationally.  
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 3 The sample 
This chapter describes the GP sample and sampling methods used in the BEACH program. 
The methods are only summarised in this chapter. A more detailed explanation of the 
BEACH methods are described in Chapter 2. 
A summary of the BEACH data sets is reported for each year from 2004–05 to 2013–14 in the 
companion report, A decade of Australian general practice activity 2004–05 to 2013–14.1  
3.1 Response rate 
A random sample of GPs who claimed at least 375 general practice Medicare items of service 
in the previous 3 months, is regularly drawn from Medicare claims data by the Australian 
Government Department of Health (DoH) (see Chapter 2). 
Contact was attempted with 4,894 GPs, but 24.4% could not be contacted. Nearly one-third 
of these had moved (and were untraceable), or had retired or died (Table 3.1), but more than 
half (58.6%) were those with whom contact could not be established after five calls. Younger 
GPs were harder to contact. In previous years these have largely been registrars moving 
through practices during training, who were no longer at the nominated practice and could 
not be traced. This year we were not able to measure the proportion of ‘no contact’ GPs who 
were registrars as, owing to changes in the privacy requirements for data provided by the 
DoH, information relating to any GPs who do not participate in BEACH must be destroyed 
quarterly, so is not available for comparison. 
The fact that one in four GPs were not contactable may be a reflection of the uptake of 
electronic communication between GPs and DoH. Updating practice location may be 
overlooked, and may result in the contact details being out-of-date at the time the samples 
are provided. 
The final participating sample consisted of 959 practitioners, representing 25.9% of those 
who were contacted and available, and 19.6% of those with whom contact was attempted 
(Table 3.1). 
Table 3.1: Recruitment and participation rates 
Type of contact Number 
Per cent of  
approached  
(n = 4,894) 
Per cent of contacts 
established  
(n = 3,702) 
Letter sent and phone contact attempted 4,894 100.0 — 
No contact  1,192 24.4 — 
 No phone number 18 0.4 — 
 Moved/retired/deceased 376 7.7 — 
 Unavailable (overseas, maternity leave, etc) 99 2.0 — 
 No contact after five calls 699 14.3 — 
Telephone contact established 3,702 75.6 100.0 
 Declined to participate 2,453 50.0 66.3 
 Agreed but withdrew 290 5.9 7.8 
 Agreed and completed 959 19.6 25.9 
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 3.2 Representativeness of the GP sample 
Whenever possible, the study group of GPs should be compared with the population from 
which the GPs were drawn (the sample frame) to identify and, if necessary, adjust for any 
sample bias that may affect the findings of the study. Comparisons between characteristics 
of the final GP sample and those of the GPs in the sample frame are provided below. The 
method by which weightings are generated as a result of these comparisons and applied to 
the data are described in Section 3.3.  
Statistical comparisons, using the chi-square statistic (χ2) (significant at the 5% level), were 
made between BEACH participants, and all recognised GPs in the sample frame during the 
study period (Table 3.2). The GP characteristics data for BEACH participants were drawn 
from their GP profile questionnaire. DoH provided the grouped data for all GPs in the 
sample frame, drawn from Medicare claims data. 
Table 3.2 demonstrates that there were no significant differences in GP characteristics 
between the final sample of BEACH participants and all GPs in the sample frame, in terms 
of sex and practice location as classified by the Australian Standard Geographical 
Classification (ASGC). In the final BEACH GP sample, there was a slight under-
representation of GPs in the <35 year and 35–44 year age groups, and a slight over-
representation in the  
55+ years age group, compared with the Australian sample frame. The final BEACH GP 
sample was also over-represented in the proportion of GPs who had graduated from their 
primary medical degree in Australia (place of graduation), and there were some slight 
variations in state representation.  
This result differs from year to year (the previous report showed no significant differences in 
terms of sex, place of graduation, state or practice location by ASGC, but a slight variation in 
some categories of GP age31).The effect of random sampling may influence this measure as, 
occasionally, the randomly selected recruitment sample can differ slightly from the sample 
frame in one or more variables, which can affect the ultimate representativeness of the final 
participant group.  
The changes to privacy requirements regarding data provided by the DoH mean that we are 
no longer able to examine this possibility on an annual basis. 
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 Table 3.2: Comparison of BEACH participants and all active recognised GPs in Australia (the 
sample frame) 
Variable 
BEACH(a)(b)  Australia(a)(c) 
Number 
Per cent of GPs 
(n = 959)  Number 
Per cent of GPs 
(n = 22,598)  
Sex (χ2 = 1.6, p = 0.21)      
 Males 547 57.0  13,353  59.1 
 Females 412 43.0   9,245  40.9 
Age (χ2 = 12.8, p = 0.005)      
 < 35 years 59 6.2   1,873  8.3 
 35–44 years 171 17.9   4,653  20.6 
 45–54 years 271 28.4   6,406  28.3 
 55+ years 453 47.5   9,666  42.8 
 Missing 5   —  
Place of graduation (χ2 = 28.1, p < 0.001)      
 Australia 678 71.0  14,132  62.5 
 Overseas 277 29.0   8,466  37.5 
 Missing 4   —  
State (χ2 = 16.5, p = 0.02)      
 New South Wales 339 35.6   7,384  32.7 
 Victoria 233 24.4   5,587  24.7 
 Queensland 197 20.7   4,557  20.2 
 South Australia 61 6.4   1,825  8.1 
 Western Australia 70 7.3   2,108  9.3 
 Tasmania 31 3.3  601  2.7 
 Australian Capital Territory 20 2.1  355  0.8 
 Northern Territory 2 0.2  181  1.6 
 Missing 6   —  
ASGC (χ2 = 8.1, p = 0.15)      
 Major Cities of Australia 657 68.9   15,970  70.7 
 Inner Regional Australia 205 21.5   4,301  19.0 
 Outer Regional Australia 80 8.4   1,869  8.3 
 Remote Australia 9 0.9  275  1.2 
 Very Remote Australia 2 0.2  180  0.8 
 Missing 6   3  
(a) Missing data removed. 
(b) Data drawn from the BEACH GP profile completed by each participating GP. 
(c) All GPs who claimed at least 375 MBS GP consultation services during the most recent 3-month Medicare Australia data period. 
Data provided by the Australian Government Department of Health. 
Note: ASGC – Australian Standard Geographical Classification.63 
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 GP activity in the previous year 
Data on the number of MBS general practice service items claimed in the previous year were 
also provided by DoH for each GP in the drawn samples, and for all GPs (as a group) in the 
sample frame. These data were used to determine the ‘activity level’ of each GP, and to 
compare the activity level of the final participants with that of GPs in the sample frame.  
When comparing GP activity level in the previous 12 months, the proportion of GPs in the 
final participant sample who had claimed fewer than 1,500 services in the previous year, 
was half that of GPs in the sample frame, and a larger proportion had claimed 1,501–3,000 
services. There was a larger proportion of BEACH participants who claimed 3,001–6,000 and 
a smaller proportion with >6,000 claims. However, comparison of the mean number of 
claims made by the participating GPs and those in the GP sample frame showed a difference 
of only 290.8 services per year, or 5.6 consultations per week (on a 52-week year, or 6 per 
week on a 48-week year, assuming 4 weeks leave) (Table 3.3).  
This result differs from year to year (the previous report showed no significant difference in 
mean activity level between the final BEACH sample and the Australian sample frame31). 
The effect of random sampling may also influence this measure as, occasionally, the 
randomly selected recruitment sample can differ slightly from the sample frame in one or 
more variables, which can affect the ultimate representativeness of the final participant 
group.  
The changes to privacy requirements regarding data provided by the DoH mean that we are 
no longer able to examine this possibility. 
Table 3.3: Activity level in the previous 12 months of participating GPs and GPs in the sample 
frame (measured by the number of GP service items claimed) 
Variable 
Participants(a)  
(n = 959)  
Australia(b) 
(n = 21,649) 
Number of 
GPs Per cent  
Number of 
GPs Per cent 
Activity (χ2 = 58.8389, p < 0.0001)      
 1–1,500 services in previous year 39 4.1  1,883 8.7 
 1,501–3,000 services in previous year 235 24.5  4,145 19.1 
 3,001–6,000 services in previous year 440 45.9  8,606 39.8 
 > 6,000 services in previous year 245 25.6  7,015 32.4 
 Number of claims 95% CI  
Number of 
claims  
Mean activity level  4,841.5 4,663.4–5,019.6  5,132.3 — 
Standard deviation 2,810.3 —  — — 
Median activity level 4,219.0 —  — — 
(a) Missing data removed 
(b) Number of GPs for whom these data were provided 
Note: The ‘n’ for Australia reported above differs from that of Table 3.2 because activity level is only provided for GPs who were in the sample 
frame for the entire year. GPs coming into the sample frame part-way through the year do not have an ‘activity level’ for the previous year; 
CI – confidence interval. 
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 3.3 Weighting the data 
Age–sex weights  
As described in Section 3.2, comparisons are made annually to test how representative 
BEACH participants are of the GPs in the original Australian sample frame. Occasionally, 
where participants in a particular age or sex group are over-represented or under-
represented, GP age–sex weights need to be applied to the data sets in post-stratification 
weighting to achieve comparable estimates and precision. Because there are always 
marginal (even if not statistically significant) differences, even in years where the BEACH 
participants are representative in all age and sex categories, post-stratification weighting is 
applied for consistency over recording years. 
Activity weights  
In BEACH, each GP provides details of 100 encounters. There is considerable variation 
among GPs in the number of services each provides in a given year. Encounters were 
therefore assigned an additional weight directly proportional to the activity level of the 
recording GP. Please note – GP activity level was measured as the number of MBS general 
practice service items claimed by the GP in the previous 12 months (data supplied by DoH). 
Because the measure is based on annual activity, estimates could only be provided for GPs 
who had claimed service items during the whole year. Those entering the sample frame part 
way through the year (e.g. new graduates, migrants) will have met the eligibility criteria for 
inclusion in the BEACH sample (i.e. claiming a minimum of 375 MBS GP consultation 
services during the most recent 3-month Medicare Australia data period) but would not 
have an annual activity level.  
Total weights  
The final weighted estimates were calculated by multiplying raw rates by the GP age–sex 
weight and the GP sampling fraction of services in the previous 12 months. Table 3.4 shows 
the precision ratio calculated before and after weighting the encounter data. 
3.4 Representativeness of the encounter sample 
BEACH aims to gain a representative sample of GP–patient encounters. To assess the 
representativeness of the final weighted sample of encounters, the age–sex distribution of 
patients at weighted BEACH encounters with GP consultation service items claimed 
(excluding those with Department of Veterans’ Affairs [DVA] patients) was compared with 
that of patients at all encounters claimed as GP consultation service items through Medicare 
in the 2013–14 study period (data provided by DoH).  
As shown in Table 3.4, there is an excellent fit of the age–sex distribution of patients at the 
weighted BEACH encounters with that of the MBS claims distribution, with most precision 
ratios within the 0.91–1.09 range. This indicates that the BEACH sample is a good 
representation of Australian GP–patient encounters, as no age–sex category varied by more 
than 13% from the population distribution, and only a few by 13%. 
The age–sex distribution of patients at BEACH encounters and for MBS GP consultation 
service item claims, is shown graphically for all patients in Figure 3.1, for males in 
Figure 3.2, and for females in Figure 3.3. 
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 Table 3.4: Age–sex distribution of patients at BEACH and MBS GP consultation service items 
 
BEACH–raw(a)  BEACH–weighted(b)  Australia(c)  
Precision ratios 
(Australia = 1.00) 
Sex/age 
Number 
Per cent  
(n = 80,190)  Number 
Per cent 
(n = 80,238)  
Per cent 
(n = 112,096,991)  Raw(a) Weighted(c) 
All           
 < 1 year  1,604  2.0   1,560 1.9   1.9  1.04 1.01 
 1–4 years  3,603  4.5   3,601 4.5   5.0  0.91 0.91 
 5–14 years  4,198  5.2   4,362 5.4   6.1  0.86 0.89 
 15–24 years  6,063  7.6   6,276  7.8   8.5  0.89 0.92 
 25–44 years  16,991  21.2  17,166  21.4   22.8  0.93 0.94 
 45–64 years  21,941  27.4  21,711  27.1   26.8  1.02 1.01 
 65–74 years  12,272  15.3  12,279  15.3   13.6  1.13 1.13 
 75+ years  13,518  16.9  13,282  16.6   15.4  1.10 1.08 
Male           
 < 1 year 859 1.1  840   1.0   1.0  1.04 1.02 
 1–4 years  1,941  2.4   1,941   2.4   2.6  0.92 0.92 
 5–14 years  2,139  2.7   2,266   2.8   3.1  0.85 0.90 
 15–24 years  2,025  2.5   2,278   2.8   3.1  0.82 0.92 
 25–44 years  5,664  7.1   6,306   7.9   8.6  0.82 0.92 
 45–64 years  8,597  10.7   9,407  11.7   11.6  0.93 1.01 
 65–74 years  5,244  6.5   5,629   7.0   6.3  1.05 1.12 
 75+ years  5,356  6.7   5,634   7.0   6.4  1.04 1.09 
Female           
 < 1 year 745  0.9  720  0.9   0.9  1.04 1.01 
 1–4 years  1,662  2.1   1,659  2.1   2.3  0.89 0.89 
 5–14 years  2,059  2.6   2,096  2.6   3.0  0.86 0.88 
 15–24 years  4,038  5.0   3,998  5.0   5.4  0.93 0.92 
 25–44 years  11,327  14.1   10,860  13.5   14.2  0.99 0.95 
 45–64 years  13,344  16.6   12,305  15.3   15.2  1.09 1.01 
 65–74 years 7,028  8.8   6,650  8.3   7.3  1.20 1.13 
 75+ years  8,162  10.2   7,648  9.5   8.9  1.14 1.07 
(a) Unweighted GP consultation Medicare service items only, excluding encounters with patients who hold a DVA Repatriation health card. 
(b) Calculated from BEACH weighted data, excluding encounters with patients who hold a DVA Repatriation health card. 
(c) MBS claims data provided by the Australian Government Department of Health. 
Note: GP consultation Medicare services – see ‘Glossary’. Only encounters with a valid age and sex are included in the comparison. 
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 Figure 3.1: Age distribution of all patients at BEACH and MBS GP consultation services, 2013–14 
 
 
 
 
 
 
 
Figure 3.2: Age distribution of male patients at BEACH and MBS GP consultation services, 
2013–14 
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Figure 3.3: Age distribution of female patients at BEACH and MBS GP consultation services, 
2013–14 
3.5 The weighted data set 
The final unweighted data set from the 16th year of collection contained encounters, reasons 
for encounters, problems and management/treatments. The apparent number of encounters 
and number of medications increased after weighting, and the number of reasons for 
encounter, problems managed, other treatments, referrals, imaging and pathology all 
decreased after weighting. Raw and weighted totals for each data element are shown in 
Table 3.5. The weighted data set is used for all analyses in the remainder of this report. 
Table 3.5: The BEACH data set, 2013–14 
Variable Raw Weighted 
General practitioners 959 959 
Encounters 95,900 95,879 
Reasons for encounter 150,368 148,880 
Problems managed 156,546 151,675 
Medications 98,959 98,394 
Other treatments(a) 56,513 54,104 
Referrals and admissions 16,176 15,012 
Pathology 50,925 47,035 
Imaging 10,907 10,460 
Other investigations 841 753 
(a) Other treatments excludes injections for immunisations/vaccinations (raw n = 4,591, weighted  
n = 4,245) (see Chapter 10). 
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 4 The participating GPs 
This chapter reports data collected between April 2013 and March 2014 (the 16th year of the 
BEACH program) about the participating GPs and their practices. Details of GP and practice 
characteristics are reported for each year from 2004–05 to 2013–14 in the 10-year summary 
report, A decade of Australian general practice activity 2004–05 to 2013–14.1  
4.1 Characteristics of the GP participants 
All participants returned a GP profile questionnaire, although some were incomplete. The 
results are provided in Tables 4.1 and 4.2 (median results not tabulated). Of the 959 
participants: 
• 57.0% were male, and 47.5% were aged 55 years and over (mean age 53.0 years; median 
age 54.0 years) 
• 63.7% had been in general practice for more than 20 years 
• 71.0% had graduated in Australia and 9.7% in Asia 
• 30.6% spent more than 40 hours on average per week on direct patient care services 
(mean hours worked was 36.8; median was 37.0 hours)  
• 36.1% expected to decrease their hours spent on direct patient care in the next 5 years 
• 56.0% were Fellows of the RACGP, and 6.3% were Fellows of the ACRRM 
• 54.0% had provided care in a residential aged care facility in the previous month 
• 68.9% practised in Major cities (using Australian Standard Geographical Classification63) 
• 74.4% worked at only one practice location in a regular week, and 21.0% worked in two 
• 31.8% were in practices of fewer than five individual GPs, and 25.6% were in practices of 
10 or more individual GPs. On average, there were 7.2 individual GPs per practice, with 
a median of 6 per practice 
• 51.9% were in practices of fewer than five full-time-equivalent (FTE) GPs. On average, 
there were 5.2 FTE GPs per practice, with a median of 4.5 FTE GPs per practice 
• 83.3% of the GPs worked in a practice that employed practice nursing staff—for more 
than one-third of these (39.4%) the practice employed less than two FTEs (35–45 hours 
per week). On average, there were 0.4 FTE practice nurses per FTE GP 
• nearly three-quarters (73.8%) had a co-located pathology laboratory or collection centre 
in, or within 50 metres of the practice, and more than half (55.8%) a co-located 
psychologist  
• 43.0% worked in a practice that provided their own or cooperative after-hours care, and 
56.4% in a practice that used a deputising service for after-hours patient care (multiple 
responses allowed). 
Those interested in the clinical activity of overseas trained doctors will find more 
information in Bayram et al. (2007) Clinical activity of overseas trained doctors practising in 
general practice in Australia.64 Readers interested in the effects of GP age on clinical practice 
will find more information in Charles et al. (2006) The independent effect of age of general 
practitioner on clinical practice.65 For more information about the effect of the sex of the GP on 
clinical practice see Harrison et al. (2011) Sex of the GP.66  
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 Table 4.1: Characteristics of participating GPs and their practices 
GP characteristic Number(a) 
Per cent of GPs(a) 
(n = 959) 
Sex (missing n = 0)   
 Male 547 57.0 
 Female 412 43.0 
Age (missing n = 5)   
 < 35 years 59 6.2 
 35–44 years 171 17.9 
 45–54 years 271 28.4 
 55+ years 453 47.5 
Years in general practice (missing n = 10)   
 < 2 years 9 0.9 
 2–5 years 100 10.5 
 6–10 years 86 9.1 
 11–19 years 150 15.8 
 20+ years 604 63.7 
Place of graduation (missing n = 4)   
 Australia 678 71.0 
 Overseas 277 29.0 
  Asia 93 9.7 
  United Kingdom/Ireland 81 8.5 
  Africa and Middle East 48 5.0 
  Europe 22 2.3 
  New Zealand 18 1.9 
  Other 15 1.6 
Direct patient care hours (worked) per week (missing n = 14)   
 ≤ 10 hours 10 1.1 
 11–20 hours 96 10.2 
 21–40 hours 550 58.2 
 41–60 hours 274 29.0 
 61+ hours 15 1.6 
Expectations for providing direct patient care in 5 yrs time (missing n = 8)   
 Increase number of working hours 87 9.1 
 No change to number of working hours 392 41.2 
 Decrease number of working hours 343 36.1 
 Stop working as a GP 88 9.3 
 Unsure about future work as a GP 41 4.3 
Currently in general practice training program (missing n = 14) 44 4.7 
Fellow of RACGP (missing n = 7) 533 56.0 
Fellow of ACRRM (missing n = 37) 58 6.3 
(continued) 
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 Table 4.1 (continued): Characteristics of participating GPs and their practices 
GP characteristic Number(a) 
Per cent of GPs(a) 
 (n = 959) 
Patient care provided in previous month(b)    
 In a residential aged care facility (missing n = 5) 515 54.0 
 As a salaried/sessional hospital medical officer (missing n = 5) 116 12.2 
Practice location by ASGC remoteness structure (missing n = 6)   
 Major cities 657 68.9 
 Inner regional 205 21.5 
 Outer regional 80 8.4 
 Remote 9 0.9 
 Very remote 2 0.2 
Number of practice locations worked at in a regular week (missing n = 17)   
 1 701 74.4 
 2 198 21.0 
 3 34 3.6 
 4+ 9 1.0 
Size of practice – number of individual GPs (missing n = 27)   
 Solo 81 8.7 
 2–4  215 23.1 
 5–9  397 42.6 
 10–14 166 17.8 
 15+  73 7.8 
Size of practice – full-time equivalent GPs (missing n = 128)   
 < 1 4 0.5 
 1.0– <2 82 9.8 
 2.0– <3 101 12.2 
 3.0– <4 116 14.0 
 4.0– <5 128 15.4 
 5.0– <10 311 37.4 
 10.0– <15 67 8.1 
 15+ 22 2.6 
Practice nurse at major practice address (missing n = 12) 789 83.3 
Number of individual practice nurses (missing n = 29)   
 0 158 17.0 
 1 126 13.5 
 2  215 23.1 
 3 171 18.4 
 4–5  158 17.0 
 6+ 102 11.0 
(continued) 
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 Table 4.1 (continued): Characteristics of participating GPs and their practices 
GP characteristic Number(a) 
Per cent of GPs(a) 
 (n = 959) 
Number of full-time equivalent practice nurses (missing n = 164)   
 0 158 19.9 
 < 1 47 5.9 
 1.0– <2 266 33.5 
 2.0– <3 168 21.1 
 3.0– <4 83 10.4 
 4.0+ 73 9.2 
Co-located services(c) (missing n = 18)   
 Pathology laboratory/collection centre 694 73.8 
 Psychologist 525 55.8 
 Physiotherapist 474 40.4 
 Medical specialist 209 22.2 
 Imaging/radiology services 214 22.7 
 Dietitian 410 43.6 
 Podiatrist 386 41.0 
 Other service 199 21.2 
 None 64 6.8 
After-hours arrangements(b) (missing n = 8)   
 Practice does own and/or cooperative with other practices 409 43.0 
  Practice does its own 292 30.7 
  Cooperative with other practices 135 14.2 
 Deputising service 536 56.4 
 Other arrangement 87 9.2 
(a) Missing data removed. 
(b) Multiple responses allowed. 
(c) Services located/available in the practice, in the same building or within 50 metres, available on a daily or regular basis. 
Note: ASGC – Australian Standard Geographical Classification; RACGP – Royal Australian College of General Practitioners;  
ACRRM – Australian College of Rural and Remote Medicine. 
 
 
Table 4.2: Means of selected characteristics of participating GPs and their practices 
Characteristic 
Mean 
(n = 959) 
95% 
LCL 
95% 
UCL 
Mean age of participating GPs (missing n = 5) 53.0 52.3 53.7 
Mean hours worked per week on direct patient care (missing n = 14) 36.8 36.0 37.6 
Mean number of individual GPs at major practice address (missing n = 27) 7.2 6.9 7.5 
Mean number of FTE GPs at major practice address (missing n = 128) 5.2 5.0 5.5 
FTE Practice nurse: FTE GP (missing n = 220) 0.4 0.3 0.4 
Note: LCL – lower confidence limit; UCL – upper confidence limit; FTE – full-time equivalent. 
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 4.2 Computer use at GP practices 
As computers are increasingly being used by GPs in their clinical activity, the GP profile 
questionnaire was redesigned in 2013–14 to gain more comprehensive information about the 
uses to which computers are put in a general practice clinical environment (see Appendix 2). 
In particular, more specific information was collected about electronic and other prescribing, 
and whether the medical records used were paper only, a mix of paper and electronic 
medical records, or whether the records were completely paperless. 
Table 4.3 shows the proportion of individual participating GPs who used computers for 
each of the listed activities. 
• Only 2.4% of GPs did not use a computer at all for clinical purposes. 
• 96.3% of GPs were producing prescriptions electronically (either ePrescribing or 
printing scripts). 
• More than two-thirds (69.9%) reported they used electronic medical records exclusively 
(that is, were paperless). 
• More than one-quarter (27.4%) reported maintaining a hybrid record where some 
patient information is kept electronically and some on paper records. 
Table 4.3: Computer applications available/used at major practice address 
Computer use Number 
Per cent of GPs  
(n = 959) 
Computer not used for any clinical purposes (missing n = 5) 23 2.4 
 Not available  14 1.5 
 Available, not used 5 0.5 
 Internet/email only 4 0.4 
Clinical use   
Prescribing(a) (missing n = 40)   
 Electronic (ePrescribing online) 291 31.7 
  (*Electronic + print scripts) (84) (9.1) 
 Print scripts only 589 64.1 
 Paper only (handwritten) 34 3.7 
 Both print scripts and handwritten 5 0.5 
Internet (missing n = 5) 735 77.0 
Email (missing n = 5) 582 61.0 
Medical records (missing n = 11)   
 Complete (paperless) 663 69.9 
 Partial/hybrid records 260 27.4 
 Paper records only 25 2.6 
(a) Multiple responses allowed.  
* Subset of ePrescribing. 
 
Those interested in the effect of computerisation on quality of care in general practice will 
find more detailed information in Henderson (2007) The effect of computerisation on the quality 
of care in Australian general practice.67  
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 4.3 Changes in characteristics of the GPs over the 
decade 2004–05 to 2013–14 
Changes over the decade 2004–05 to 2013–14 are described in detail in Chapter 4 of the 
accompanying report, A decade of Australian general practice activity 2004–05 to 2013–14.1 
Briefly, the major changes in the characteristics of the participating GPs were: 
• the proportion of GP participants who were female increased over time 
• the proportion of GPs who were younger than 45 years decreased, whereas the 
proportion aged 55 years or more increased over the decade 
• reflecting the increase in the age of GP participants, the proportion who had worked in 
general practice for more than 20 years also increased significantly over time 
• the proportion of GPs working 21–40 hours per week on direct patient care significantly 
increased, and the proportion working 41–60 hours, and the proportion working more 
than 60 hours, significantly decreased 
• the mean number of hours spent on direct patient care significantly decreased 
• the proportion of participants holding the Fellowship of the RACGP increased over the 
decade 
• the proportion of GPs in solo practice decreased over time, and the proportion in 
practices with 10 or more individual GPs almost doubled 
• fewer practices are providing after-hours care on their own, or in cooperation with other 
practices, but more practices are using deputising services for after-hours care than a 
decade ago 
• computers have become increasingly available at practices, as has their use for clinical 
activity.  
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 5 The encounters 
This chapter describes the content and types of encounters recorded in the 2013–14 
BEACH year. Data about the encounters are reported for each year from 2004–05 to 2013–14 
in the 10-year report, A decade of Australian general practice activity 2004–05 to 2013–14.1  
5.1 Content of the encounters 
In 2013–14, details of 95,879 encounters (weighted data) were available for 959 GPs. A 
summary of these encounters is provided in Table 5.1. Reasons for encounter (RFEs) and 
problems managed are expressed as rates per 100 encounters. Each management action is 
presented in terms of both a rate per 100 encounters and a rate per 100 problems managed, 
with 95% confidence limits. 
• On average, patients gave 155 RFEs, and GPs managed about 158 problems per 
100 encounters. 
• Chronic problems accounted for 35.6% of all problems managed, and an average of 56.3 
chronic problems were managed per 100 encounters. 
• New problems accounted for 37.0% of all problems, and on average 58.5 new problems 
were managed per 100 encounters. 
• Work-related problems were managed at a rate of 2.4 per 100 encounters. 
• Medications were the most common treatment choice (102.6 per 100 encounters), most of 
these being prescribed (83.5 per 100), rather than supplied by the GP (10.2 per 100) or 
advised for over-the-counter purchase (8.9 per 100). 
• For an ‘average’ 100 GP–patient encounters, GPs provided 103 medications and 
38 clinical treatments (such as advice and counselling), undertook 19 procedures, made 
10 referrals to medical specialists and 5 to allied health services, and placed 49 pathology 
test orders and 11 imaging test orders (Table 5.1). 
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 Table 5.1: Summary of morbidity and management at GP–patient encounters 
Variable Number 
Rate per 100 
encounters 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Rate per 100 
problems  
(n = 151,675) 
95% 
LCL 
95% 
UCL 
General practitioners 959 — — — — — — 
Encounters 95,879 — — — — — — 
Reasons for encounter  148,880  155.3 153.3 157.3 — — — 
Problems managed  151,675  158.2 155.7 160.7 — — — 
 New problems 56,126  58.5 57.0 60.1 37.0 36.0 38.0 
 Chronic problems 54,027  56.3 54.4 58.3 35.6 34.7 36.6 
 Work-related  2,268  2.4 2.2 2.5 1.5 1.4 1.6 
Medications 98,394  102.6 100.1 105.2 64.9 63.5 66.2 
 Prescribed 80,046  83.5 81.2 85.8 52.8 51.5 54.1 
 GP-supplied 9,797  10.2 9.4 11.0 6.5 6.0 6.9 
 Advised OTC  8,550  8.9 8.2 9.6 5.6 5.2 6.1 
Other treatments(a)  54,104  56.4 53.8 59.0 35.7 34.2 37.2 
 Clinical*  36,024  37.6 35.3 39.8 23.8 22.4 25.1 
 Procedural*  18,081  18.9 18.0 19.7 11.9 11.4 12.4 
Referrals  15,012  15.7 15.1 16.3 9.9 9.6 10.2 
 Medical specialist*  9,139  9.5 9.1 9.9 6.0 5.8 6.3 
 Allied health services*  4,728  4.9 4.6 5.2 3.1 2.9 3.3 
 Hospital* 382  0.4 0.3 0.5 0.3 0.2 0.3 
 Emergency department* 272  0.3 0.2 0.3 0.2 0.2 0.2 
 Other referrals* 491  0.5 0.4 0.6 0.3 0.3 0.4 
Pathology  47,035  49.1 47.1 51.0 31.0 30.0 32.1 
Imaging  10,460  10.9 10.5 11.4 6.9 6.6 7.2 
Other investigations(b) 753  0.8 0.7 0.9 0.5 0.4 0.5 
(a) Other treatments includes treatment given by practice nurses in the context of the GP–patient encounter and treatment given by GPs. 
(b) Other investigations reported here include only those ordered by the GP. Other investigations in Chapter 12 include those ordered by the 
GP and those done by the GP or practice staff. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, <hdl.handle.net/2123/11882>). 
Note: LCL – lower confidence limit; UCL – upper confidence limit; OTC – over-the-counter. 
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 5.2 Encounter type 
During the first 7 years of the BEACH program, where one (or more) Medicare Benefits 
Schedule/Department of Veterans’ Affairs (MBS/DVA) item number was claimable for the 
encounter, GP participants were asked to record only one item number. Where multiple 
item numbers (e.g. an A1 item such as ‘standard surgery consultation’ and a procedural item 
number) were claimable for an encounter, GPs were instructed to record the lower of the 
item numbers (usually an A1 item number). 
Changes to the BEACH form were made in the 2005–06 BEACH year to capture practice 
nurse activity associated with GP–patient consultations. One of these changes was to allow 
GPs to record up to three Medicare item numbers per encounter. For comparability with 
earlier years, in Tables 5.3 and 5.4 only one item number per MBS/DVA-claimable 
encounter has been counted. Selection of one item number was undertaken on a priority 
basis: consultation item numbers overrode incentive item numbers, which overrode 
procedural item numbers, which overrode other Medicare item numbers.  
Table 5.2 provides an overview of the MBS/DVA item numbers recorded in BEACH in  
2013–14. At least one MBS/DVA item number was recorded at 84,153 encounters (87.8% of 
all BEACH encounters). A single item number was recorded at 95.6% of BEACH encounters 
said to be claimable from the MBS/DVA. 
Table 5.2: Overview of MBS items recorded 
Variable Number 
Per cent of MBS/DVA encounters 
(n = 84,153) 
Encounters at which one MBS item was recorded 80,464  95.6 
Encounters at which two MBS items were recorded 3,217  3.8 
Encounters at which three MBS items were recorded  472  0.6 
Total encounters at which at least one item was recorded 84,153  100.0 
Note: MBS – Medicare Benefits Schedule; DVA – Department of Veterans’ Affairs. 
Of the 88,151 encounters where a payment source was recorded (counting only one item 
number per encounter), 95.5% related to MBS/DVA GP items of service. Items with other 
health professionals not accompanied by a GP item of service were recorded infrequently.  
Table 5.3 reports the breakdown of encounter type by payment source, counting a single 
Medicare item number per encounter (where applicable).  
• Indirect encounters (where the patient was not seen by the GP) accounted for 1.7%, and 
direct encounters for 98.2% of encounters at which a payment source was recorded. 
• The vast majority of all direct encounters (97.1%) were claimable through Medicare or 
the DVA. 
• Direct encounters where the GP indicated that no charge was made were rare, 
accounting for 0.4% of encounters. 
• Encounters claimable through workers compensation accounted for 1.7%. 
• Encounters claimable through other sources (e.g. hospital-paid encounters) accounted 
for 0.7%. 
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 Table 5.3: Type of encounter at which a source of payment was recorded for the encounter 
(counting one item number per encounter) 
Type of encounter Number 
Per cent of 
encounters(a) 
(n = 88,151) 
95% 
LCL 
95% 
UCL 
Per cent of direct 
encounters 
(n = 86,607) 
Indirect encounters(b) 1,542 1.7 1.5 2.0  
Direct encounters 86,607 98.2 98.0 98.5 100.0 
 MBS/DVA items of service (direct encounters only)(c) 84,136 95.4 95.1 95.8 97.1 
 Workers compensation 1,537 1.7 1.6 1.9 1.8 
 Other paid (hospital, state, etc.) 603 0.7 0.5 0.8 0.7 
 No charge 332 0.4 0.3 0.5 0.4 
Other health professional only items (unspecified as 
direct or indirect) 2 0.0Ŧ 0.0 0.0 — 
Total 88,151 100.0 — — — 
(a) Missing data removed from analysis (n = 7,728). 
(b) Five encounters involving chronic disease management or case conference items were recorded as indirect encounters. 
(c) Includes direct encounters at which either a GP or an item with an other health professional (or both) was recorded. 
Ŧ Rates are reported to one decimal place. This indicates that the rate is less than 0.05 per 100 encounters. 
Note: LCL – lower confidence limit; UCL – upper confidence limit; MBS – Medicare Benefits Schedule; DVA – Australian Government Department 
of Veterans’ Affairs. 
Table 5.4 provides a summary of the MBS items recorded in BEACH, counting one item 
number per encounter. This provides comparable results about item numbers recorded to 
those reported in previous years.  
• Standard surgery consultations accounted for 78.8% of MBS/DVA-claimable GP 
consultations, and for 75.2% of all encounters for which a payment source was recorded.  
• 11.5% of MBS/DVA-claimable encounters were claimable as long or prolonged surgery 
consultations. 
• Home or institution visits, and visits at residential aged care facilities were all relatively 
rare, together accounting for 2.8% of MBS/DVA-claimable encounters. 
• About 1.4% of encounters were claimable as GP mental health care items, 1.4% as 
chronic disease management items, and 0.4% as health assessments.  
• There was a decrease in home visits in the decade to 201068 and this has important 
implications for ageing patients wishing to be managed at home rather than in 
institutional care. The changes to the Medicare schedule in May 2010 mean that it is no 
longer possible to separate home visits from institutional visits using Medicare item 
numbers. The BEACH collection form was altered from the 2012–13 BEACH data year 
onwards to include a tick box to identify home visits. In 2013–14, there were 633 
encounters identified as home visits at a rate of 0.7 per 100 encounters (95% CI: 0.4–1.0). 
An MBS/DVA GP item was recorded at 628 home visit encounters, or 0.7% (95% CI: 
0.4–1.1) of encounters at which an MBS/DVA item was recorded (results not tabled). 
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 Table 5.4: Summary of GP only MBS/DVA items recorded (counting one item per encounter) 
MBS/DVA item Number 
Rate per 100 
encounters(a) 
(n = 88,151) 
95% 
LCL 
95% 
UCL 
Per cent of 
MBS/DVA  
GP items  
(n = 84,142) 
Short surgery consultations 1,654 1.9 1.6 2.2 2.0 
Standard surgery consultations 66,304 75.2 74.0 76.5 78.8 
Long surgery consultations 8,983 10.2 9.5 10.9 10.7 
Prolonged surgery consultations 707 0.8 0.6 1.0 0.8 
Residential aged care facility (RACF) visits 1,558 1.8 1.2 2.3 1.9 
Home or institution visits (excluding RACF) 755 0.9 0.7 1.1 0.9 
GP mental health care 1,205 1.4 1.2 1.5 1.4 
Chronic disease management items 1,255 1.4 1.2 1.6 1.5 
Health assessments 355 0.4 0.3 0.5 0.4 
Case conferences 6 0.0Ŧ 0.0 0.0 0.0 
Attendances associated with Practice 
Incentives Program payments 
159 0.2 0.1 0.2 0.2 
Other items 1,201 1.4 1.0 1.7 1.4 
 Therapeutic procedures 311 0.4 0.3 0.4 0.4 
 Surgical operations 366 0.4 0.3 0.5 0.4 
 Acupuncture 144 0.2 0.1 0.3 0.2 
 Other items 381 0.4 0.1 0.7 0.5 
Total MBS/DVA items of service (GPs only) 84,142 95,5 95.1 95.8 100.0 
(a) Encounters with missing payment source were removed from analysis (n = 7,728). Denominator used for analysis n = 88,151. 
Ŧ Rates are reported to one decimal place. This indicates that the rate is less than 0.05 per 100 encounters. 
Note: LCL – lower confidence limit; UCL – upper confidence limit; MBS – Medicare Benefits Schedule; DVA – Australian Government Department 
of Veterans’ Affairs; GP – general practitioner; RACF – residential aged care facility. 
Table 5.5 provides the distribution of all MBS/DVA item numbers recorded across Medicare 
item number groups and the number of encounters at which at least one of each type of item 
number was recorded. Overall, there were 88,314 MBS item numbers recorded at 84,153 
MBS/DVA-claimable encounters in 2013–14, an average of 1.0 item per encounter claimable 
through MBS/DVA.  
Surgery consultations (including short, standard, long and prolonged) were the most 
commonly recorded type of item number, accounting for 87.9% of all MBS items, one of 
these items being recorded at 92.3% of MBS claimable encounters.  
Items for hospital, residential aged care and home visits together accounted for 2.6% of all 
MBS items. Items for other practice nurse, Aboriginal health worker and allied health 
services accounted for 0.4% of all MBS items, and were recorded at 0.6% of claimable 
encounters at which at least one MBS item was recorded.  
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 Table 5.5: Distribution of MBS/DVA service item numbers recorded, across item number groups 
and encounters 
Items/encounters 
All MBS/ 
DVA items(a) 
(n = 88,314)  
Encounters with at least 
one item recorded(b) 
(n = 84,153) 
Number Per cent  Number Per cent  
95% 
LCL 
95% 
UCL 
Surgery consultations 77,649 87.9  77,648 92.3` 91.4 93.1 
Home, institution and residential aged care visits 2,313 2.6  2,313 2.7 2.1 3.4 
Chronic disease management items (including 
case conferences) 
2,609 3.0 
 
1,910 2.3 2 2.6 
Other practice nurse/Aboriginal health 
worker/allied health worker services 
387 0.4 
 
387 0.5 0.3 0.6 
GP mental health care items 1,580 1.8  1,580 1.9 1.7 2.1 
Surgical operations 1,268 1.4  1,205 1.4 1.2 1.6 
Diagnostic procedures and investigations 601 0.7  577 0.7 0.6 0.8 
Health assessments 504 0.6  504 0.6 0.5 0.7 
Therapeutic procedures 424 0.5  419 0.5 0.4 0.6 
Acupuncture 146 0.2  146 0.2 0.1 0.3 
Pathology services 176 0.2  173 0.2 0.2 0.3 
Attendances associated with Practice Incentives 
Program payments 
200 0.2 
 
199 0.2 0.2 0.3 
Other items 448 0.5  447 0.5 0.2 0.8 
Total items 88,314 100.0  — — — — 
(a) Up to three MBS/DVA items could be recorded at each encounter.  
(b) Identifies encounters where at least one item from the MBS group was recorded. 
Note: MBS – Medicare Benefits Schedule; DVA – Australian Government Department of Veterans’ Affairs; LCL – lower confidence limit; UCL – 
upper confidence limit. 
5.3 Consultation length 
In a subsample of 31,816 BEACH MBS/DVA-claimable encounters at which start and finish 
times had been recorded by the GP, the mean length of consultation in 2013–14 was 
14.8 minutes (95% CI: 14.6–15.7). The median length was 13.0 minutes (results not tabled). 
For A1 MBS/DVA-claimable encounters, the mean length of consultation in 2013–14 was 
14.4 minutes (95% CI: 14.1–14.7), and the median length was 13.0 minutes (results not 
tabled).  
Methods describing the substudy from which data on consultation length are collected are 
described in Section 2.6. In all our previous reports of consultation length, we have relied on 
the raw data from those ‘timed’ consultations for which a Medicare/DVA item was 
recorded as claimable. In this analysis, for the first time we weighted the timed encounters 
by GP age–sex and by activity level (the number of consultations they claimed in a year 
through Medicare or DVA). This ensured that the distribution of length of consultations 
reflected the distribution for length of all Medicare claimed GP encounters, rather than being 
a description of time spent by the sampled GPs. 
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 The determinants of consultation length were investigated by Britt et al. (2004) in 
Determinants of GP billing in Australia: content and time69 and Britt et al. (2005) in Determinants 
of consultation length in Australian general practice.70 Length of GP consultations is also 
discussed in a ‘Byte from BEACH’ published on the FMRC website (2014): Britt H, Valenti L, 
Miller G. Debunking the myth of general practice as ‘6 minute medicine’.71 
5.4 Changes in the encounters over the decade 
2004–05 to 2013–14 
Chapter 5 of the companion report, A decade of Australian general practice activity 2004–05 to 
2013–14,1 provides an overview of changes in general practice encounters over the past 
decade. The major changes between 2004–05 and 2013–14 are summarised below. 
• There was an increase in the average number of problems managed at encounter, from 
146 per 100 encounters in 2004–05 to 158 in 2013–14. This change was reflected in an 
increase in the number of new and chronic problems managed per 100 encounters.  
• The number of work-related problems managed significantly decreased over the 10 
years, from 3.1 to 2.4 per 100 encounters.  
Of the encounters claimable from Medicare/DVA: 
• short surgery consultations as a proportion of all Medicare/DVA-claimed consultations 
increased over the study period 
• the proportion claimable as: chronic disease management items; health assessments; and 
GP mental health care, all increased significantly 
• the mean length A1 Medicare/DVA-claimable GP–patient encounters in 2013–14 was 
significantly longer than in many years in the previous decade. The mean length of all 
Medicare/DVA-claimable encounters increased significantly over the decade from 14.1 
minutes to 14.8 minutes. The median length of both groups of Medicare/DVA-claimable 
GP–patient encounters increased from 12 to 13 minutes from 2012–13 to 2013–14.. 
The changes in management actions are reported in terms of rates per 100 encounters. As 
there was a significant increase in the number of problems managed at encounters, it may 
therefore be more informative to consider changes in management actions in terms of rates 
per 100 problems managed. 
• The number of procedures undertaken per 100 encounters rose significantly from 15.5 to 
18.9 per 100 encounters.  
• There was an increased rate of referrals, which was reflected in referrals to allied health 
services and to medical specialists. 
• Pathology test/battery order rates increased by 34%. Orders for imaging tests also 
increased.  
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 6 The patients 
This chapter reports data collected between April 2013 and March 2014 about the 
characteristics of patients at GP encounters and their reasons for encounter, from the 16th year 
of the BEACH program. Data on patient characteristics and reasons for encounter are 
reported for each year from 2004–05 to 2013–14 in the 10-year report, A decade of Australian 
general practice activity 2004–05 to 2013–14.1  
6.1 Age–sex distribution of patients at encounter 
The age–sex distribution of patients at encounters is shown in Figure 6.1. Females accounted 
for the greater proportion (56.6%) of encounters (Table 6.1). This was reflected across all age 
groups except among children aged less than 15 years (Figure 6.1). 
Patients aged less than 25 years accounted for 18.9% of encounters; those aged 25–44 years 
for 21.5%; those aged 45–64 years accounted for 27.2 and those aged 65 years and over for 
32.5% of encounters (Table 6.1). 
 
  
 
 
 
Note: Missing data removed. The distributions will not agree perfectly with those in Table 6.1 because of missing data in either age or  
sex fields. 
Figure 6.1: Age–sex distribution of patients at encounter, 2013–14 
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 Female 0.9 2.0 2.4 4.9 13.5 15.2 8.0 10.2
 Male 1.0 2.3 2.7 2.8 8.0 12.0 7.0 7.3
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 6.2 Other patient characteristics 
Table 6.1 presents other characteristics of the patients at GP encounters. In summary: 
• the patient was new to the practice at 6.6% of encounters 
• nearly half of the encounters were with patients who held a Commonwealth concession 
card (43.5%) and/or a Repatriation health card (2.2%) 
• at 1 in 10 encounters the patient was from a non-English-speaking background 
• at 1.7% of encounters the patient identified themselves as an Aboriginal and/or Torres 
Strait Islander person. 
Table 6.1: Characteristics of the patients at encounters 
Patient characteristics Number 
Per cent of encounters 
(n = 95,879) 
95% 
LCL 
95%  
UCL 
Sex (missing)(a) (927)    
 Males 40,904 43.1 42.2 44.0 
 Females 54,048 56.9 56.0 57.8 
Age group (missing)(a) (814)    
 < 1 year 1,779 1.9 1.7 2.0 
 1–4 years 4,017 4.2 3.9 4.5 
 5–14 years 4,851 5.1 4.8 5.4 
 15–24 years 7,299 7.7 7.3 8.1 
 25–44 years 20,428 21.5 20.7 22.3 
 45–64 years 25,795 27.1 26.6 27.7 
 65–74 years 14,203 14.9 14.4 15.5 
 75+ years 16,692 17.6 16.6 18.5 
New patient to practice (missing)(a) (2,017)    
 New patient to practice 6,168 6.6 6.0 7.1 
 Patient seen previously 87,694 93.4 92.9 94.0 
Commonwealth concession card status (missing)(a) (8,623)    
 Has a Commonwealth concession card 40,560 43.5 41.9 45.1 
 No Commonwealth concession card 52,663 56.5 54.9 58.1 
Repatriation health card status (missing)(a) (9,961)    
 Has a Repatriation health card 2,080 2.2 2.0 2.4 
 No Repatriation health card 90,688 97.8 97.6 98.0 
Language status (missing)(a) (9,859)    
 Non-English-speaking background(b) 8,615 10.0 8.2 11.8 
 English-speaking background 77,405 90.0 88.2 91.8 
Indigenous status (missing)(a) (9,998)    
 Aboriginal and/or Torres Strait Islander(c) 1,429 1.7 1.3 2.1 
 Non-Indigenous 84,451 98.3 97.9 98.7 
(a) Missing data removed. 
(b) Speaks a language other than English as their primary language at home. 
(c) Self-identified.  
Note: LCL – lower confidence limit; UCL – upper confidence limit. 
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 6.3 Patient reasons for encounter 
Patient reasons for encounter (RFEs) reflect the patient’s demand for care and can provide 
an indication of service use patterns, which may benefit from intervention at a population 
level.72  
RFEs are those concerns and expectations that patients bring to the GP. Participating GPs 
were asked to record at least one, and up to three, patient RFEs in words as close as possible 
to those used by the patient, before the diagnostic or management process had begun. These 
reflect the patient’s view of their reasons for consulting the GP. RFEs can be expressed in 
terms of one or more symptoms (for example, ‘itchy eyes’, ‘chest pain’), in diagnostic terms 
(for example, ‘about my diabetes’, ‘for my hypertension’), a request for a service (‘I need 
more scripts’, ‘I want a referral’), an expressed fear of disease or a need for a check-up. 
Patient RFEs can have a one-to-one, one-to-many, many-to-one or many-to-many 
relationship to problems managed. That is, the patient may describe a single RFE that relates 
to a single problem managed at the encounter, a single RFE that relates to multiple 
problems, multiple RFEs that relate to a single problem managed, or multiple RFEs that 
relate to multiple problems managed at the encounter. GPs may also manage a problem that 
was unrelated to the patient’s RFE (e.g. a patient presents about their diabetes but while they 
are there the GP also provides a vaccination and performs a Pap smear). 
Number of reasons for encounter 
There were 148,880 RFEs recorded at 95,879 encounters in 2013–14 (Table 6.3). At 57.7% of 
encounters only one RFE was recorded, at 29.4% two RFEs were recorded and at 12.9% of 
encounters three RFEs were recorded (Table 6.2). On average, patients presented with 155.3 
RFEs per 100 encounters, or about one-and-a-half RFEs per encounter (Table 6.3). 
Table 6.2: Number of patient reasons for encounter  
Number of RFEs at encounter 
Number of encounters 
(n = 95,879) 
Per cent of 
encounters 
95% 
LCL 
95% 
UCL 
One RFE 55,276 57.7 56.4 59.0 
Two RFEs 28,204 29.4 28.7 30.1 
Three RFEs 12,399 12.9 12.1 13.7 
Total 95,879 100.0 — — 
Note: RFEs – reasons for encounter; LCL – lower confidence limit; UCL – upper confidence limit. 
Reasons for encounter by ICPC-2 component 
The distribution of patient RFEs by ICPC-2 component is presented in Table 6.3, expressed 
as a percentage of all RFEs and as a rate per 100 encounters with 95% confidence limits. In 
the ‘diagnosis, diseases’ group we provide data about infections, injuries, neoplasms, 
congenital anomalies and ‘other’ diagnoses.  
Approximately 4 out of 10 (40.2%) patient RFEs were expressed in terms of a symptom or 
complaint (for example, ‘tired’, ‘fever’). RFEs described in diagnostic terms (for example, 
‘about my diabetes’, ‘for my depression’) accounted for 19.1% of RFEs. The remaining 40.7% 
of RFEs were described in terms of processes of care, such as requests for a health check, 
requests for prescriptions, referrals, test results or medical certificates. 
On average at 100 encounters, patients described 62.5 ‘symptom or complaint’ RFEs and 29.7 
diagnosis/disease RFEs, made 26.4 presentations for a procedure and made 16.2 requests for 
treatment. 
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 Table 6.3: Patient reasons for encounter by ICPC-2 component 
ICPC-2 component Number 
Per cent of  
total RFEs 
(n = 148,880) 
Rate per 100 
encounters 
(n = 95,879) 
95%  
LCL 
95%  
UCL 
Symptoms and complaints 59,905 40.2 62.5 60.6 64.4 
Diagnosis, diseases 28,431 19.1 29.7 28.1 31.2 
 Infections 6,507 4.4 6.8 6.3 7.3 
 Injuries 4,342 2.9 4.5 4.3 4.8 
 Neoplasms 967 0.6 1.0 0.9 1.1 
 Congenital anomalies 223 0.1 0.2 0.2 0.3 
 Other diagnoses, diseases 16,392 11.0 17.1 15.9 18.2 
Diagnostic and preventive procedures 25,309 17.0 26.4 25.4 27.4 
Medications, treatments and therapeutics 15,550 10.4 16.2 15.5 17.0 
Results 9,000 6.0 9.4 8.9 9.9 
Referrals and other RFEs 7,572 5.1 7.9 7.4 8.4 
Administrative 3,114 2.1 3.2 3.0 6.5 
Total RFEs 148,880 100.0 155.3 153.3 157.3 
Note: RFEs – reasons for encounter; LCL – lower confidence limit; UCL – upper confidence limit. 
Reasons for encounter by ICPC-2 chapter  
The distribution of patient RFEs by ICPC-2 chapter and the most common RFEs within each 
chapter are presented in Table 6.4. Each chapter and individual RFE is expressed as a 
percentage of all RFEs and as a rate per 100 encounters with 95% confidence limits.  
RFEs of a general and unspecified nature were presented at a rate of 45.1 per 100 encounters, 
with requests for prescriptions, general check-ups and test results the most frequently 
recorded of these. RFEs related to the respiratory system occurred at a rate of 19.1 per 100 
encounters, those related to skin at a rate of 15.9 per 100, and those relating to the 
musculoskeletal system at a rate of 15.6 per 100 encounters (Table 6.4). 
The far right column of Table 6.4 shows the proportion of patient encounters where there is 
at least one RFE within an ICPC-2 chapter (representing body systems). Patients may 
describe multiple RFEs that would be classified within the same ICPC-2 chapter (e.g. 
depression and anxiety; rheumatoid arthritis and osteoporosis), however this column will 
only report only one instance per chapter.  
RFEs classified as ‘General and unspecified’ were described at least once at 39.2% of 
encounters in 2013–14, equating to approximately 52.3 million encounters nationally in 
2013–14. At least one respiratory RFEs was recorded at 16.5% of encounters, while one or 
more skin RFEs were recorded at 14.9% of encounters. 
You can use these two results together and extrapolate both. Using respiratory related RFEs 
as an example, we estimate that nationally in 2013–14, patients described 25.5 million RFEs 
related to the respiratory system, at least 22 million GP–patient encounters. 
  
 47
 Table 6.4: Patient reasons for encounter by ICPC-2 chapter and most frequent individual reasons 
for encounter within chapter  
Reasons for encounter Number 
Per cent of 
total RFEs(a) 
(n = 148,880) 
Rate per 100 
encounters 
 (n = 95,879) 
95%  
LCL 
95%  
UCL 
Per cent of 
encounters(b)  
(n = 95,879) 
(95% CI) 
General and unspecified 43,288 29.1 45.1 43.8 46.5 39.2 
(38.2–40.2) 
 Prescription NOS 9,436 6.3 9.8 9.2 10.5 — 
 General check-up* 4,595 3.1 4.8 4.5 5.1 — 
 Results tests/procedures NOS 7,665 5.1 8.0 7.6 8.4 — 
 Administrative procedure NOS 2,818 1.9 2.9 2.7 3.1 — 
 Immunisation/vaccination NOS 2,122 1.4 2.2 1.9 2.5 — 
 Fever 1,722 1.2 1.8 1.5 2.1 — 
 Other referrals NEC 1,347 0.9 1.4 1.3 1.5 — 
 Weakness/tiredness 1,311 0.9 1.4 1.2 1.5 — 
 Observation/health education/advice/ 
 diet NOS 
1,078 0.7 1.1 1.0 1.2 — 
 Blood test NOS 1,045 0.7 1.1 1.0 1.2 — 
 Clarify or discuss patient’s RFE 850 0.6 0.9 0.8 1.0 — 
 Follow-up encounter unspecified 818 0.5 0.9 0.7 1.0 — 
 Chest pain NOS 815 0.5 0.9 0.8 0.9 — 
 Other reason for encounter NEC 755 0.5 0.8 0.7 0.9 — 
 Trauma/injury NOS 711 0.5 0.7 0.7 0.8 — 
Respiratory 18,269 12.3 19.1 18.2 19.9 16.5 
(15.8–17.1) 
 Cough 5,245 3.5 5.5 5.1 5.9 — 
 Immunisation/vaccination – respiratory 2,713 1.8 2.8 2.3 3.3 — 
 Throat symptom/complaint 2,392 1.6 2.5 2.3 2.7 — 
 Upper respiratory tract infection 1,616 1.1 1.7 1.5 1.9 — 
 Sneezing/nasal congestion 1,146 0.8 1.2 1.0 1.4 — 
 Shortness of breath/dyspnoea 705 0.5 0.7 0.6 0.8 — 
Skin 15,233 10.2 15.9 15.2 16.5 14.9 
(14.3–15.5) 
 Rash* 2,481 1.7 2.6 2.4 2.8 — 
 Skin symptom/complaint, other 1,756 1.2 1.8 1.7 2.0 — 
 Skin check-up* 1,466 1.0 1.5 1.3 1.8 — 
 Swelling (skin)* 984 0.7 1.0 0.9 1.1 — 
 Laceration/cut 755 0.5 0.8 0.7 0.9 — 
(continued) 
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 Table 6.4 (continued): Patient reasons for encounter by ICPC-2 chapter and most frequent 
individual reasons for encounter within chapter  
Reasons for encounter Number 
Per cent of 
total RFEs(a) 
(n = 148,880) 
Rate per 100 
encounters 
(n = 95,879) 
95%  
LCL 
95%  
UCL 
Per cent of 
encounters(b)  
(n = 95,879) 
(95% CI) 
Musculoskeletal 14,969 10.1 15.6 15.1 16.1 14.4 
(14.0–14.9) 
 Back complaint* 3,110 2.1 3.2 3.0 3.5 — 
 Knee symptom/complaint 1,259 0.8 1.3 1.2 1.4 — 
 Shoulder symptom/complaint 1,128 0.8 1.2 1.1 1.3 — 
 Foot/toe symptom/complaint 1,056 0.7 1.1 1.0 1.2 — 
 Leg/thigh symptom/complaint 919 0.6 1.0 0.9 1.0 — 
 Musculoskeletal injury NOS 783 0.5 0.8 0.7 0.9 — 
 Neck symptom/complaint 769 0.5 0.8 0.7 0.9 — 
Circulatory 9,607 6.5 10.0 9.4 10.6 9.6 
(9.0–10.1) 
 Cardiovascular check-up* 4,156 2.8 4.3 3.9 4.7 — 
 Hypertension/high blood pressure* 1,840 1.2 1.9 1.6 2.3 — 
 Prescription – cardiovascular 680 0.5 0.7 0.6 0.8 — 
Digestive 9,331 6.3 9.7 9.4 10.6 8.7 
(8.4–8.9) 
 Abdominal pain* 1,970 1.3 2.1 1.9 2.2 — 
 Diarrhoea 1,157 0.8 1.2 1.1 1.3 — 
 Vomiting 814 0.5 0.8 0.8 0.9 — 
Psychological 8,876 6.0 9.3 8.8 9.7 8.4 
(8.0–8.8) 
 Depression* 2,034 1.4 2.1 1.9 2.3 — 
 Anxiety* 1,372 0.9 1.4 1.3 1.6 — 
 Sleep disturbance 942 0.6 1.0 0.9 1.1 — 
Endocrine and metabolic 6,043 4.1 6.3 5.9 6.7 6.0 
(5.7–6.4) 
 Diabetes (non-gestational)* 1,299 0.9 1.4 1.2 1.5 — 
 Prescription – endocrine/metabolic 912 0.6 1.0 0.8 1.1 — 
Female genital system 4,532 3.0 4.7 4.4 5.0 4.4 
(4.1–4.7) 
 Female genital check-up/Pap smear* 1,664 1.1 1.7 1.6 1.9 — 
Neurological 4,141 2.8 4.3 4.1 4.5 4.1 
(3.9–4.7) 
 Headache* 1,444 1.0 1.5 1.4 1.6 — 
 Vertigo/dizziness 993 0.7 1.0 1.0 1.1 — 
Ear 3,219 2.2 3.4 3.2 3.5 3.2 
(3.1–3.4) 
 Ear pain/earache 1,159 0.8 1.2 1.1 1.3 — 
Pregnancy and family planning 2,885 1.9 3.0 2.8 3.2 2.9 
(2.7–3.1) 
(continued) 
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 Table 6.4 (continued): Patient reasons for encounter by ICPC-2 chapter and most frequent 
individual reasons for encounter within chapter  
Reasons for encounter Number 
Per cent of 
total RFEs(a) 
(n = 148,880) 
Rate per 100 
encounters 
(n = 95,879) 
95%  
LCL 
95%  
UCL 
Per cent of 
encounters(b)  
(n = 95,879) 
(95% CI) 
Urology 2,662 1.8 2.8 2.6 2.9 2.5 
(2.4–2.7) 
Eye 1,954 1.3 2.0 1.9 2.2 1.9 
(1.8–2.1) 
Blood and blood-forming organs 1,660 1.1 1.7 1.6 1.9 1.7 
(1.6–1.9) 
 Blood test – blood and blood 
 forming organs 
1,064 0.7 1.1 1.0 1.3 — 
Male genital system 1,151 0.8 1.2 1.1 1.3 1.2 
(1.1–1.3) 
Social 1,060 0.7 1.1 1.0 1.2 1.1 
(1.0–1.2) 
Total RFEs 148,880 100.0 155.3 153.3 157.3 — 
(a) Only individual RFEs accounting for ≥ 0.5% of total RFEs are included. 
(b) The proportion of all encounters at which the patient described at least one reason for encounter that was classified in the chapter. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Table A4.1 <hdl.handle.net/2123/11882>). 
Note: RFEs – reasons for encounter; LCL – lower confidence limit; UCL – upper confidence limit; CI – confidence interval; NEC – not elsewhere 
classified; NOS – not otherwise specified. 
Most frequent patient reasons for encounter 
The 30 most commonly recorded RFEs (Table 6.5), accounted for more than half (58.7%) of 
all RFEs. In this analysis, the specific ICPC-2 chapter to which an across-chapter concept 
belongs is disregarded, so that, for example, ‘check-up – all’ includes all check-ups from all 
ICPC-2 chapters, irrespective of whether or not the body system was specified.  
Of the top 30 RFEs (Table 6.5), most were either symptom or disease descriptions such as 
cough, throat complaint, back complaint and rash. However, four of the top five RFEs 
reflected requests for a process of care (that is, requests for check-up, prescription, test result 
and immunisation), and together accounted for about one-quarter of all RFEs (27.0%). 
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  Table 6.5: Thirty most frequent patient reasons for encounter 
Patient reason for encounter Number 
Per cent of  
total RFEs 
(n = 148,880) 
Rate per 100 
encounters 
(n = 95,879) 
95%  
LCL 
95%  
UCL 
Check-up – all* 13,601 9.1 14.2 13.5 14.8 
Prescription – all* 12,671 8.5 13.2 12.5 13.9 
Test results* 9,000 6.0 9.4 8.9 9.9 
Cough 5,245 3.5 5.5 5.1 5.9 
Immunisation/vaccination – all* 4,968 3.3 5.2 4.6 5.8 
Administrative procedure – all* 3,114 2.1 3.2 3.0 3.5 
Back complaint* 3,110 2.1 3.2 3.0 3.5 
Blood test – all* 2,544 1.7 2.7 2.4 2.9 
Rash* 2,481 1.7 2.6 2.4 2.8 
Throat symptom/complaint 2,392 1.6 2.5 2.3 2.7 
Depression* 2,034 1.4 2.1 1.9 2.3 
Abdominal pain* 1,970 1.3 2.1 1.9 2.2 
Hypertension/high blood pressure* 1,840 1.2 1.9 1.6 2.3 
Skin symptom/complaint, other 1,756 1.2 1.8 1.7 2.0 
Fever 1,722 1.2 1.8 1.5 2.1 
Observation/health education/advice/diet – all* 1,660 1.1 1.7 1.6 1.9 
Upper respiratory tract infection 1,616 1.1 1.7 1.5 1.9 
Headache* 1,444 1.0 1.5 1.4 1.6 
Anxiety* 1,372 0.9 1.4 1.3 1.6 
Other referrals NEC 1,347 0.9 1.4 1.3 1.5 
Diabetes – all* 1,311 0.9 1.4 1.2 1.5 
Weakness/tiredness 1,311 0.9 1.4 1.2 1.5 
Knee symptom/complaint 1,259 0.8 1.3 1.2 1.4 
Ear pain/earache 1,159 0.8 1.2 1.1 1.3 
Diarrhoea 1,157 0.8 1.2 1.1 1.3 
Sneezing/nasal congestion 1,146 0.8 1.2 1.0 1.4 
Shoulder symptom/complaint 1,128 0.8 1.2 1.1 1.3 
Foot/toe symptom/complaint 1,056 0.7 1.1 1.0 1.2 
Vertigo/dizziness 993 0.7 1.0 1.0 1.1 
Swelling (skin)* 984 0.7 1.0 0.9 1.1 
Subtotal 87,392 58.7 — — — 
Total RFEs 148,880 100.0 155.3 153.3 157.3 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Table A4.1, <hdl.handle.net/2123/11882>). 
Note: RFEs – reasons for encounter; LCL – lower confidence limit; UCL – upper confidence limit; NEC – not elsewhere classified. 
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 6.4  Changes in patients and their reasons for 
encounter over the decade 2004–05 to 2013–14 
An overview of changes in the characteristics of patients at encounters and their reasons for 
encounter over the decade 2004–05 to 2013–14, can be found in Chapter 6 of the companion 
report, A decade of Australian general practice activity 2004–05 to 2013–14.1 Major changes are 
summarised below.  
With the ageing of the Australian population, the proportion of the Australian population 
that was aged 65 years and over increased from 12.8% in 2004 to 14.4% in 2013.2 Over the 
same period, the proportion of BEACH encounters with patients aged 65 years and over 
increased from 26.5% to 32.5%. When extrapolated, this change (in combination with the 
increased number of encounters nationally) means that in 2013–14 there were 17.3 million 
more encounters with older patients nationally than a decade earlier. 
The increase in the proportion of encounters with older patients was greater than the 
population increase in this age group, because older patients attend general practice more 
often than do younger patients.73 This change in the age distribution of patients at GP 
encounters will affect all aspects of general practice as older patients are more likely to have 
more problems managed at encounters, more chronic conditions managed and are more 
likely to have multimorbidity.74  
There was a significant decrease in the proportion of encounters with patients who were 
new to the practice (from 9.1% in 2004–05 to 6.6% in 2013–14). This may be due to the need 
for continuity of care for chronic conditions. The proportion of encounters with patients 
holding a Commonwealth concession card decreased from 47.5% to 43.5% over the decade. 
The proportion of patients holding a Repatriation health card decreased by one-third, from 
3.6% in 2004–05 to 2.2% in 2013–14. This is probably due to a decline in the number of World 
War 2 veterans and their partners in the population. 
Over the decade, there was a significant increase in the number of reasons for encounter 
recorded per 100 encounters, from 149.6 in 2004–05 to 155.3 in 2013–14, with fewer patients 
giving a single RFE and more giving two or three RFEs. This increase in RFEs is also 
probably related to the increasing proportion of encounters with older people, who are more 
likely to visit for multiple chronic disease management. There was a significant decrease in 
the rate of RFEs described as symptoms and complaints, and increases in rates of patient 
presentations for tests and test results. This is also probably due to the increased proportion 
of encounters that are with older patients and the increase in chronic condition management 
which require regular attendance and monitoring. The increase in patients’ requests for tests 
and test results ties in with the increased use of pathology and imaging testing over the 
decade. One increase unrelated to the ageing of the population was a large increase in 
requests for administrative procedures such as sickness certificates. This is probably due to 
an increasing number of policies forcing workers to provide such documentation to claim 
sick days. 
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 7 Problems managed 
A ‘problem managed’ is a formal statement of the provider’s understanding of a health 
problem presented by the patient, family or community, and can be described in terms of a 
disease, symptom or complaint, social problem or ill-defined condition managed at the 
encounter. GPs were instructed to record each problem at the most specific level possible 
from the information available. As a result, the problem managed may at times be limited to 
the level of a presenting symptom. 
At each patient encounter, up to four problems could be recorded by the GP. A minimum of 
one problem was compulsory. The status of each problem to the patient – new (first 
presentation to a medical practitioner) or old (follow-up of previous problem) – was also 
indicated. The concept of a principal diagnosis, which is often used in hospital statistics, is 
not adopted in studies of general practice where multiple problem management is the norm 
rather than the exception. Further, the range of problems managed at the encounter often 
crosses multiple body systems and may include undiagnosed symptoms, psychosocial 
problems or chronic disease, which makes the designation of a principal diagnosis difficult. 
Thus, the order in which the problems were recorded by the GP is not significant. All 
problems managed include those that involved management by a practice nurse at the 
recorded encounter, which are also reported separately in Chapter 10.  
There are two ways to describe the frequency of problems managed: as a percentage of all 
problems managed in the study or as a rate at which problems are managed per 
100 encounters. Where groups of problems are reported (for example, circulatory problems) 
it must be remembered that more than one of that type of problem (such as hypertension 
and heart failure) may have been managed at a single encounter. We therefore report these 
data in a variety of ways to aid interpretation and reporting.  
The reader must be mindful that although a rate per 100 encounters for a single ungrouped 
problem that can only be managed once per encounter, (for example, ‘asthma, 2.0 per 100 
encounters’), can be regarded as equivalent to ‘asthma is managed at 2.0% of encounters’, 
such a statement cannot be made for grouped concepts (ICPC-2 chapters and those marked 
with asterisks in the tables). A new column has been added to Table 7.3 in this year’s report 
describing the proportion of encounters during which at least one problem within each 
ICPC-2 chapter was managed. This allows users to make the following types of statements: 
‘at least one psychological problem was managed at 12.8% of encounters’; or (using the 
extrapolation methods described in Chapter 2) ‘at least one digestive problem was managed 
at 14.3 million general practice encounters in 2013–14.’  
Changes in the problems managed in Australian general practice from the BEACH study are 
reported for each year from 2004–05 to 2013–14 in the 10-year report, A decade of Australian 
general practice activity 2004–05 to 2013–14.1  
7.1 Number of problems managed at encounter 
In 2013–14, there were 151,675 problems managed, at a rate of 158.2 per 100 encounters 
(Table 7.2, total row). Up to four problems managed can be recorded at each BEACH 
encounter, (see Chapter 2). Table 7.1 shows that one problem was managed at 59.6% of 
encounters and two problems managed at more than one-quarter of encounters (26.3%). 
Approximately 10% of encounters involved the management of three problems (10.4%), and 
four problems were managed at only 3.7% of encounters. 
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 Table 7.1: Number of problems managed at an encounter 
Number of problems managed at encounter Number of encounters Per cent 95% LCL 95% UCL 
One problem 57,156 59.6 58.2 61.0 
Two problems 25,195 26.3 25.5 27.1 
Three problems 9,985 10.4 9.8 11.0 
Four problems 3,544 3.7 3.3 4.1 
Total 95,879 100.0 — — 
Note: LCL – lower confidence limit; UCL – upper confidence limit. 
Figure 7.1 shows the age–sex-specific rates of problems managed. The number of problems 
managed increased steadily with the age of the patient from young adulthood up to those 
aged 65–74 years.  
Significantly more problems were managed overall at encounters with female patients 
(160.8 per 100 encounters, 95% CI: 158.1–163.4) than at those with male patients (155.0 per 
100 encounters, 95% CI: 152.4–157.6) (results not tabled). Figure 7.1 demonstrates that this 
difference was evident in the 15–24, 25–44 and 45–64 year age groups. For both sexes, the 
number of problems managed at encounters significantly increased with each step in adult 
age up to those aged 45–64. There was no difference in the average number of problems 
managed between males and females for those aged 65–74 and 75 years and over. 
 
 
Note: Missing data removed. 
Figure 7.1: Age–sex-specific rates of problems managed per 100 encounters, 2013–14 
(95% confidence intervals) 
<1 1–4 5–14 15–24 25–44 45–64 65–74 75+
Male 123.4 118.8 118.8 124.2 138.5 162.5 180.8 177.3
Female 122.6 116.6 118.4 138.9 146.8 169.7 182.8 181.3
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 7.2 Problems managed by ICPC-2 component 
A broader view of the types of problems managed in general practice can be seen by 
examining problems managed from the perspective of the component structure of the  
ICPC-2 classification (as described in Section 2.8). Table 7.2 lists the distribution of problems 
managed by ICPC-2 component.  
Nearly two-thirds (65.1%) of problems were described as diagnoses or diseases. Of these, the 
majority were ‘other diagnoses’ (accounting for 42.9% of all problems managed), followed 
by infections (13.9%), injuries (4.6%) and neoplasms (3.2%). 
Nearly 1 in 5 problems (19.1%) were undiagnosed, and managed as a symptom or 
complaint. In some situations, rather than providing clinical descriptions of the problem 
under management, processes of care were recorded. The processes recorded most often 
were diagnostic and preventive procedures (e.g. check-ups), accounting for 9.9% of 
problems managed. 
At an ‘average’ 100 encounters GPs managed 103 diagnoses/diseases: 22 infections; 7 
injuries; and 5 neoplasms. They also managed an average of 30 symptoms and complaints, 
and 16 problems described as a diagnostic and preventive procedure.  
Table 7.2: Problems managed by ICPC-2 component 
ICPC-2 component Number 
Per cent of 
total problems 
(n = 151,675) 
Rate per 100 
encounters 
(n = 95,879) 
95% 
 LCL 
95% 
 UCL 
Diagnosis, diseases 98,669 65.1 102.9 100.8 105.0 
 Infections 21,018 13.9 21.9 21.1 22.7 
 Injuries 7,006 4.6 7.3 7.0 7.6 
 Neoplasms 4,836 3.2 5.0 4.7 5.4 
 Congenital anomalies 697 0.5 0.7 0.6 0.8 
 Other diagnoses 65,112 42.9 67.9 65.9 69.9 
Symptoms and complaints 29,034 19.1 30.3 29.3 31.2 
Diagnostic and preventive procedures 15,076 9.9 15.7 14.9 16.6 
Medications, treatments and therapeutics 4,257 2.8 4.4 4.1 4.8 
Results 2,083 1.4 2.2 1.9 2.4 
Administrative 1,339 0.9 1.4 1.2 1.6 
Referrals and other RFEs 1,216 0.8 1.3 1.1 1.4 
Total problems  151,675 100.0 158.2 155.7 160.7 
Note: LCL – lower confidence limit; UCL – upper confidence limit; RFE – reason for encounter.  
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 7.3 Problems managed by ICPC-2 chapter 
The frequency and the distribution of problems managed are presented in Table 7.3 by 
ICPC-2 chapter (equivalent to body systems, as described in Chapter 2). Rates per 100 
encounters and the proportion of total problems are provided at the ICPC-2 chapter level, 
and for frequent individual problems within each chapter. Individual problems accounting 
for at least 0.5% of all problems managed are listed in the table, in decreasing order of 
frequency within chapter. 
The most common problems managed were: 
• problems of a general and unspecified nature (20.3 per 100 encounters and 12.8% of all 
problems), particularly general check-ups, prescriptions and general immunisations  
• respiratory problems (19.0 per 100 encounters), in particular upper respiratory tract 
infections, respiratory immunisations, asthma and acute bronchitis/bronchiolitis  
• those classified to the musculoskeletal system (18.4 per 100 encounters), such as arthritis 
and back complaints 
• skin problems (17.9 per 100 encounters), contact dermatitis and malignant skin 
neoplasms being the most common 
• circulatory problems (17.3 per 100), led by hypertension and atrial fibrillation  
• psychological problems (13.7 per 100), with depression and anxiety being the most 
common (Table 7.3). 
The last column in Table 7.3, a new addition this year, describes the proportion of 
encounters at which at least one problem within an ICPC-2 chapter was managed. GPs may 
manage more than one problem within an ICPC-2 chapter (e.g. depression and anxiety; 
rheumatoid arthritis and osteoporosis), but this table reports only one instance per chapter.  
At least one general and unspecified problem was managed at 18.7% of encounters in  
2013–14, equating to approximately 24.9 million encounters at which at least one general and 
unspecified problem was managed in 2013–14. At least one respiratory problem was 
managed at 18.2% of encounters, which extrapolates to 24.3 million encounters at which at 
least one respiratory problem was managed nationally in 2013–14 (Table 7.3). 
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 Table 7.3: Problems managed by ICPC-2 chapter and frequent individual problems within chapter  
Problem managed  Number 
Per cent total 
problems(a)  
(n = 151,675) 
Rate per 100 
encounters 
(n = 95,879) 
95%  
LCL 
95%  
UCL 
Per cent of 
encounters(b)  
(n = 95,879) 
(95% CI) 
General and unspecified 19,462 12.8 20.3 19.4 21.2 18.7 
(18.0–19.4) 
 General check-up* 2,925 1.9 3.1 2.8 3.3 — 
 Prescription NOS 1,897 1.3 2.0 1.8 2.2 — 
 Immunisation/vaccination NOS 1,821 1.2 1.9 1.7 2.1 — 
 Results tests/procedures NOS 1,624 1.1 1.7 1.5 1.9 — 
 Administrative procedure NOS 1,221 0.8 1.3 1.1 1.4 — 
 Viral disease, other/NOS 1,050 0.7 1.1 0.9 1.2 — 
 Abnormal result/investigation NOS 997 0.7 1.0 0.9 1.1 — 
 Weakness/tiredness, general 714 0.5 0.7 0.7 0.8 — 
Respiratory 18,251 12.0 19.0 18.3 19.8 18.2 
(17.5–18.9) 
 Upper respiratory tract infection 4,705 3.1 4.9 4.5 5.3 — 
 Immunisation/vaccination – 
 respiratory 
3,460 2.3 3.6 3.0 4.2 — 
 Asthma 1,874 1.2 2.0 1.8 2.1 — 
 Acute bronchitis/bronchiolitis 1,781 1.2 1.9 1.7 2.0 — 
 Sinusitis acute/chronic  1,036 0.7 1.1 1.0 1.2 — 
 Chronic obstructive pulmonary 
 disease 
941 0.6 1.0 0.9 1.1 — 
Musculoskeletal 17,607 11.6 18.4 17.8 18.9 17.4 
(16.9–17.9) 
 Arthritis – all* 3,781 2.5 3.9 3.7 4.2 — 
  Osteoarthritis* 2,761 1.8 2.9 2.7 3.1 — 
 Back complaint* 3,016 2.0 3.1 2.9 3.4 — 
 Sprain/strain* 1,228 0.8 1.3 1.2 1.4 — 
 Bursitis/tendonitis/synovitis NOS 1,206 0.8 1.3 1.2 1.4 — 
 Fracture* 991 0.7 1.0 0.9 1.1 — 
 Injury musculoskeletal NOS 861 0.6 0.9 0.8 1.0 — 
 Osteoporosis 837 0.6 0.9 0.8 1.0 — 
Skin 17,150 11.3 17.9 17.2 18.6 16.8 
(16.2–17.4) 
 Contact dermatitis 1,630 1.1 1.7 1.6 1.8 — 
 Malignant neoplasm, skin 1,348 0.9 1.4 1.2 1.6 — 
 Solar keratosis/sunburn 1,214 0.8 1.3 1.1 1.4 — 
 Skin disease, other 1,103 0.7 1.2 1.0 1.3 — 
 Laceration/cut 998 0.7 1.0 0.9 1.1 — 
 Skin symptom/complaint, other 782 0.5 0.8 0.7 0.9 — 
 Chronic skin ulcer (including 
 varicose ulcer) 
686 0.5 0.7 0.6 0.8 — 
(continued) 
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 Table 7.3 (continued): Problems managed by ICPC-2 chapter and frequent individual problems 
within chapter 
Problem managed  Number 
Per cent total 
problems(a)  
(n = 151,675) 
Rate per 100 
encounters 
(n = 95,879) 
95%  
LCL 
95%  
UCL 
Per cent of 
encounters(b)  
(n = 95,879) 
(95% CI) 
Circulatory 16,572 10.9 17.3 16.5 18.1 16.1 
(15.3–16.8) 
 Hypertension* 8,297 5.5 8.7 8.1 9.2 — 
 Atrial fibrillation/flutter 1,450 1.0 1.5 1.4 1.7 — 
 Cardiovascular check-up* 1,117 0.7 1.2 0.9 1.4 — 
 Ischaemic heart disease* 1,096 0.7 1.1 1.0 1.3 — 
Psychological 13,091 8.6 13.7 13.0 14.3 12.8 
(12.3–13.4) 
 Depression* 4,123 2.7 4.3 4.1 4.5 — 
 Anxiety* 2,155 1.4 2.2 2.1 2.4 — 
 Sleep disturbance 1,480 1.0 1.5 1.4 1.7 — 
 Acute stress reaction 737 0.5 0.8 0.7 0.9 — 
Endocrine and metabolic 13,001 8.6 13.6 13.0 14.1 12.4 
(11.9–12.8) 
 Diabetes (non-gestational)* 4,002 2.6 4.2 3.9 4.4 — 
 Lipid disorder 2,953 1.9 3.1 2.8 3.3 — 
 Vitamin/nutritional deficiency 1,338 0.9 1.4 1.3 1.5 — 
 Hypothyroidism/myxoedema  818 0.5 0.9 0.8 0.9 — 
 Obesity (BMI > 30) 705 0.5 0.7 0.6 0.8 — 
Digestive 10,691 7.0 11.2 10.8 11.5 10.7 
(10.4–11.0) 
 Gastro-oesophageal reflux disease* 2,467 1.6 2.6 2.4 2.7 — 
 Gastroenteritis* 1,315 0.9 1.4 1.2 1.5 — 
 Constipation 697 0.5 0.7 0.7 0.8 — 
 Abdominal pain* 693 0.5 0.7 0.7 0.8 — 
Female genital system 5,352 3.5 5.6 5.2 5.9 5.2 
(4.8–5.5) 
 Female genital check-up/Pap 
 smear* 
1,597 1.1 1.7 1.5 1.8 — 
Neurological 3,820 2.5 4.0 3.8 4.2 3.9 
(3.7–4.1) 
 Headache* 1,025 0.7 1.1 1.0 1.2 — 
Urology 3,485 2.3 3.6 3.5 3.8 3.6 
(3.4–3.8) 
 Urinary tract infection* 1,724 1.1 1.8 1.7 1.9 — 
Ear 3,380 2.2 3.5 3.4 3.7 3.5 
(3.3–3.6) 
 Acute otitis media/myringitis 809 0.5 0.8 0.8 0.9 — 
 Excessive ear wax 787 0.5 0.8 0.8 0.9 — 
(continued) 
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 Table 7.3 (continued): Problems managed by ICPC-2 chapter and frequent individual problems 
within chapter 
Problem managed  Number 
Per cent total 
problems(a)  
(n = 151,675) 
Rate per 100 
encounters 
(n = 95,879) 
95%  
LCL 
95%  
UCL 
Per cent of 
encounters  
(n = 95,879) 
(95% CI) 
Pregnancy and family planning 3,349 2.2 3.5 3.2 3.7 3.4 
(3.2–3.6) 
 Pregnancy* 1,084 0.7 1.1 1.0 1.3 — 
 Oral contraception* 931 0.6 1.0 0.9 1.1 — 
Eye 2,144 1.4 2.2 2.1 2.4 2.2 
(2.1–2.3) 
Male genital system 1,858 1.2 1.9 1.8 2.1 1.9 
(1.8–2.0) 
Blood and blood-forming organs 1,606 1.1 1.7 1.6 1.8 1.7 
(1.5–1.8) 
Social 856 0.6 0.9 0.8 1.0 0.9 
(0.8–1.0) 
Total problems 151,675 100.0 158.2 155.7 160.7 — 
(a) Only those individual problems accounting for ≥ 0.5% of total problems are included in the table. 
(b) The proportion of all encounters at which at least one problem classified in this chapter was managed. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Table A4.1 <hdl.handle.net/2123/11882>). 
Note: LCL – lower confidence limit; UCL – upper confidence limit; CI – confidence interval; NOS – not otherwise specified. 
7.4 Most frequently managed problems 
Table 7.4 shows the most frequently managed individual problems in general practice, in 
decreasing order of frequency. These 35 problems accounted for 53.7% of all problems 
managed, and the top 10 problems accounted for 30.3%. 
In this analysis, the specific chapter to which ‘across chapter concepts’ (for example, 
check-ups, immunisation/vaccination and prescriptions) apply is ignored, and the concept 
is grouped with all similar concepts regardless of body system. For example, immunisation/ 
vaccination includes vaccinations for influenza, childhood diseases, hepatitis and many 
others. 
Hypertension was the most common problem managed (8.7 per 100 encounters), followed 
by check-up (7.0 per 100), immunisation/vaccination (5.8 per 100), upper respiratory tract 
infection (URTI) (4.9 per 100) and depression (4.3 per 100) (Table 7.4).  
The percentage of each problem that was ‘new’ is listed in the far right column in Table 7.4. 
If a problem was new to the patient, or a new episode of a recurrent problem and the patient 
had not been treated for that problem or episode by any medical practitioner before the 
encounter, it was considered a new problem. This can provide a measure of general practice 
incidence. For example, only 4.5% of all contacts with hypertension were new diagnoses. In 
contrast, 77.3% of URTI problems were new to the patient, suggesting that the majority of 
people with URTIs who attend the GP do so only once per episode.  
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 Table 7.4: Most frequently managed problems 
Problem managed Number 
Per cent of 
total problems 
(n = 151,675) 
Rate per 100 
encounters 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
New as per 
cent of all 
problems(a) 
Hypertension* 8,297 5.5 8.7 8.1 9.2 4.5 
Check-up – all* 6,670 4.4 7.0 6.5 7.4 42.6 
Immunisation/vaccination – all* 5,515 3.6 5.8 5.1 6.4 64.5 
Upper respiratory tract infection 4,705 3.1 4.9 4.5 5.3 77.3 
Depression* 4,123 2.7 4.3 4.1 4.5 13.3 
Diabetes – all* 4,038 2.7 4.2 3.9 4.5 5.2 
Arthritis – all* 3,829 2.5 4.0 3.8 4.2 18.2 
Back complaint* 3,016 2.0 3.1 2.9 3.4 23.7 
Lipid disorder 2,953 1.9 3.1 2.8 3.3 9.6 
Prescription – all* 2,950 1.9 3.1 2.7 3.4 6.3 
Gastro-oesophageal reflux 
disease* 
2,467 1.6 2.6 2.4 2.7 14.9 
Anxiety* 2,155 1.4 2.2 2.1 2.4 20.4 
Test results* 2,083 1.4 2.2 1.9 2.4 31.8 
Asthma 1,874 1.2 2.0 1.8 2.1 20.7 
Acute bronchitis/bronchiolitis 1,781 1.2 1.9 1.7 2.0 69.9 
Urinary tract infection* 1,724 1.1 1.8 1.7 1.9 64.1 
Contact dermatitis 1,630 1.1 1.7 1.6 1.8 44.6 
Sleep disturbance 1,480 1.0 1.5 1.4 1.7 21.0 
Atrial fibrillation/flutter 1,450 1.0 1.5 1.4 1.7 6.1 
Malignant neoplasm, skin 1,348 0.9 1.4 1.2 1.6 57.4 
Administrative procedure – all* 1,339 0.9 1.4 1.2 1.6 42.0 
Vitamin/nutritional deficiency 1,338 0.9 1.4 1.3 1.5 28.6 
Gastroenteritis* 1,315 0.9 1.4 1.2 1.5 77.4 
Abnormal test results* 1,241 0.8 1.3 1.2 1.4 45.8 
Sprain/strain* 1,228 0.8 1.3 1.2 1.4 63.0 
Solar keratosis/sunburn 1,214 0.8 1.3 1.1 1.4 50.6 
Bursitis/tendonitis/synovitis NOS 1,206 0.8 1.3 1.2 1.4 55.6 
Skin disease, other 1,103 0.7 1.2 1.0 1.3 59.0 
Ischaemic heart disease* 1,096 0.7 1.1 1.0 1.3 8.8 
Pregnancy* 1,084 0.7 1.1 1.0 1.3 39.0 
Viral disease, other/NOS  1,050 0.7 1.1 0.9 1.2 74.8 
Sinusitis acute/chronic 1,036 0.7 1.1 1.0 1.2 61.4 
Headache* 1,025 0.7 1.1 1.0 1.2 32.0 
Laceration/cut 998 0.7 1.0 0.9 1.1 41.4 
Fracture* 991 0.7 1.0 0.9 1.1 44.0 
Subtotal  81,352 53.7 — — — — 
Total problems 151,675 100.0 158.2 155.7 160.7 37.0 
(a) The proportion of total contacts with this problem that were accounted for by new problems. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Table A4.1 <hdl.handle.net/2123/11882>). 
Note: LCL – lower confidence limit; UCL – upper confidence limit; NOS – not otherwise specified. 
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 7.5 Most common new problems 
For each problem managed, participating GPs are asked to indicate whether the problem 
under management was a new problem for the patient (see definition in Section 7.4). 
Table 7.5 lists the most common new problems managed in general practice, in decreasing 
order of frequency. Overall, 56,126 problems (37.0% of all problems) were specified as being 
new, being managed at a rate of 58.5 per 100 encounters. 
New problems were often acute in nature, such as URTI (3.8 per 100 encounters), acute 
bronchitis/bronchiolitis (1.3 per 100) and urinary tract infection (1.2 per 100). Preventive 
activities were also frequently recorded, including immunisation/ 
vaccination (3.7 per 100 encounters) and check-ups (3.0 per 100) (Table 7.5). 
The far right column of this table shows the new cases of this problem as a proportion of 
total contacts with this problem. This provides an indication of the incidence of each 
problem. For example, the 549 new cases of depression represented only 13% of all GP 
contacts with diagnosed depression, suggesting that by far the majority of contacts for 
depression were for ongoing management. In contrast, 77% of gastroenteritis contacts were 
first consultations with a medical practitioner for this episode, the balance (23%) being 
follow-up consultations for this episode. This indicates that most patients only require one 
visit to a GP for the management of an episode of gastroenteritis. 
Table 7.5: Most frequently managed new problems 
New problem managed Number 
Per cent of total 
 new problems 
(n = 56,126) 
Rate per 100 
 encounters 
(n = 95,879) 
95% 
 LCL 
95% 
UCL 
New as per 
cent of all 
problems(a) 
Upper respiratory tract infection 3,639 6.5 3.8 3.5 4.1 77.3 
Immunisation/vaccination – all* 3,557 6.3 3.7 3.2 4.2 64.5 
Check-up – all* 2,842 5.1 3.0 2.7 3.2 42.6 
Acute bronchitis/bronchiolitis 1,245 2.2 1.3 1.2 1.4 69.9 
Urinary tract infection* 1,105 2.0 1.2 1.1 1.3 64.1 
Gastroenteritis* 1,018 1.8 1.1 1.0 1.2 77.4 
Viral disease, other/NOS 785 1.4 0.8 0.7 1.0 74.8 
Sprain/strain* 774 1.4 0.8 0.7 0.9 63.0 
Malignant neoplasm, skin 774 1.4 0.8 0.7 0.9 57.4 
Contact dermatitis  726 1.3 0.8 0.7 0.8 44.6 
Back complaint* 715 1.3 0.7 0.7 0.8 23.7 
Arthritis – all* 698 1.2 0.7 0.7 0.8 18.2 
Bursitis/tendonitis/synovitis NOS 671 1.2 0.7 0.6 0.8 55.6 
Test results* 662 1.2 0.7 0.6 0.8 31.8 
Skin disease, other 651 1.2 0.7 0.6 0.8 59.0 
Sinusitis acute/chronic  637 1.1 0.7 0.6 0.7 61.4 
Solar keratosis/sunburn 615 1.1 0.6 0.5 0.7 50.6 
Acute otitis media/myringitis 578 1.0 0.6 0.5 0.7 71.5 
Abnormal test results* 569 1.0 0.6 0.5 0.7 45.8 
Administrative procedure – all* 563 1.0 0.6 0.5 0.7 42.0 
Depression* 549 1.0 0.6 0.5 0.6 13.3 
(continued) 
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 Table 7.5 (continued): Most frequently managed new problems 
New problem managed Number 
Per cent of total 
 new problems 
(n = 56,126) 
Rate per 100 
 encounters 
(n = 95,879) 
95% 
 LCL 
95% 
UCL 
New as per 
cent of all 
problems(a) 
Excessive ear wax 500 0.9 0.5 0.5 0.6 63.6 
Tonsillitis* 483 0.9 0.5 0.4 0.6 73.3 
Skin symptom/complaint 476 0.8 0.5 0.4 0.6 60.8 
Observation/health education/ 
advice/diet – all* 
456 0.8 0.5 0.4 0.5 54.8 
Musculoskeletal injury NOS 450 0.8 0.5 0.4 0.5 52.2 
Anxiety* 439 0.8 0.5 0.4 0.5 20.4 
Fracture* 436 0.8 0.5 0.4 0.5 44.0 
Pregnancy* 422 0.8 0.4 0.4 0.5 39.0 
Subtotal 27,035 48.3 — — — — 
Total new problems 56,126 100.0 58.5 57.0 60.1 — 
(a) The proportion of total contacts with this problem that were accounted for by new problems. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Table A4.1 <hdl.handle.net/2123/11882>). 
Note: LCL – lower confidence limit; UCL – upper confidence limit; NOS – not otherwise specified. 
7.6 Most frequently managed chronic problems 
To identify chronic conditions, a list classified according to ICPC-2, based on work 
undertaken by O’Halloran et al. in 200442 and regularly updated (see ‘Chronic conditions’ 
grouper G84 in the ‘Analysis and reporting’ section of the ICPC-2 PLUS Demonstrator75), 
was applied to the BEACH data set. More than one-third (35.6%) of the problems managed 
in general practice were chronic. At least one chronic problem was managed at 42.4% of 
encounters (95% CI: 41.2–43.5) (results not tabled), and chronic problems were managed at 
an average rate of 56.3 per 100 encounters (Table 7.6). 
In other parts of this chapter, both chronic and non-chronic conditions (for example, 
diabetes and gestational diabetes) may have been grouped together when reporting (for 
example, diabetes – all*, Table 7.4). In this section, only problems regarded as chronic have 
been included in the analysis. For this reason, the condition labels and figures in this 
analysis may differ from those in Table 7.4. Where the group used for the chronic analysis 
differs from that used in other analyses in this report, the labels are marked with a double 
asterisk (for example, Diabetes [non-gestational]**). Codes included (asterisked concepts) 
can be found in Appendix 4, Table A4.2. 
Table 7.6 shows the most frequently managed chronic problems in descending order of 
frequency. Together, these 30 chronic problems accounted for 79.6% of all chronic problems 
managed, and for 28.3% of all problems managed. Half of all chronic problems managed 
(51.0%) were accounted for by the top seven chronic problems: non-gestational hypertension 
(15.3% of chronic conditions), depressive disorder (7.6%), non-gestational diabetes (7.4%), 
chronic arthritis (7.1%), lipid disorder (5.5%), oesophageal disease (4.6%) and asthma (3.5%) 
(Table 7.6).  
Extrapolation of these results suggests that, across Australia in 2013–14, there were 
11.5 million encounters involving non-gestational hypertension, 5.7 million involving 
depression and 5.6 million involving non-gestational diabetes.  
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 Table 7.6: Most frequently managed chronic problems 
Chronic problem managed Number 
Per cent of total 
chronic problems 
(n = 54,027) 
Rate per 100 
encounters 
(n = 95,879) 
95% 
 LCL 
95% 
UCL 
Hypertension (non-gestational)** 8,284 15.3 8.6 8.1 9.2 
Depressive disorder** 4,092 7.6 4.3 4.0 4.5 
Diabetes (non-gestational)** 4,002 7.4 4.2 3.9 4.4 
Chronic arthritis** 3,815 7.1 4.0 3.8 4.2 
Lipid disorder 2,953 5.5 3.1 2.8 3.3 
Oesophageal disease 2,510 4.6 2.6 2.5 2.8 
Asthma 1,874 3.5 2.0 1.8 2.1 
Atrial fibrillation/flutter 1,450 2.7 1.5 1.4 1.7 
Malignant neoplasm, skin 1,348 2.5 1.4 1.2 1.6 
Ischaemic heart disease** 1,096 2.0 1.1 1.0 1.3 
Chronic obstructive pulmonary disease 941 1.7 1.0 0.9 1.1 
Back syndrome with radiating pain** 938 1.7 1.0 0.9 1.1 
Osteoporosis 837 1.5 0.9 0.8 1.0 
Hypothyroidism/myxoedema 818 1.5 0.9 0.8 0.9 
Obesity (BMI > 30) 705 1.3 0.7 0.6 0.8 
Chronic skin ulcer (including varicose ulcer) 686 1.3 0.7 0.6 0.8 
Shoulder syndrome (excluding arthritis)** 614 1.1 0.6 0.6 0.7 
Migraine 581 1.1 0.6 0.5 0.7 
Heart failure 572 1.1 0.6 0.5 0.7 
Dementia (including senile, Alzheimer’s) 546 1.0 0.6 0.4 0.7 
Gout 544 1.0 0.6 0.5 0.6 
Chronic pain NOS 520 1.0 0.5 0.5 0.6 
Anxiety disorder** 493 0.9 0.5 0.4 0.6 
Chronic back pain** 475 0.9 0.5 0.4 0.6 
Schizophrenia 457 0.8 0.5 0.4 0.5 
Chronic kidney disease** 423 0.8 0.4 0.4 0.5 
Chronic acne** 400 0.7 0.4 0.4 0.5 
Back syndrome without radiating pain 
(excluding arthritis, sprains and strains)** 
351 0.6 0.4 0.3 0.4 
Malignant neoplasm prostate 334 0.6 0.3 0.3 0.4 
Affective psychosis 334 0.6 0.3 0.3 0.4 
Subtotal 42,993 79.6 — — — 
Total chronic problems 54,027 100.0 56.3 54.3 58.3 
** Includes multiple ICPC-2 or ICPC-2 PLUS codes and indicates that this group differs from that used for analysis in other sections of this 
chapter, as only chronic conditions have been included in this analysis (see Appendix 4, Table A4.2 <hdl.handle.net/2123/11882>). 
Note: LCL – lower confidence limit; UCL – upper confidence limit; BMI – body mass index; NOS – not otherwise specified. 
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 7.7 Work-related problems managed 
The work-related status of a problem under management was determined by the GP, and is 
defined as any problem that is (in the GP’s view) likely to have resulted from work-related 
activity or workplace exposure, or that has been significantly exacerbated by work activity 
or workplace exposure. Work-related problems accounted for 1.5% of problems and were 
managed at a rate of 2.4 per 100 encounters in 2013–14 (Table 7.7). This suggests that 
nationally 3.2 million problems managed in general practice were likely to be work-related.  
The most common work-related problems were musculoskeletal problems, accounting for 
56.9% of work-related problems and managed at a rate of 1.3 per 100 general practice 
encounters. Of all musculoskeletal problems managed in general practice, 7.3% were 
work-related. The most common musculoskeletal work-related problems were back 
complaint (14.6% of work-related problems), sprain and strain (8.2%), unspecified 
musculoskeletal injury (8.1%), and shoulder syndrome (3.3%). 
Work-related psychological problems accounted for 13.2% of total work-related problems, 
and were managed at a rate of 0.3 per 100 encounters. The most common were depression 
(3.7% of work-related problems), acute stress reaction (3.0%), post-traumatic stress disorder 
(2.9%) and anxiety (2.7%). Psychological work-related problems accounted for only 2.3% of 
all psychological problems managed in general practice.  
Table 7.7: Work-related problems, by type and most frequently managed individual problems 
Work-related problem managed Number 
Per cent of total 
WR problems 
(n = 2,268) 
Rate per 100 
encounters 
(n = 95,879) 
95% 
 LCL 
95% 
UCL 
WR as per 
cent of all 
problems(a)  
Musculoskeletal problems 1,291 56.9 1.3 1.2 1.5 7.3 
 Back complaint* 331 14.6 0.3 0.3 0.4 11.0 
 Sprain/strain* 185 8.2 0.2 0.2 0.2 15.1 
 Injury musculoskeletal NOS 185 8.1 0.2 0.2 0.2 21.4 
 Shoulder syndrome 75 3.3 0.1 0.1 0.1 12.2 
 Bursitis/tendonitis/synovitis NOS 70 3.1 0.1 0.0 0.1 5.8 
 Fracture* 68 3.0 0.1 0.0 0.1 6.8 
 Acute internal knee damage 55 2.4 0.1 0.0 0.1 16.5 
Psychological problems 299 13.2 0.3 0.3 0.4 2.3 
 Depression* 83 3.7 0.1 0.1 0.1 2.0 
 Acute stress reaction 69 3.0 0.1 0.0 0.1 9.3 
 Post-traumatic stress disorder 66 2.9 0.1 0.0 0.1 38.4 
 Anxiety* 61 2.7 0.1 0.0 0.1 2.8 
Other work-related problems 678 29.9 0.7 0.6 0.8 0.6 
 General check-up* 79 3.5 0.1 0.1 0.1 1.2 
 Administrative procedure – all* 70 3.1 0.1 0.0 0.1 5.2 
 Injury skin, other 56 2.4 0.1 0.0 0.1 11.7 
 Laceration/cut 56 2.4 0.1 0.0 0.1 5.6 
Total work-related problems 2,268 100.0 2.4 2.2 2.5 1.5 
(a) The proportion of total contacts with this problem that was accounted for by work-related problems. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Table A4.1 <hdl.handle.net/2123/11882>). 
Note: WR – work-related; LCL – lower confidence limit; UCL – upper confidence limit; NOS – not otherwise specified. Only the most frequent 
individual work-related problems accounting for ≥ 1.4% of total work-related problems are reported. 
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 7.8  Changes in problems managed over the 
decade 2004–05 to 2013–14 
Data about the problems managed in general practice from each of the past 10 years of the 
BEACH study, 2004–05 to 2013–14 are reported in Chapter 7 of the companion report, A 
decade of Australian general practice activity 2004–05 to 2013–14.1 Major changes that occurred 
over the decade are summarised below. 
Overall, the number of problems managed at general practice encounters increased from 
145.5 per 100 encounters in 2004–05, to 158.2 per 100 encounters in 2013–14. When this result 
is extrapolated to estimate national figures this represents an additional 68.2 million 
problems managed at general practice encounters in 2013–14 than in 2004–05. A rise in GP 
attendances over the decade also contributed to this increase. This was reflected in 
significant increases over the decade in the management of both chronic conditions (from 
51.7 to 56.3 per 100 encounters) and new problems (55.2 to 58.5 per 100 encounters). 
Changes in some of the most common individual problems managed in general practice are 
summarised below. 
• General check-ups were managed more often in 2013–14 than in 2004–05, increasing 
from 2.1 to 3.1 per 100 encounters. This represents an additional 2.1 million more 
occasions where general check-ups were managed in 2013–14 than in 2004–05.  
• The management rate of depression increased from 3.7 per 100 encounters to 4.3 per 100 
between 2004–05 and 2013–14, suggesting about 2.1 million more occasions where 
depression was managed in 2013–14 than in 2004–05. 
• The management rate of diabetes increased significantly from 3.2 per 100 encounters in 
2004–05 to 4.2 per 100 encounters in 2013–14, an estimated 2.5 million more occasions of 
diabetes management in 2013–14 than in 2004–05.  
• The management of asthma decreased from 2.3 per 100 encounters in 2004–05 to 2.0 per 
100 encounters in 2013–14. However, due to a rise in the number of general practice 
attendances nationally, there was an estimated national increase of 410,000 occasions of 
asthma management in 2013–14 compared with 2004–05. Similarly, the management 
rate of acute bronchitis/bronchiolitis decreased from 2.4 to 1.9 per 100 encounters over 
the decade, but there were an additional 180,000 more occasions where acute 
bronchitis/bronchiolitis was managed in 2013–14 compared with 2004–05.  
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 8 Overview of management 
The BEACH survey form allows GPs to record several aspects of patient management for 
each problem managed at each encounter. Pharmaceutical management is recorded in 
detail. Other modes of treatment, including clinical treatments (for example, counselling) 
and procedures, recorded briefly in the GP’s own words, are also related to a single 
problem. The form allows for referrals, hospital admissions, pathology and imaging test 
orders to be related to a single problem or to multiple problems (see Appendix 1). 
A summary of management at general practice encounters from 2004–05 to 2013–14 is 
reported for each year in the 10-year report, A decade of Australian general practice activity  
2004–05 to 2013–14.1  
At the 95,879 encounters, GPs undertook 225,758 management activities in total. The most 
common management form was medication, either prescribed, GP-supplied, or advised for 
over-the-counter purchase. ‘Other treatments’ were the second most common management 
activity, with clinical treatments more frequent than procedural treatments (Table 8.1). 
For an ‘average’ 100 patient problems managed, GPs provided 53 prescriptions and 
24 clinical treatments, undertook 12 procedures, made 6 referrals to medical specialists and 3 
to allied health services, and placed 31 pathology test/battery orders and 7 imaging test 
orders. 
Table 8.1: Summary of management 
Management type Number 
Rate per 100 
encounters 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Rate per 100 
problems  
(n = 151,675) 
95% 
LCL 
95% 
UCL 
Medications 98,394 102.6 100.1 105.2 64.9 63.5 66.2 
 Prescribed  80,046 83.5 81.2 85.8 52.8 51.5 54.1 
 GP-supplied 9,797 10.2 9.4 11.0 6.5 6.0 6.9 
 Advised OTC 8,550 8.9 8.2 9.6 5.6 5.2 6.1 
Other treatments 54,104  56.4 53.8 59.0 35.7 34.2 37.2 
 Clinical* 36,024 37.6 35.3 39.8 23.8 22.4 25.1 
 Procedural* 18,081 18.9 18.0 19.7 11.9 11.4 12.4 
Referrals and admissions 15,012 15.7 15.1 16.3 9.9 9.6 10.2 
 Medical specialist* 9,139 9.5 9.1 9.9 6.0 5.8 6.3 
 Allied health services* 4,728 4.9 4.6 5.2 3.1 2.9 3.3 
 Hospital* 382 0.4 0.3 0.5 0.3 0.2 0.3 
 Emergency department* 272 0.3 0.2 0.3 0.2 0.2 0.2 
 Other referrals* 491 0.5 0.4 0.6 0.3 0.3 0.4 
Pathology 47,035 49.1 47.1 51.0 31.0 30.0 32.1 
Imaging 10,460 10.9 10.5 11.4 6.9 6.6 7.2 
Other investigations(a) 753 0.8 0.7 0.9 0.5 0.4 0.5 
Total management activities  225,758 235.5 — — 148.8 — — 
(a) Other investigations reported here include only those ordered by the GP. Other investigations in Chapter 12 include those ordered by the 
GP and those done by the GP or practice staff. 
* Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 4, <hdl.handle.net/2123/11882>). 
Note: LCL – lower confidence limit; UCL – upper confidence limit; OTC – over-the-counter. 
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 The number of encounters or problems for which at least one form of management was 
recorded by the GPs gives us another perspective (Table 8.2). At least one management 
action was recorded at 91.3% of encounters, for 85.1% of problems managed. 
• At least one medication or other treatment was given for 70.9% of the problems 
managed. 
• At least one medication (most commonly prescribed) was prescribed, supplied or 
advised for more than half (50.7%) of the problems managed. 
• At least one other treatment (most commonly clinical) was provided for nearly one-third 
(31.6%) of problems managed. 
• At least one referral (most commonly to a medical specialist) was made for 9.8% of 
problems managed. 
• At least one investigation (most commonly pathology) was requested for 19.1% of 
problems managed (Table 8.2). 
When extrapolated nationally based on the total number of MBS claims for GP items of 
service (see Section 2.11), which in 2013–14 was 133,400,000: 
• at least one medication was prescribed, advised for over-the-counter purchase, or 
supplied by the GP at approximately 82.8 million (95% CI: 81.6–84.0 million) GP–patient 
encounters across the country in 2013–14 
• at least one procedure was undertaken at 22.4 million (95% CI: 21.5–23.3 million) 
encounters nationally 
• at least one referral to a specialist, allied health professional, hospital or emergency 
department was provided by GPs at 19.2 million (95% CI: 18.5–19.9 million) encounters 
nationally 
• at least one pathology, imaging or other investigation was ordered at 34.8 million (95% 
CI: 33.8–35.8 million) encounters across Australia in 2013–14.  
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 Table 8.2: Encounters and problems for which management was recorded 
Management type 
Number of 
encounters 
Per cent of all 
encounters 
(n = 95,879) 95% LCL 95% UCL 
Number of 
problems 
Per cent of all 
problems 
(n = 151,675) 95% LCL 95% UCL 
At least one management type 87,580 91.3 90.7 92.0 129,110 85.1 84.4 85.8 
 At least one medication or other treatment 77,610 80.9 80.1 81.8 107,478 70.9 70.0 71.7 
  At least one medication  59,554 62.1 61.2 63.0 76,878 50.7 49.8 51.6 
  At least one prescription 49,998 52.1 51.2 53.1 63,373 41.8 40.8 42.7 
  At least one GP-supplied 7,947 8.3 7.6 9.0 8,191 5.4 5.0 5.8 
  At least one OTC advised 7,483 7.8 7.2 8.4 7,687 5.1 4.7 5.4 
  At least one other treatment 40,853 42.6 41.0 44.2 47,910 31.6 30.4 32.8 
  At least one clinical treatment 28,098 29.3 27.8 30.8 32,386 21.4 20.2 22.5 
  At least one procedural treatment 16,117 16.8 16.1 17.5 16,962 11.2 10.7 11.6 
 At least one referral or admission 13,788 14.4 13.9 14.9 14,905 9.8 9.5 10.2 
  At least one referral to a medical specialist 8,679 9.1 8.7 9.4 9,231 6.1 5.9 6.3 
  At least one referral to allied health services 4,434 4.6 4.4 4.9 4,712 3.1 2.9 3.3 
  At least one referral to hospital 382 0.4 0.3 0.5 389 0.3 0.2 0.3 
  At least one referral to emergency department 272 0.3 0.2 0.3 275 0.2 0.2 0.2 
  At least one other referral 490 0.5 0.4 0.6 516 0.3 0.3 0.4 
 At least one investigation 24,983 26.1 25.3 26.8 28,972 19.1 18.6 19.6 
  At least one pathology order 18,282 19.1 18.4 19.7 21,064 13.9 13.5 14.3 
  At least one imaging order 8,939 9.3 9.0 9.7 9,322 6.1 5.9 6.4 
  At least one other investigation(a) 718 0.7 0.7 0.8 735 0.5 0.4 0.5 
(a) Other investigations reported here only include those ordered by the GP. Other investigations in Chapter 12 include those ordered by the GP and those done by the GP or practice staff. 
Note: LCL – lower confidence limit; UCL – upper confidence limit; OTC – over-the-counter. 
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The combinations of management types related to each problem were investigated. The 
majority of treatments occurred as a single component, or in combination with one other 
component. Management was provided: 
• as a single component for almost two-thirds (60.7%) of the problems managed 
• as a double component for 20.8% of problems managed (Table 8.3) 
• less often (3.6%) with more than two components (results not tabled). 
Table 8.3 lists the most common management combinations, where management action(s) 
was recorded. Medication alone was the most common management, followed by a clinical 
treatment alone, and the combination of a medication and a clinical treatment. When a 
problem was referred it was most likely that no other treatments were given for that problem 
at the encounter.  
Table 8.3: Most common management combinations 
1+ 
medication 
1+ clinical 
treatment 
1+ procedural  
treatment 
1+  
referral 
1+ imaging 
order 
1+ pathology 
order 
Per cent of 
total 
problems  
(n = 151,675) 
Per cent  
of total 
encounters 
 (n = 95,879) 
No recorded management 14.9 8.7 
1+ management recorded   
1      33.2 26.8 
      10.1 7.2 
      6.2 10.1 
      5.2 3.0 
      5.1 3.6 
      4.6 3.9 
      3.0 4.6 
      2.9 4.6 
      2.5 1.8 
      1.4 1.4 
      1.4 3.0 
      1.2 1.3 
      1.1 2.0 
      1.1 1.4 
      0.6 1.9 
      0.6 0.7 
      0.4 0.7 
      0.4 1.3 
      0.4 0.5 
      0.3 1.1 
Note: 1+ – at least one specified management type. 
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 8.1  Changes in management over the decade 
2004–05 to 2013–14 
Changes in management over the decade 2004–05 to 2013–14 are described in detail in 
Chapter 8 of the accompanying report, A decade of Australian general practice activity 2004–05 
to 2013–14.1 In that publication, changes over time are largely reported in terms of changes in 
management actions as a rate per 100 problems. This reflects change in how GPs are 
managing problems after accounting for the significant increase in the number of problems 
managed per encounter over the decade. 
The major changes over the 10 years to 2013–14 are summarised below. 
• There was a significant decrease in the rate of medications being prescribed/supplied by 
the GP or advised for over-the-counter purchase, from 69.8 per 100 problems in 2004–05 
to 64.9 per 100 problems in 2013–14. 
• The major contributor to the above change was a significant decrease in the rate of 
prescribed medications over the time period, from 57.3 to 52.8 per 100 problems. GP 
supplied medications had significantly increased in 2008–09 and 2009–10, but decreased 
again in 2011–12 to a rate not significantly different from the 2004–05 result. 
• The introduction of MBS item numbers for practice nurse activity in 2005–06 led to a 
significant decrease in the rate of clinical treatments given by GPs, from a peak of 27.0  
in 2004–05 to a low point of 19.9 per 100 problems managed in 2006–07. However, the 
rate of GP-provided clinical treatments then gradually increased such that, while there 
appears to be a significant difference between the start and end of the decade, the 
2013–14 rate is similar to the rate prior to the 2004–05 peak. The original impact of 
practice nurses on this area of GP workload was no longer observed, suggesting that by 
2013–14, GPs were again performing clinical treatments at a similar rate to that prior to 
the introduction of practice nurse item numbers. 
• There was a significant increase in the rate at which procedural treatments were 
undertaken, from 10.6 per 100 problems managed in 2004–05 to 11.9 per 100 problems  
in 2013–14.  
• The rate of referrals to other health providers significantly increased, from 7.9 to 9.9 per 
100 problems between 2004–05 and 2013–14, influenced by a 63% increase in referrals to 
allied health services over the period (1.9 to 3.1 per 100 problems managed).  
It was further influenced by an increase in referrals to emergency departments (0.1 to 
0.2 per 100 problems managed).  
• The rate at which pathology tests/batteries were ordered significantly increased by 23%, 
from 25.2 tests/batteries per 100 problems managed in 2004–05 to 31.0 in 2013–14.  
• The rate at which imaging was ordered increased significantly, from 5.7 imaging orders 
per 100 problems managed in 2004–05 to 6.9 per 100 in 2013–14. 
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 9 Medications 
GPs could record up to four medications for each of four problems managed — a maximum 
of 16 medications per encounter. Each medication could be recorded as prescribed (the 
default), supplied by the GP, or recommended for over-the-counter (OTC) purchase. The 
generic name of a medication is its non-proprietary name, which describes the 
pharmaceutical substance(s) or active pharmaceutical ingredient(s).  
• GPs were asked to: 
– record the generic or brand name, the strength, regimen and number of repeats 
ordered for each medication 
– designate this as a new or continued medication for this patient for this problem. 
• Generic or brand names were entered in the database in the manner recorded by the GP. 
• Medications were coded using the Coding Atlas of Pharmaceutical Substances (CAPS) 
system developed by the FMRC, a hierarchical classification system which is able to 
capture details of products down to the generic and brand level. Every medication in the 
CAPS coding system is mapped to the international Anatomical Therapeutic Chemical 
(ATC) classification index.76 
• The reporting of results at drug group, subgroup and generic level uses 
ATC levels 1, 3 and 5. The most frequently prescribed, supplied or advised individual 
medications are reported at the CAPS generic level (equivalent to ATC level 5) because 
ATC does not include many of the over-the-counter medications that arise in BEACH. 
Further, some ATC level 5 labels are not sufficiently specific for clarity. 
Data on medications are reported for each year from 2004–05 to 2013–14 in the 10-year 
summary report, A decade of Australian general practice activity 2004–05 to 2013–14.1 
Readers interested in adverse drug events will find more detailed information from the 
BEACH program in Drugs causing adverse events in patients aged 45 or older: a randomised survey 
of general practice patients.77 
9.1 Source of medications 
As reported in Chapter 8, a total of 98,394 medications were recorded, at rates of 103 per 
100 encounters and 65 per 100 problems managed. We can derive from Table 8.1 that: 
• 4 out of 5 medications (81.4%) were prescribed 
• 10.0% of medications were supplied to the patient by the GP 
• 8.7% of medications were recommended by the GP for over-the-counter purchase. 
When medication rates per 100 encounters are extrapolated to the 133.4 million general 
practice Medicare-claimed encounters in Australia from April 2013 to March 2014, we 
estimate that GPs in Australia: 
• prescribed, supplied or advised at least one medication at 82.8 million encounters (62.1% 
of encounters, Table 8.2) 
• wrote a prescription (with/without repeats) for more than 111.4 million medications 
• supplied 13.6 million medications directly to the patient 
• recommended medications for OTC purchase 11.9 million times. 
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 9.2 Prescribed medications 
There were 80,046 prescriptions recorded, at rates of 84 per 100 encounters and 
53 per 100 problems managed (Table 8.1). GPs recorded 80.1% of prescribed medications by 
brand (proprietary) name and 19.9% by their generic (non-proprietary) name. Some of the 
medications most likely to be recorded by generic name were amoxycillin, warfarin and 
prednisolone (results not tabled). 
As shown in Table 8.2, at least one prescription was given at 52.1% of encounters. 
Extrapolated to the 133.4 million general practice Medicare-claimed encounters, we estimate 
that GPs prescribed at least one medication at 69.5 million encounters. 
At least one prescription was given for 41.8% of problems managed. 
• No prescription was given for 58.2% of problems managed 
• One prescription was given for 33.6% of problems managed 
• Two prescriptions were given for 6.0% of problems managed 
• Three or four prescriptions were given for 2.2% of problems managed (Figure 9.1). 
 
 
 
 
Figure 9.1: Number of medications prescribed per problem, 2013–14 
Number of repeats 
For 62,567 prescriptions (78.2% of all prescriptions) the GPs recorded ‘number of repeats’. 
The distribution of the specified number of repeats (from nil to more than five) is provided in 
Figure 9.2. For 34.0% of these prescriptions, the GP specified that no repeats had been 
prescribed, and for 37.8% five repeats were ordered. The latter proportion reflects the 
Pharmaceutical Benefits Scheme (PBS) provision of one month’s supply and five repeats for 
many medications used for chronic conditions such as hypertension. The ordering of one 
repeat was also quite common (14.9%). 
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Figure 9.2: Number of repeats ordered per prescription, 2013–14 
Age–sex-specific rates of prescribed medications 
Age–sex-specific analysis found similar prescription rates for male (84 per 100 encounters) 
and female patients (83 per 100). It also showed the well-described tendency for the number 
of prescriptions written at each encounter to rise with the advancing age of the patient.  
The rate of prescribing almost doubled from 54 per 100 encounters for patients aged less than 
25 years to 104 per 100 encounters for patients aged 65 years and over (results not tabled). 
However, Figure 9.3 demonstrates that this age-based increase lessens if the prescription rate 
is considered in terms of the number of problems being managed in each age group. This 
suggests that a substantial part of the higher prescription rate for older patients is due to the 
increased number of health problems they have managed at an encounter. The remaining 
increase in prescription rate associated with patient age is probably a reflection of the 
problems under management, as the rate of chronic problem management increases with 
patient age.78  
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Figure 9.3: Age–sex-specific prescription rates per 100 problems managed, 2013–14 
Types of medications prescribed 
Table 9.1 shows the distribution of prescribed medications using the WHO ATC 
classification.76 This allows comparison with other data sources such as those produced from 
PBS data. The table lists medications in frequency order within ATC levels 1, 3 and 5. 
Prescriptions are presented as a percentage of total prescriptions, as a rate per 100 
encounters, and as a rate per 100 problems managed, each with 95% confidence intervals.  
The high number of opioids shown in this table (compared with BEACH data published 
before 2010) is due to our reclassification of some medications in 2010. We re-coded codeine 
combinations which contained 30 mg of codeine as opioids in the ATC index, whereas pre-
2010 they were coded as ‘other analgesics and antipyretics’. In the ATC classification, either 
grouping is correct. We decided to place high-dose codeine products in the opioid group in 
accordance with MIMS grouping79 and following the Poisons Regulations of the Therapeutic 
Goods Administration,80 which stipulates that high-dose codeine combinations are 
Schedule 4 (prescription only) medications. However, a few combination analgesics 
containing less than 30 mg of codeine but classified as Schedule 4, will not be counted in this 
group because there are other criteria that form part of the scheduling of prescription-only 
codeine. One of them is pack-size, which is not recorded in BEACH. 
Similarly, before 2010 all aspirin (acetylsalicylic acid) was classified in the analgesic group of 
neurological medications. In 2010, we split aspirin into two different codes depending on 
dosage. We reclassified low-dose (100 mg) plain aspirin as an antithrombotic medication in 
the blood medications group, while higher doses and combinations with other 
analgesic/antipyretics remain in the neurological group. 
If readers are making comparisons with previous BEACH publications, they should note that 
this change has caused the opioid and antithrombotic groups to increase, and ‘other 
analgesics and antipyretics’ to decrease. In the companion report to this publication, A decade 
of Australian general practice activity 2004–05 to 2013–14,1 medications have been re-analysed 
across all 10 years, and the results incorporate these adjustments.   
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Table 9.1: Prescribed medications by ATC levels 1, 3 and 5  
  
ATC Classification level 
Number 
Per cent of 
prescribed 
medications 
(n = 80,046) 
Rate per 100 
encounters 
 (95% CI) 
(n = 95,879) 
Rate per 100 
problems 
 (95% CI)  
(n = 151,675) 1 3 5 
Nervous system  19,400 24.2 20.2 (19.3–21.1) 12.8 (12.3–13.3) 
  Opioids 5,825 7.3 6.1 (5.7–6.4) 3.8 (3.6–4.1) 
 Oxycodone 1,657 2.1 1.7 (1.6–1.9) 1.1 (1.0–1.2) 
  Codeine, combinations excluding psycholeptics 1,482 1.9 1.5 (1.4–1.7) 1.0 (0.9–1.1) 
  Tramadol 855 1.1 0.9 (0.8–1.0) 0.6 (0.5–0.6) 
 Buprenorphine 644 0.8 0.7 (0.6–0.8) 0.4 (0.4–0.5) 
  Antidepressants 3,987 5.0 4.2 (3.9–4.4) 2.6 (2.5–2.8) 
  Escitalopram 574 0.7 0.6 (0.5–0.7) 0.4 (0.3–0.4) 
  Sertraline 499 0.6 0.5 (0.5–0.6) 0.3 (0.3–0.4) 
 Amitriptyline 470 0.6 0.5 (0.4–0.6) 0.3 (0.3–0.3) 
  Other analgesics and antipyretics 2,517 3.1 2.6 (2.4–2.9) 1.7 (1.5–1.8) 
  Paracetamol, plain 2,407 3.0 2.5 (2.3–2.7) 1.6 (1.4–1.7) 
  Anxiolytics 1,803 2.3 1.9 (1.7–2.1) 1.2 (1.1–1.3) 
  Diazepam 1,164 1.5 1.2 (1.1–1.3) 0.8 (0.7–0.8) 
  Oxazepam 443 0.6 0.5 (0.4–0.5) 0.3 (0.3–0.3) 
  Hypnotics and sedatives 1,422 1.8 1.5 (1.4–1.6) 0.9 (0.9–1.0) 
  Temazepam 939 1.2 1.0 (0.9–1.1) 0.6 (0.6–0.7) 
  Antipsychotics 1,225 1.5 1.3 (1.2–1.4) 0.8 (0.7–0.9) 
  Antiepileptics 1,094 1.4 1.1 (1.0–1.2) 0.7 (0.7–0.8) 
 Pregabalin 539 0.7 0.6 (0.5–0.6) 0.4 (0.3–0.4) 
  Drugs used in addictive disorders 894 1.1 0.9 (0.6–1.3) 0.6 (0.4–0.8) 
Cardiovascular system 15,184 19.0 15.8 (15.0–16.7) 10.0 (9.5–10.5) 
 Lipid modifying agents, plain 3,474 4.3 3.6 (3.4–3.8) 2.3 (2.2–2.4) 
 Atorvastatin 1,364 1.7 1.4 (1.3–1.5) 0.9 (0.8–1.0) 
 Rosuvastatin 1,225 1.5 1.3 (1.2–1.4) 0.8 (0.7–0.9) 
 Angiotensin II antagonists, plain 2,150 2.7 2.2 (2.1–2.4) 1.4 (1.3–1.5) 
 Irbesartan 788 1.0 0.8 (0.7–0.9) 0.5 (0.5–0.6) 
 Candesartan 586 0.7 0.6 (0.5–0.7) 0.4 (0.3–0.4) 
 Telmisartan 557 0.7 0.6 (0.5–0.7) 0.4 (0.3–0.4) 
 ACE inhibitors, plain 1,907 2.4 2.0 (1.8–2.1) 1.3 (1.2–1.4) 
 Perindopril 1,105 1.4 1.2 (1.0–1.3) 0.7 (0.7–0.8) 
 Ramipril 536 0.7 0.6 (0.5–0.6) 0.4 (0.3–0.4) 
 Beta blocking agents 1,554 1.9 1.6 (1.5–1.8) 1.0 (0.9–1.1) 
 Atenolol 616 0.8 0.6 (0.6–0.7) 0.4 (0.4–0.5) 
 Metoprolol 496 0.6 0.5 (0.5–0.6) 0.3 (0.3–0.4) 
 Angiotensin II antagonists, combinations 1,514 1.9 1.6 (1.4–1.7) 1.0 (0.9–1.1) 
 Irbesartan and diuretics 530 0.7 0.6 (0.5–0.6) 0.3 (0.3–0.4) 
 (continued)  
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Table 9.1 (continued): Prescribed medications by ATC levels 1, 3 and 5  
 
ATC Classification level 
Number 
Per cent of 
prescribed 
medications 
(n = 80,046) 
Rate per 100 
encounters 
 (95% CI) 
(n = 95,879) 
Rate per 100 
problems 
 (95% CI)  
(n = 151,675) 1 3 5 
 Selective calcium channel blockers with mainly 
vascular effects 
1,205 1.5 1.3 (1.1–1.4) 0.8 (0.7–0.9) 
 Amlodipine 568 0.7 0.6 (0.5–0.7) 0.4 (0.3–0.4) 
 High-ceiling diuretics 611 0.8 0.6 (0.6–0.7) 0.4 (0.4–0.4) 
 Frusemide 608 0.8 0.6 (0.6–0.7) 0.4 (0.4–0.4) 
 ACE inhibitors, combinations 607 0.8 0.6 (0.6–0.7) 0.4 (0.4–0.4) 
Anti-infective for systemic use 13,778 17.2 14.4 (13.7–15.0) 9.1 (8.6–9.5) 
  Beta-lactam antibacterials, penicillins 4,938 6.2 5.2 (4.8–5.5) 3.3 (3.0–3.5) 
 Amoxycillin 2,423 3.0 2.5 (2.3–2.7) 1.6 (1.5–1.7) 
 Amoxycillin and enzyme inhibitor 1,655 2.1 1.7 (1.6–1.9) 1.1 (1.0–1.2) 
 Other beta-lactam antibacterials 2,888 3.6 3.0 (2.8–3.2) 1.9 (1.8–2.0) 
 Cephalexin 2,460 3.1 2.6 (2.4–2.7) 1.6 (1.5–1.7) 
 Macrolides, lincosamides and streptogramins 1,929 2.4 2.0 (1.8–2.2) 1.3 (1.2–1.4) 
 Roxithromycin 763 1.0 0.8 (0.7–0.9) 0.5 (0.4–0.6) 
 Clarithromycin 513 0.6 0.5 (0.4–0.6) 0.3 (0.3–0.4) 
 Tetracyclines 854 1.1 0.9 (0.8–1.0) 0.6 (0.5–0.6) 
 Doxycycline 738 0.9 0.8 (0.7–0.8) 0.5 (0.4–0.5) 
 Sulfonamides and trimethoprim 708 0.9 0.7 (0.7–0.8) 0.5 (0.4–0.5) 
 Trimethoprim 542 0.7 0.6 (0.5–0.6) 0.4 (0.3–0.4) 
 Viral vaccines 683 0.9 0.7 (0.6–0.9) 0.5 (0.4–0.5) 
Alimentary tract and metabolism 8,317 10.4 8.7 (8.3–9.1 5.5 (5.3–5.7) 
 Drugs for peptic ulcer and gastro-oesophageal 
reflux 
3,363 4.2 3.5 (3.3–3.7) 2.2 (2.1–2.3) 
 Esomeprazole 1,645 2.1 1.7 (1.6–1.8) 1.1 (1.0–1.2) 
 Pantoprazole 683 0.9 0.7 (0.6–0.8) 0.5 (0.4–0.5) 
 Blood glucose lowering drugs, excluding insulins 2,060 2.6 2.1 (1.9–2.4) 1.4 (1.2–1.5) 
 Metformin 1,164 1.5 1.2 (1.1–1.3) 0.8 (0.7–0.8) 
 Gliclazide 406 0.5 0.4 (0.4–0.5) 0.3 (0.2–0.3) 
 Propulsives 601 0.8 0.6 (0.6–0.7) 0.4 (0.4–0.4) 
 Metoclopramide 483 0.6 0.5 (0.4–0.6) 0.3 (0.3–0.4) 
 Insulins and analogues 520 0.6 0.5 (0.5–0.6) 0.3 (0.3–0.4) 
 Drugs for constipation 509 0.6 0.5 (0.5–0.6) 0.3 (0.3–0.4) 
Respiratory system 4,670 5.8 4.9 (4.6–5.2) 3.1 (2.9–3.3) 
 Adrenergics, inhalants 2,509 3.1 2.6 (2.4–2.8) 1.7 (1.5–1.8) 
 Salbutamol 1,171 1.5 1.2 (1.1–1.3) 0.8 (0.7–0.8) 
 Salmeterol and fluticasone 743 0.9 0.8 (0.7–0.9) 0.5 (0.4–0.5) 
 Formoterol and budesonide 466 0.6 0.5 (0.4–0.5) 0.3 (0.3–0.3) 
(continued)  
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Table 9.1 (continued): Prescribed medications by ATC levels 1, 3 and 5  
 
ATC Classification level 
Number 
Per cent of 
prescribed 
medications 
(n = 80,046) 
Rate per 100 
encounters 
 (95% CI) 
(n = 95,879) 
Rate per 100 
problems 
 (95% CI)  
(n = 151,675) 1 3 5 
 Other drugs for obstructive airway diseases, 
inhalants 
796 1.0 0.8 (0.7–0.9) 0.5 (0.5–0.6) 
Musculoskeletal system 4,093 5.1 4.3 (4.0–4.5) 2.7 (2.5–2.9) 
 Anti-inflammatory and antirheumatic products,  
non-steroid 
2,801 3.5 2.9 (2.7–3.1) 1.8 (1.7–2.0) 
 Meloxicam 850 1.1 0.9 (0.8–1.0) 0.6 (0.5–0.6) 
 Diclofenac 524 0.7 0.5 (0.5–0.6) 0.3 (0.3–0.4) 
 Celecoxib 478 0.6 0.5 (0.4–0.6) 0.3 (0.3–0.4) 
 Drugs affecting bone structure and mineralization 526 0.7 0.5 (0.5–0.6) 0.3 (0.3–0.4) 
 Antigout preparations 488 0.6 0.5 (0.4–0.6) 0.3 (0.3–0.4) 
Dermatologicals 3,615 4.5 3.8 (3.6–4.0) 2.4 (2.3–2.5) 
 Corticosteroids, plain 2,033 2.5 2.1 (2.0–2.3) 1.3 (1.3–1.4) 
 Betamethasone 667 0.8 0.7 (0.6–0.8) 0.4 (0.4–0.5) 
 Mometasone 576 0.7 0.6 (0.5–0.7) 0.4 (0.3–0.4) 
Genitourinary system and sex hormones 3,002 3.8 3.1 (3.0–3.3) 2.0 (1.9–2.1) 
 Hormonal contraceptives for systemic use 1,186 1.5 1.2 (1.1–1.3) 0.8 (0.7–0.8) 
 Levonorgestrel and ethinyloestradiol 717 0.9 0.7 (0.7–0.8) 0.5 (0.4–0.5) 
 Estrogens 500 0.6 0.5 (0.5–0.6) 0.3 (0.3–0.4) 
 Urologicals 445 0.6 0.5 (0.4–0.5) 0.3 (0.3–0.3) 
Blood and blood-forming organs 2,685 3.4 2.8 (2.6–3.0) 1.8 (1.6–1.9) 
 Antithrombotic agents 2,053 2.6 2.1 (2.0–2.3) 1.4 (1.2–1.5) 
 Warfarin 1,082 1.4 1.1 (1.0–1.3) 0.7 (0.6–0.8) 
Systemic hormonal preparations, excluding sex 
hormones  
2,507 3.1 2.6 (2.5–2.8) 1.7 (1.6–1.7) 
  Corticosteroids for systemic use, plain  1,480 1.8 1.5 (1.4–1.7) 1.0 (0.9–1.1) 
  Prednisolone 906 1.1 0.9 (0.9–1.0) 0.6 (0.5–0.7) 
  Thyroid preparations  786 1.0 0.8 (0.7–0.9) 0.5 (0.5–0.6) 
  Levothyroxine sodium 761 1.0 0.8 (0.7–0.9) 0.5 (0.5–0.6) 
Sensory organs  1,906 2.4 2.0 (1.9–2.1) 1.3 (1.2–1.3) 
  Anti-infectives ophthalmological  631 0.8 0.7 (0.6–0.7) 0.4 (0.4–0.5) 
  Chloramphenicol ophthalmological 564 0.7 0.6 (0.5–0.7) 0.4 (0.3–0.4) 
  Corticosteroids and anti-infective in combination 
otological  
578 0.7 0.6 (0.6–0.7) 0.4 (0.3–0.4) 
Antineoplastic and immunomodulating agents  421 0.5 0.4 (0.4–0.5) 0.3 (0.2–0.3) 
Antiparasitic products, insecticides and repellent 262 0.3 0.3 (0.2–0.4) 0.2 (0.1–0.2) 
Various  206 0.3 0.2 (0.2–0.3) 0.1 (0.1–0.2) 
Total prescribed medications 80,046 100.0 83.5 (81.2–85.8) 52.8 (51.5–54.1) 
Note: ATC – Anatomical Therapeutic Chemical classification; CI – confidence interval; ACE – angiotensin-converting enzyme. 
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 Most frequently prescribed medications 
The most frequently prescribed individual medications are reported at the CAPS generic 
level (ATC level 5 equivalent) in Table 9.2. Together these 30 medications made up 43.7% of 
all prescribed medications.  
Table 9.2: Most frequently prescribed medications  
Generic medication Number 
Per cent of 
prescribed 
medications 
(n = 80,046) 
Rate per 100 
encounters 
 (95% CI) 
(n = 95,879) 
Rate per 100 
problems 
 (95% CI)  
(n = 151,675) 
Cephalexin 2,460 3.1 2.6 (2.4–2.7) 1.6 (1.5–1.7) 
Amoxycillin 2,423 3.0 2.5 (2.3–2.7) 1.6 (1.5–1.7) 
Paracetamol [plain] 2,407 3.0 2.5 (2.3–2.7) 1.6 (1.4–1.7) 
Oxycodone 1,657 2.1 1.7 (1.6–1.9) 1.1 (1.0–1.2) 
Amoxycillin/potassium clavulanate 1,655 2.1 1.7 (1.6–1.9) 1.1 (1.0–1.2) 
Esomeprazole 1,645 2.1 1.7 (1.6–1.8) 1.1 (1.0–1.2) 
Paracetamol/codeine 1,448 1.8 1.5 (1.4–1.6) 1.0 (0.9–1.0) 
Atorvastatin 1,364 1.7 1.4 (1.3–1.5) 0.9 (0.8–1.0) 
Rosuvastatin 1,225 1.5 1.3 (1.2–1.4) 0.8 (0.7–0.9) 
Salbutamol 1,179 1.5 1.2 (1.1–1.4) 0.8 (0.7–0.9) 
Metformin 1,164 1.5 1.2 (1.1–1.3) 0.8 (0.7–0.8) 
Diazepam 1,164 1.5 1.2 (1.1–1.3) 0.8 (0.7–0.8) 
Perindopril 1,105 1.4 1.2 (1.0–1.3) 0.7 (0.7–0.8) 
Warfarin sodium 1,082 1.4 1.1 (1.0–1.3) 0.7 (0.6–0.8) 
Temazepam 939 1.2 1.0 (0.9–1.1) 0.6 (0.6–0.7) 
Tramadol 855 1.1 0.9 (0.8–1.0) 0.6 (0.5–0.6) 
Meloxicam 850 1.1 0.9 (0.8–1.0) 0.5 (0.5–0.6) 
Irbesartan 788 1.0 0.8 (0.7–0.9) 0.5 (0.4–0.6) 
Roxithromycin 763 1.0 0.8 (0.7–0.9) 0.5 (0.4–0.6) 
Thyroxine 761 1.0 0.8 (0.7–0.9) 0.5 (0.5–0.6) 
Fluticasone/salmeterol 743 0.9 0.8 (0.7–0.9) 0.5 (0.4–0.5) 
Doxycycline 738 0.9 0.8 (0.7–0.8) 0.5 (0.4–0.5) 
Levonorgestrel/ethinyloestradiol 717 0.9 0.7 (0.7–0.8) 0.5 (0.4–0.5) 
Pantoprazole 683 0.9 0.7 (0.6–0.8) 0.5 (0.4–0.5) 
Betamethasone topical 667 0.8 0.7 (0.6–0.8) 0.4 (0.4–0.5) 
Buprenorphine 644 0.8 0.7 (0.6–0.8) 0.4 (0.4–0.5) 
Atenolol 616 0.8 0.6 (0.6–0.7) 0.4 (0.4–0.5) 
Frusemide  608 0.8 0.6 (0.6–0.7) 0.4 (0.4–0.4) 
Prednisolone 589 0.7 0.6 (0.5–0.7) 0.4 (0.3–0.4) 
Candesartan cilexetil 586 0.7 0.6 (0.5–0.7) 0.4 (0.3–0.4) 
Subtotal 33,525 43.7 — — 
Total prescribed medications 80,046 100.0 83.5 (81.2–85.8) 52.8 (51.5–54.1) 
Note: CI – confidence interval. 
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 9.3 Medications supplied by GPs 
GPs supplied 9,797 medications in 2013–14, at a rate of 10.2 medications per 100 encounters, 
and 6.5 per 100 problems managed. At least one medication was supplied at 8.3% of 
encounters, for 5.4% of all problems managed, an estimated 11.1 million encounters 
nationally where GPs supplied at least one medication. Table 9.3 shows the top supplied 
medications. At least one medication was supplied for 5.4% of all problems managed. The 
most frequently supplied medications are listed in Table 9.3. 
Table 9.3: Medications most frequently supplied by GPs  
Generic medication Number 
Per cent of GP 
supplied 
medications 
(n = 9,797) 
Rate per 100 
encounters 
 (95% CI) 
(n = 95,879) 
Rate per 100 
problems 
 (95% CI)  
(n = 151,675) 
Influenza virus vaccine 3,174 32.4 3.3 (2.7–3.9) 2.1 (1.7–2.5) 
Pneumococcal vaccine 583 5.9 0.6 (0.5–0.7) 0.4 (0.3–0.4) 
Vitamin B12 (cobalamin) 441 4.5 0.5 (0.4–0.5) 0.3 (0.2–0.3) 
Diphtheria/pertussis/tetanus/hepatitis B/polio/ 
Haemophilus influenzae B vaccine 
420 4.3 0.4 (0.4–0.5) 0.3 (0.2–0.3) 
Measles/mumps/rubella vaccine 297 3.0 0.3 (0.3–0.4) 0.2 (0.2–0.2) 
Rotavirus vaccine 279 2.8 0.3 (0.3–0.3) 0.2 (0.2–0.2) 
Triple antigen (diphtheria/pertussis/tetanus) 183 1.9 0.2 (0.2–0.2) 0.1 (0.1–0.1) 
ADT/CDT (diphtheria/tetanus) vaccine 180 1.8 0.2 (0.2–0.2) 0.1 (0.1–0.1) 
Allergen treatment 123 1.3 0.1 (0.1–0.2) 0.1 (0.1–0.1) 
Hepatitis A vaccine 112 1.1 0.1 (0.1–0.3) 0.1 (0.1–0.1) 
Metoclopramide 112 1.1 0.1 (0.1–0.2) 0.1 (0.0–0.1) 
Hepatitis B vaccine 100 1.0 0.1 (0.1–0.1) 0.1 (0.0–0.1) 
Diphtheria/pertussis/tetanus/polio vaccine 95 1.0 0.1 (0.1–0.1) 0.1 (0.0–0.1) 
Hepatitis A/typhoid (Salmonella typhi) vaccine 94 1.0 0.1 (0.1–0.1) 0.1 (0.0–0.1) 
Meningitis vaccine 89 0.9 0.1 (0.1–0.1) 0.1 (0.0–0.1) 
Chickenpox (varicella zoster) 84 0.9 0.1 (0.1–0.1) 0.1 (0.0–0.1) 
Methylprednisolone 83 0.8 0.1 (0.0–0.2) 0.1 (0.0–0.1) 
Local anaesthetic injection 82 0.8 0.1 (0.0–0.2) 0.1 (0.0–0.1) 
Typhoid vaccine (Salmonella typhi) 82 0.8 0.1 (0.1–0.1) 0.1 (0.0–0.1) 
Haemophilus influenzae B vaccine 75 0.8 0.1 (0.1–0.1) 0.0 (0.0–0.1) 
Testosterone 71 0.7 0.1 (0.1–0.1) 0.0 (0.0–0.1) 
Medroxyprogesterone 65 0.7 0.1 (0.0–0.1) 0.0 (0.0–0.1) 
Mometasone nasal 64 0.7 0.1 (0.0–0.1) 0.0 (0.0–0.1) 
Betamethasone systemic 58 0.6 0.1 (0.0–0.1) 0.0 (0.0–0.1) 
Salbutamol 56 0.6 0.1 (0.0–0.1) 0.0 (0.0–0.1) 
Immunisation 56 0.6 0.1 (0.0–0.1) 0.0 (0.0–0.1) 
Hepatitis A and B vaccine 55 0.6 0.1 (0.0–0.1) 0.0 (0.0–0.0) 
Steroid injection NEC 52 0.5 0.1 (0.0–0.1) 0.0 (0.0–0.0) 
Measles/mumps/rubella/varicella zoster vaccine 51 0.5 0.1 (0.0–0.1) 0.0 (0.0–0.0) 
Subtotal 7,265 74.1 — — 
Total supplied medications 9,797 100.00 10.2 (9.4–11.0) 6.5 (6.0–6.9) 
Note: CI – confidence interval; ADT – adult diphtheria tetanus; CDT – child diphtheria tetanus; NEC – not elsewhere classified; HPV – human 
papillomavirus. 
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 9.4  Medications advised for over-the-counter 
purchase 
The GPs recorded 8,550 medications as recommended for OTC purchase, at rates of 8.9 per 
100 encounters and 5.6 per 100 problems managed. At least one OTC medication was 
advised at 7.8% of encounters, an estimated 10.4 million encounters nationally where GPs 
recommended at least one OTC medication. At least one OTC medication was advised for 
5.1% of problems (Table 8.2). Table 9.4 shows the top 30 advised medications at the CAPS 
generic level (ATC level 5 equivalent). A wide range of medications was recorded in this 
group, the most common being paracetamol, which accounted for 25.3% of these 
medications. The re-classification of aspirin described in Section 9.2 also affected rates of 
advised OTC medications, as higher-dose analgesic aspirin and low-dose aspirin for 
antithrombotic purposes are presented separately here. 
Table 9.4: Most frequently advised over-the-counter medications  
Generic medication Number 
Per cent of 
OTC 
medications 
(n = 8,550) 
Rate per 100 
encounters 
 (95% CI) 
(n = 95,879) 
Rate per 100 
problems 
 (95% CI)  
(n = 151,675) 
Paracetamol [plain] 2,164 25.3 2.3 (1.9–2.6)  1.4 (1.2–1.6) 
Ibuprofen 597 7.0 0.6 (0.5–0.7) 0.4 (0.3–0.5) 
Vitamin D3 (cholecalciferol) 238 2.8 0.2 (0.2–0.3) 0.2 (0.1–0.2) 
Loratadine 223 2.6 0.2 (0.2–0.3) 0.1 (0.1–0.2) 
Sodium/potassium/citric acid/glucose 202 2.4 0.2 (0.2–0.3) 0.1 (0.1–0.2) 
Sodium chloride topical nasal 182 2.1 0.2 (0.1–0.2) 0.1 (0.1–0.1) 
Diclofenac topical 156 1.8 0.2 (0.1–0.2) 0.1 (0.1–0.1) 
Saline bath/solution/gargle 153 1.8 0.2 (0.1–0.2) 0.1 (0.1–0.1) 
Simple analgesics 147 1.7 0.2 (0.1–0.2) 0.1 (0.1–0.1) 
Hydrocortisone/clotrimazole 111 1.3 0.1 (0.1–0.1) 0.1 (0.1–0.1) 
Cream/ointment/lotion NEC 109 1.3 0.1 (0.1–0.2) 0.1 (0.0–0.1) 
Cetirizine 102 1.2 0.1 (0.1–0.1) 0.1 (0.1–0.1) 
Clotrimazole topical 100 1.2 0.1 (0.1–0.1) 0.1 (0.0–0.1) 
Fexofenadine 97 1.1 0.1 (0.1–0.1) 0.1 (0.0–0.1) 
Paracetamol/codeine 89 1.0 0.1 (0.1–0.1) 0.1 (0.0–0.1) 
Hydrocortisone topical 87 1.0 0.1 (0.1–0.1) 0.1 (0.0–0.1) 
Docusate otic 86 1.0 0.1 (0.1–0.1) 0.1 (0.0–0.1) 
Ferrous sulfate/sodium ascorbate 84 1.0 0.1 (0.1–0.1) 0.1 (0.0–0.1) 
Hyoscine butylbromide 78 0.9 0.1 (0.1–0.1) 0.1 (0.0–0.1) 
Aspirin analgesic 73 0.9 0.1 (0.0–0.1) 0.0 (0.0–0.1) 
Cinchocaine/hydrocortisone topical rectal 71 0.8 0.1 (0.0–0.1) 0.0 (0.0–0.1) 
Bromhexine 68 0.8 0.1 (0.0–0.1) 0.0 (0.0–0.1) 
Vitamin D 66 0.8 0.1 (0.0–0.1) 0.0 (0.0–0.1) 
Loperamide 66 0.8 0.1 (0.0–0.1) 0.0 (0.0–0.1) 
(continued) 
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Table 9.4 (continued): Most frequently advised over-the-counter medications  
Generic medication Number 
Per cent of 
OTC 
medications 
(n = 8,550) 
Rate per 100 
encounters 
 (95% CI) 
(n = 95,879) 
Rate per 100 
problems 
 (95% CI) 
(n = 151,675) 
Aspirin cardiovascular 65 0.8 0.1 (0.0–0.1) 0.0 (0.0–0.1) 
Sodium chloride/potassium chloride/sodium 
bicarbonate 
62 0.7 0.1 (0.0–0.1) 0.0 (0.0–0.1) 
Sorbolene/glycerol/cetomacrogol 57 0.7 0.1 (0.0–0.1) 0.0 (0.0–0.1) 
Fish oil 57 0.7 0.1 (0.0–0.1) 0.0 (0.0–0.0) 
Supplemental/enteral nutrition 54 0.6 0.1 (0.0–0.1) 0.0 (0.0–0.0) 
Multivitamins with minerals 54 0.6 0.1 (0.0–0.1) 0.0 (0.0–0.1) 
Subtotal 5,701 66.7 — — 
Total advised medications 8,550 100.0 8.9 (8.2–9.6) 5.6 (5.2–6.1) 
Note: OTC – over-the-counter; CI – confidence interval; NEC – not elsewhere classified. 
9.5  Changes in medications over the decade 
2004–05 to 2013–14  
Data on medications are reported for each year from 2004–05 to 2013–14 in Chapter 9 of the 
companion report, A decade of Australian general practice activity 2004–05 to 2013–14.1 In that 
report, changes over time are measured as change in the management of problems (that is, as 
a rate per 100 problems). This reflects change in how GPs are managing problems, and takes 
into account the significant increase in the number of problems managed per encounter over 
the decade to 2013–14. 
The rate at which medications were prescribed decreased significantly from 2004–05 
(58.8 per 100 problems, 95% CI: 57.3–60.3) to 2013–14 (53.8 per 100, 95% CI: 52.5–55.1). 
Among the prescribed drug groups that decreased significantly were antibacterials for 
systemic use, drugs for obstructive airway diseases, systemic anti-inflammatory medications, 
corticosteroid dermatological preparations and sex hormones. At the same time, prescribing 
rates of several drug groups increased significantly, including psychoanaleptics, lipid 
modifying agents, digestive drugs for acid-related disorders, corticosteroids for systemic use, 
and antiepileptic drugs. 
At the individual generic level, significant increases were found in the prescribing rates of a 
number of medications. Among them were oxycodone, esomeprazole, rosuvastatin, 
perindopril and pantoprazole. On the other hand, amoxycillin, paracetamol/codeine 
combination products, roxithromycin, levonorgoestrel/ethinyloestradiol, diclofenac sodium 
systemic and simvastatin were among the medications for which significant decreases in 
prescribing rates occurred over time.  
Other changes that occurred over the 10-year period were a steady rise in the proportion of 
prescriptions for which five repeats were recorded, and a corresponding decrease in those 
for which no repeats, one, three or four repeats were recorded. There was a significant 
increase in the rate of influenza vaccine supplied to the patient by GPs, and an increase in the 
rate of vitamin D3 advised for over-the-counter purchase. 
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 10 Other treatments 
The BEACH survey form allows GPs to record up to two other (non-pharmacological) 
treatments for each problem managed at the encounter. Other treatments include all clinical 
and procedural treatments provided. These groups are defined in Appendix 4, Tables A4.4 
and A4.5. 
Routine clinical measurements or observations, such as measurements of blood pressure and 
physical examinations, were not recorded if they were undertaken by the GP. However GPs 
were instructed to record clinical measurements or observations if these were undertaken by 
the practice nurse (PN) or Aboriginal health worker (AHW) in conjunction with the GP at the 
encounter. 
In Sections 10.1–10.3 inclusive, ‘other treatments’ have been counted irrespective of whether 
they were done by the GP or by the PN/AHW. That is, the non-pharmacological 
management provided at general practice patient encounters is described, rather than 
management provided specifically by the GP. However in the analysis of procedural 
treatments, injections given in provision of vaccines were removed, as this action has already 
been counted and reported in Section 9.3 Medications supplied by the GPs.  
In Section 10.4, treatments provided by the PN/AHW (including the injections given for 
vaccination) are reported separately, to provide a picture of the work they undertake in 
association with GP–patient encounters. 
Data on other treatments are reported for each year from 2004–05 to 2013–14 in the 10-year 
report, A decade of Australian general practice activity 2004–05 to 2013–14.1  
10.1 Number of other treatments 
In 2013–14, a total of 54,104 other treatments were recorded, at a rate of 56.4 per 100 
encounters. Two-thirds (66.6%) of these were clinical treatments. At least one other treatment 
was provided at 42.6% of all encounters, and for 31.6% of all problems managed. For every 
100 problems managed, 24 clinical treatments and 12 procedures were provided by a GP or 
PN/AHW (Table 10.1). 
Table 10.1: Summary of other treatments 
Variable Number 
Rate per 100 
encounters 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Rate per 100 
problems 
(n = 151,675) 
95% 
LCL 
95% 
UCL 
At least one other treatment 40,853 42.6 41.0 44.2 31.6 30.4 32.8 
Other treatments 54,104 56.4 53.8 59.0 35.7 34.2 37.2 
 Clinical treatments 36,024 37.6 35.3 39.8 23.8 22.4 25.1 
 Procedural treatments(a) 18,081 18.9 18.0 19.7 11.9 11.4 12.4 
(a) Excludes all local injection/infiltrations performed for immunisations/vaccinations (n = 4,245). 
Note: LCL – lower confidence limit; UCL – upper confidence limit. 
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Table 10.2 shows the relationship between other treatments and pharmacological treatments 
given for problems managed.  
• For 63.9% of the problems that were managed with an ‘other treatment’, no medication 
was prescribed, supplied or advised for that problem at that encounter. 
• Around 1 in 5 problems (21.4%) were managed with at least one clinical treatment. 
For 63.3% of these problems, no concurrent pharmacological treatment was provided. 
• Around 1 in 10 problems (11.2%) were managed with at least one procedural treatment, 
with no pharmacological management given for 64.4% of these problems. 
Table 10.2: Relationship between other treatments and pharmacological treatments 
Co-management of problems with other treatments 
Number of 
problems  
Per cent  
within class 
Per cent of  
problems 
(n = 151,675) 
95%  
LCL 
95%  
UCL 
At least one other treatment  47,910 100.0 31.6 30.4 32.8 
 Without pharmacological treatment 30,600 63.9 20.2 19.4 21.0 
At least one clinical treatment  32,386 100.0 21.4 20.2 22.5 
 Without pharmacological treatment 20,507 63.3 13.5 12.8 14.2 
At least one procedural treatment 16,962 100.0 11.2 10.7 11.6 
 Without pharmacological treatment  10,925 64.4 7.2 6.9 7.5 
Note: LCL – lower confidence limit; UCL – upper confidence limit. 
10.2 Clinical treatments 
Clinical treatments include general and specific advice, counselling or education, and 
administrative processes. During 2013–14, there were 36,024 clinical treatments recorded, at a 
rate of 37.6 per 100 encounters, or 23.8 per 100 problems managed (Table 10.1). 
Most frequent clinical treatments 
Table 10.3 lists the most common clinical treatments provided. Each clinical treatment is 
expressed as a percentage of all clinical treatments, as a rate per 100 encounters with 
95% confidence limits, and as a rate per 100 problems managed with 95% confidence limits. 
The 10 clinical treatments most often provided accounted for 85.4% of all clinical treatments. 
General advice and education was the most frequently recorded in 2013–14 (6.2 per 100 
encounters), accounting for 16.5% of all clinical treatments, followed by counselling about 
the problem under management (4.6 per 100 encounters). 
Several groups of clinical treatments related to preventive activities. The most common was 
counselling and advice about nutrition and weight (3.9 per 100 encounters), followed by 
counselling/advice for: exercise; smoking; lifestyle; prevention; and alcohol. Together, these 
preventive treatments accounted for 19.0% of clinical treatments, provided at a rate of 7.1 per 
100 encounters. 
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Table 10.3: Most frequent clinical treatments 
Clinical treatment Number 
Per cent of 
clinical 
treatments 
(n = 36,024) 
Rate per 100 
encounters 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Rate per 100 
problems 
(n = 151,675) 
95% 
LCL 
95% 
UCL 
Advice/education NEC* 5,962 16.5 6.2 5.3 7.1 3.9 3.4 4.5 
Counselling – problem* 4,404 12.2 4.6 4.0 5.2 2.9 2.5 3.3 
Counselling/advice – nutrition/weight* 3,742 10.4 3.9 3.5 4.3 2.5 2.2 2.7 
Advice/education – treatment* 3,691 10.2 3.8 3.4 4.3 2.4 2.2 2.7 
Counselling – psychological* 3,275 9.1 3.4 3.1 3.7 2.2 2.0 2.3 
Advice/education – medication* 3,250 9.0 3.4 3.1 3.7 2.1 1.9 2.3 
Other administrative procedure/ 
document (excluding sickness 
certificate)* 
2,618 7.3 2.8 2.5 3.0 1.8 1.6 1.9 
Sickness certificate* 1,459 4.1 1.5 1.3 1.7 1.0 0.8 1.1 
Reassurance, support*  1,239 3.4 1.3 1.1 1.5 0.8 0.7 1.0 
Counselling/advice – exercise* 1,130 3.1 1.2 1.0 1.4 0.7 0.6 0.9 
Counselling/advice – smoking* 632 1.8 0.7 0.6 0.8 0.4 0.4 0.5 
Counselling/advice – lifestyle* 599 1.7 0.6 0.5 0.8 0.4 0.3 0.5 
Counselling/advice – health/body* 470 1.3 0.5 0.4 0.6 0.3 0.3 0.4 
Counselling/advice – prevention* 383 1.1 0.4 0.3 0.5 0.3 0.2 0.3 
Counselling/advice – alcohol* 368 1.0 0.4 0.3 0.4 0.2 0.2 0.3 
Observe/wait* 341 0.9 0.4 0.3 0.4 0.2 0.2 0.3 
Consultation with primary care 
provider* 
289 0.8 0.3 0.2 0.4 0.2 0.1 0.2 
Family planning* 274 0.8 0.3 0.2 0.3 0.2 0.1 0.2 
Counselling/advice – relaxation* 262 0.7 0.3 0.2 0.3 0.2 0.1 0.2 
Counselling/advice – pregnancy* 249 0.7 0.3 0.2 0.3 0.2 0.1 0.2 
Subtotal  35,060 97.3 — — — — — — 
Total clinical treatments 36,024 100.0 37.6 35.3 39.8 23.8 22.4 25.1 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Table A4.4 <hdl.handle.net/2123/11882>). 
Note: LCL – lower confidence limit; UCL – upper confidence limit; NEC – not elsewhere classified. 
Problems managed with a clinical treatment 
Table 10.4 lists the top 10 problems managed with a clinical treatment. It also shows the 
extent to which clinical treatments were used for each problem, and the relationship between 
the use of a clinical treatment and the provision of medication for individual problems at 
that encounter.  
• A total of 36,024 problems (23.8% of all problems) involved one or more clinical 
treatments in their management (Table 10.1). 
• There was a very broad range of problems managed with clinical treatments. However, 
the 10 most common problems managed with a clinical treatment accounted for 30% of 
all problems for which clinical treatments were provided. 
• Depression represented the largest proportion of problems managed with a clinical 
treatment (5.5%), followed by upper respiratory tract infection (4.7%). 
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• A clinical treatment was provided at 43.4% of contacts with depression, with no 
concurrent pharmacological treatment provided for half (50.9%) of these contacts where 
a clinical treatment was provided. 
• Of the top 10 problems, acute stress reaction was the problem most likely to be managed 
with a clinical treatment (at 73.9% of contacts). Of the contacts with acute stress reaction 
where a clinical treatment was provided, 90.9% did not result in concurrent medication 
prescribed/supplied or advised for that problem. 
Table 10.4: The 10 most common problems managed with a clinical treatment 
Problem managed Number 
Per cent of 
problems with 
clinical treatment  
(n = 32,386) 
Rate per 100 
encounters(a) 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Per cent 
 of this 
problem(b) 
Per cent of 
treated 
 problems no 
medications(c) 
Depression*  1,787 5.5 1.9 1.7 2.1 43.4 50.9 
Upper respiratory tract infection 1,507 4.7 1.6 1.4 1.8 32.0 59.2 
Diabetes – all* 1,193 3.7 1.2 1.1 1.4 29.5 62.9 
Anxiety* 1,021 3.2 1.1 1.0 1.2 47.4 64.7 
Hypertension* 1,009 3.1 1.1 0.9 1.2 12.2 42.8 
Lipid disorder 790 2.4 0.8 0.7 0.9 26.7 70.8 
Gastroenteritis* 632 2.0 0.7 0.6 0.8 48.1 57.7 
Back complaint* 618 1.9 0.6 0.6 0.7 20.5 48.9 
Acute stress reaction 545 1.7 0.6 0.5 0.6 73.9 90.9 
Administrative procedure NOS 500 1.5 0.5 0.4 0.6 41.0 99.6 
Subtotal  9,602 29.6 — — — — — 
Total problems with clinical 
treatments 32,386 100.0 33.8 31.8 35.7 — — 
(a) Rate of provision of clinical treatment for selected problem per 100 total encounters. 
(b) Percentage of contacts with this problem that generated at least one clinical treatment. 
(c) The numerator is the number of contacts with this problem that generated at least one clinical treatment but generated no medications.  
The denominator is the total number of contacts for this problem that generated at least one clinical treatment (with or without medications). 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Table A4.1, <hdl.handle.net/2123/11882>). 
Note: LCL – lower confidence limit; UCL – upper confidence limit; NOS – not otherwise specified. 
10.3 Procedural treatments 
Procedural treatments include therapeutic actions and diagnostic procedures undertaken at 
the encounter. Injections for immunisations/vaccinations (n = 4,246) are not counted here as 
these were already counted as a GP-supplied medication in Section 9.3. There were 18,081 
procedures recorded at a rate of 18.9 per 100 encounters, and 11.9 per 100 problems managed 
(Table 10.1). 
Most frequent procedures 
Table 10.5 lists the most common procedural treatments recorded. Each procedural 
treatment is expressed as a percentage of all procedural treatments, as a rate per 100 
encounters and as a rate per 100 problems, both with 95% confidence limits. Some of the 
procedures (for example, international normalised ratio [INR] test, electrical tracings, 
physical function test) are investigations undertaken at the encounter. Results presented in 
Table 10.5 do not include investigations that were ordered by the GP to be performed by an 
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external provider. A summary of all investigations (both undertaken and ordered) is 
provided in Chapter 12 (Table 12.6). 
The most frequently recorded group of procedures was excision/removal tissue/biopsy/ 
destruction/debridement/cauterisation (3.2 per 100 encounters), accounting for 17.1% of 
recorded procedures; followed by dressing/pressure/compression/tamponade (2.9 per 
100 encounters). The top five procedural treatments, accounting for almost 60% of all 
procedural treatments, were provided at a rate of 11.2 per 100 encounters. 
Table 10.5: Most frequent procedural treatments 
Procedural treatment Number 
Per cent of 
procedural 
treatments 
(n = 18,081) 
Rate per 
100 
encounters 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Rate per 100 
problems 
(n = 151,675) 
95% 
LCL 
95% 
UCL 
Excision/removal tissue/biopsy/ 
destruction/debridement/cauterisation* 
3,083 17.1 3.2 2.9 3.5 2.0 1.8 2.2 
Dressing/pressure/compression/ 
tamponade* 
2,740 15.2 2.9 2.6 3.1 1.8 1.7 1.9 
Local injection/infiltration*(a) 2,463 13.6 2.6 2.3 2.8 1.6 1.5 1.8 
Physical medicine/rehabilitation – all* 1,317 7.3 1.4 1.2 1.6 0.9 0.7 1.0 
Incision/drainage/flushing/aspiration/ 
removal body fluid* 
1,137 6.3 1.2 1.1 1.3 0.7 0.7 0.8 
Repair/fixation – suture/cast/prosthetic 
device (apply/remove)*  
936 5.2 1.0 0.9 1.1 0.6 0.5 0.7 
Pap smear* 931 5.1 1.0 0.8 1.1 0.6 0.5 0.7 
INR test*  806 4.5 0.8 0.7 1.0 0.5 0.4 0.6 
Other preventive procedures/high-risk 
medication* 
753 4.2 0.8 0.7 0.9 0.5 0.4 0.6 
Other therapeutic procedures/minor 
surgery* 
750 4.1 0.8 0.6 0.9 0.5 0.4 0.6 
Electrical tracings* 746 4.1 0.8 0.7 0.9 0.5 0.4 0.6 
Check-up – PN/AHW* 630 3.5 0.7 0.5 0.8 0.4 0.3 0.5 
Physical function test* 522 2.9 0.5 0.5 0.6 0.3 0.3 0.4 
Other diagnostic procedures* 332 1.8 0.3 0.3 0.4 0.2 0.2 0.3 
Urine test* 292 1.6 0.3 0.2 0.4 0.2 0.2 0.2 
Pregnancy test* 183 1.0 0.2 0.1 0.2 0.1 0.1 0.1 
Glucose test* 149 0.8 0.2 0.1 0.2 0.1 0.1 0.1 
Hormone implant* 117 0.6 0.1 0.1 0.1 0.1 0.1 0.1 
Subtotal  17,887 98.9 — — — — — — 
Total procedural treatments  18,081 100.0 18.9 18.0 19.7 11.9 11.4 12.4 
(a) Excludes all local injection/infiltrations performed for immunisations/vaccinations (n = 4,246). 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Tables A4.5 and A4.6, <hdl.handle.net/2123/11882>). 
Note: LCL – lower confidence limit; UCL – upper confidence limit; NEC – not elsewhere classified; INR – international normalised ratio;  
PN – practice nurse; AHW – Aboriginal health worker. 
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Problems managed with a procedural treatment 
Table 10.6 lists the top 10 problems managed with a procedural treatment. It also shows the 
proportion of contacts with each problem that were managed with a procedure, and the 
proportion of these contacts where medication was not given concurrently. 
• One or more procedural treatments were provided in the management of 16,962 
problems (11.2% of all problems) (Table 10.2). 
• The top 10 problems accounted for more than one-third (34.9%) of all problems managed 
with a procedure. 
• Solar keratosis/sunburn accounted for the largest proportion of problems managed with 
a procedure, followed by female genital check-up/Pap smear. 
• Of the top 10 problems, warts were the most likely to be managed with a procedure, 
undertaken at 4 out of 5 (79.9%) wart problem contacts. Of these contacts where warts 
were managed with a procedural treatment, no medication was prescribed/supplied or 
advised for that problem at 96.0% of contacts. 
Table 10.6: The 10 most common problems managed with a procedural treatment 
Problem managed Number 
Per cent of 
problems with 
procedure 
(n = 16,962)  
Rate per 100 
encounters(a) 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Per cent of 
this 
problem(b) 
Per cent of 
treated problems 
no medications(c) 
Solar keratosis/sunburn  828 4.9 0.9 0.7 1.0 68.1 96.7 
Female genital check-up/ 
Pap smear* 
814 4.8 0.8 0.7 1.0 51.0 97.4 
Laceration/cut 777 4.6 0.8 0.7 0.9 77.9 81.8 
Malignant neoplasm, skin  642 3.8 0.7 0.5 0.8 47.6 95.1 
Excessive ear wax 565 3.3 0.6 0.5 0.7 71.8 93.8 
Warts  499 2.9 0.5 0.5 0.6 79.9 96.0 
General check-up* 494 2.9 0.5 0.4 0.6 16.9 78.0 
Chronic ulcer skin 
(including varicose ulcer) 
487 2.9 0.5 0.4 0.6 71.0 75.6 
Atrial fibrillation/flutter 462 2.7 0.5 0.4 0.6 31.9 65.1 
Back complaint* 349 2.1 0.4 0.3 0.5 11.6 41.3 
Subtotal  5,917 34.9 — — — — — 
Total problems with 
procedural treatments 
16,962 100.0 17.7 16.9 18.5 — — 
(a) Rate of provision of procedural treatment for selected problem per 100 total encounters. 
(b) Percentage of contacts with this problem that generated at least one procedural treatment. 
(c) The numerator is the number of contacts with this problem that generated at least one procedural treatment but generated no medications. 
The denominator is the total number of contacts for this problem that generated at least one procedural treatment (with or without 
medications). 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Table A4.1, <hdl.handle.net/2123/11882>). 
Note: LCL – lower confidence limit; UCL – upper confidence limit. 
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 10.4 Practice nurse/Aboriginal health worker activity 
This section describes the activities of practice nurses (PNs) and Aboriginal health workers 
(AHWs) recorded in association with the GP–patient encounters detailed by the GP BEACH 
participants. 
In 2004, four Medicare item numbers were introduced into the MBS that allowed GPs to 
claim for specified tasks done by a PN under the direction of the GP.81 In 2005–06, the 
BEACH recording form was amended to capture specific information about the actions 
practice nurses undertook in association with the GP recorded encounter. In the ‘other 
treatments’ section for each problem managed, GPs were asked to tick the ‘practice nurse’ 
box if the treatment recorded was provided by the PN rather than by the GP. If the box was 
not ticked it was assumed the GP gave the treatment. 
The survey form allows GPs to record up to two other treatments for each problem managed 
at the encounter (i.e. up to eight per encounter). Other treatments include all clinical and 
procedural treatments provided at the encounters. These groups are defined in Appendix 4, 
Tables A4.4 and A4.5. 
Over time, new PN item numbers were added to the MBS, and some items were broadened, 
to cover work done by AHWs. In January 2012, the Australian Government significantly 
altered the payment structure for PN and AHW activities in general practice, such that the 
range of claimable MBS item numbers was reduced and the Practice Nurse Incentive 
Program (PNIP) introduced. The PNIP “provides incentive payments to practices…by 
consolidating funding arrangements under the Practice Incentive Program (PIP) Practice 
Nurse Incentive”.  
The following section investigates: the proportion of encounters involving the PN/AHW; the 
proportion of these claimable with a Medicare item number; treatments provided by 
PNs/AHWs in association with the GP–patient encounters; and the problems for which 
these treatments were provided.  
Remember that these results will not include PN/AHW activities undertaken during the 
GP’s BEACH recording period that were not associated with the recorded encounter. Such 
activities could include Medicare-claimable activities (for example, chronic disease 
management) provided under instruction from the GP but not at the time of the encounter 
recorded in BEACH, or provision of other services not claimable from Medicare. 
Practice nurse/Aboriginal health worker Medicare claims 
There were 7,690 GP–patient encounters (8.0% of all encounters) at which at least one 
PN/AHW activity was recorded. However, for 75 of these, their activity was not described. 
At the remaining 7,615 encounters a PN/AHW was involved in the management of 8,041 
problems (5.3% of all problems managed at all encounters) (Table 10.7). Extrapolation of 
these results suggests that during 2013–14 practice nurses were involved in about 10.7 
million GP–patient consultations across Australia.  
A PN/AHW Medicare item was recorded at only 386 encounters: 0.4% of the 84,153 with one 
or more MBS item number(s) (Table 5.2) and 5.0% of the 7,690 encounters involving a 
PN/AHW (Table 10.7). 
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Table 10.7: Summary of PN or AHW involvement at encounters 
Variable Number 
Total encounters  95,879 
Encounters involving PN/AHW 7,690 
 Encounters at which PN/AHW activity described 7,615 
 Encounters with PN/AHW item number(s) recorded but activity not described  75 
Encounters at which one or more MBS PN/AHW item numbers were recorded as claimable  386 
Total problems managed 151,675 
Problems managed with PN/AHW-involvement 8,041 
 Per cent  (95% CI) 
Encounters involving the PN/AHW as a proportion of total encounters  8.0 (7.3–8.7) 
PN/AHW-claimable encounters as a proportion of total encounters  0.4 (0.3–0.5) 
Proportion of PN/AHW-involved encounters for which one or more PN/AHW item numbers were 
claimed from Medicare  
5.0 
(3.4–6.7) 
Problems involving the PN/AHW as a proportion of total problems (95% CI) 5.3 (4.9–5.8) 
Note: PN/AHW – practice nurse/Aboriginal health worker; MBS – Medicare Benefits Schedule; CI – confidence interval. 
Treatments provided by practice nurses or Aboriginal health worker 
at GP–patient encounters 
As shown in Section 10.1, GPs reported 54,104 other treatments. A further 1,683 local 
injections in administration of vaccine were given by a PN/AHW and 2,562 by the recording 
GP (these were not reported in Section 10.2). So, in total 58,349 other treatments were 
recorded, PNs/AHWs accounting for 8,568 of these (representing 14.7% of all other 
treatments recorded at BEACH encounters) (Table 10.8) at a rate of 8.9 per 100 recorded 
encounters. 
The vast majority (87.5%) of the PN/AHW recorded activity was procedural, and these 
procedures represented 33.6% of all procedures recorded. In contrast, clinical treatments 
accounted for 12.5% of PN/AHW recorded activity at encounters, but PNs/AHWs provided 
only 3.0% of all recorded clinical treatments. PNs/AHWs did 39.7% of the recorded 
immunisation injections at GPs encounters (Table 10.8). 
Table 10.8: Summary of treatments given by GPs, and by PN or AHW at GP–patient encounters 
Treatment 
Performed/assisted by PN/AHW  Performed by the GP 
Total number 
recorded(a) Number 
Row per cent  
of total 
 
Number 
Row per cent  
of total 
Procedures(a) 7,500 33.6  14,826 66.4 22,326 
(Immunisation injections) (1,683) (39.7)  (2,562) (60.3) (4,245) 
Clinical treatments 1,068 3.0  34,956 97.0 36,023 
All other treatments 8,568 14.7  49,782 85.3 58,349 
(a)  Procedural treatments here include all injections given by a PN/AHW or the GP for immunisations/vaccinations (n = 4,245).  
These are not included in the summary of the content of encounter in Table 5.1, summary of management in Table 8.1 or in the analyses of 
other treatments in Chapter 10, because the immunisation/vaccination is already counted as a prescription or GP-supplied medication. 
Note: PN/AHW – practice nurse/Aboriginal health worker; columns may not add to total, due to rounding. 
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Of the 7,500 procedures performed by a PN/AHW, 34.6% were injections (Table 10.9), 65.0% 
of these were for immunisations (Table 10.8). A further 19.9% were dressing/ 
pressure/compression/tamponade. Together these accounted for 54.5% of all procedures 
undertaken by PNs/AHWs in association with the recorded GP–patient encounters. Check-
ups made up 8.4%, followed by INR tests (7.6%), and electrical tracings (5.9%) (Table 10.9). 
Other administrative procedure (including administrative/documentation work but 
excluding provision of sickness certificates) was the most frequently recorded clinical 
activity, accounting for 33.0% of the 1,068 clinical treatments provided by PNs/AHWs, 
followed by counselling/advice about nutrition/weight (10.0%), counselling about a health 
problem (8.6%), and advice/education about medication (8.1%) (Table 10.9). 
Table 10.9: Most frequent activities done by a PN or AHW at GP encounters 
Activity Number 
Per cent 
of group(a) 
Rate per 100 encs 
where PN/AHW 
activity described(a) 
 (n = 7,615) 
95% 
 LCL 
95% 
UCL 
Procedural treatments 7,500 100 98.5 96.1 100.9 
 Local injection/infiltration* 2,591 34.6 34 31 37.1 
 Dressing/pressure/compression/tamponade* 1,495 19.9 19.6 17.8 21.5 
 Check-up – PN/AHW* 629 8.4 8.3 6.2 10.3 
 INR test* 571 7.6 7.5 6.2 8.8 
 Electrical tracings* 443 5.9 5.8 4.8 6.9 
 Incision/drainage/flushing/aspiration/removal body fluid* 416 5.5 5.5 4.6 6.3 
 Repair/fixation – suture/cast/prosthetic device  
 (apply/remove)* 
335 4.5 4.4 3.7 5.2 
 Excision/removal tissue/biopsy/destruction/
 debridement/cauterisation* 
271 3.6 3.6 2.8 4.3 
 Physical function test* 223 3 2.9 2.3 3.6 
 Urine test* 115 1.5 1.5 1 2 
 Other diagnostic procedures* 77 1.0 1.0 0.6 1.4 
 Other therapeutic procedures/surgery NEC* 74 1.0 1.0 0.7 1.3 
 Glucose test* 54 0.7 0.7 0.4 1 
 Pap smear* 48 0.6 0.6 0.3 1 
 Assist at operation 37 0.5 0.5 0.2 0.8 
Clinical treatments 1,068 100 14.0 11.6 16.4 
 Other administrative procedure/document 
 (excluding sickness certificate)* 
353 33.0 4.6 3.5 5.8 
 Counselling/advice – nutrition/weight*  107 10.0 1.4 0.7 2.1 
 Counselling – problem*  91 8.6 1.2 0.8 1.6 
 Advice/education – medication* 87 8.1 1.1 0.5 1.8 
 Advice/education NEC* 77 7.2 1.0 0.7 1.3 
 Advice/education – treatment* 73 6.9 1.0 0.6 1.3 
 Consultation with primary care provider* 56 5.3 0.7 0.4 1.1 
(a) Only the most common individual treatments provided by practice nurses/Aboriginal health workers are included in this table. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Tables A4.4–A4.6 <hdl.handle.net/2123/11882>). 
Note: Encs – encounters; PN/AHW – practice nurse/Aboriginal health worker; LCL – lower confidence limit; UCL – upper confidence limit; INR – 
international normalised ratio; NEC – not elsewhere classified. 
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Problems managed with practice nurse or Aboriginal health 
workers involvement at encounter 
PNs and AHWs were involved in management of a wide range of problems in association 
with the GP encounters. The problems they managed most often were immunisation/ 
vaccination (21.6% of all problems managed with the involvement of a PN or AHW), 
check-ups (5.9%), laceration/cut (5.6 %), atrial fibrillation (4.2%), diabetes and chronic skin 
ulcer (both 4.2%). Other common problems for which PNs or AHWs were involved at the 
GP–patient consultations are listed in Table 10.10. 
 
Table 10.10: The 20 most common problems managed with involvement of PNs or AHWs at 
GP–patient encounters 
Problem managed Number 
Per cent  
of problems 
involving  
PN/AHW 
(n = 8,041) 
Rate per 100 
encounters with 
recorded PN/AHW 
activity(a) 
(n = 7,615) 
95% 
LCL 
95% 
UCL 
Immunisation/vaccination – all* 1733 21.6 22.8 19.8 25.7 
Check-up – all* 475 5.9 6.2 5.4 7 
Laceration/cut 450 5.6 5.9 5.2 6.7 
Atrial fibrillation/flutter  336 4.2 4.4 3.6 5.2 
Diabetes – all* 334 4.2 4.4 3.5 5.3 
Chronic ulcer skin (including varicose ulcer) 321 4.0 4.2 3.5 4.9 
Excessive ear wax  210 2.6 2.8 2.3 3.3 
Malignant neoplasm, skin 200 2.5 2.6 1.9 3.3 
Administrative procedure – all* 128 1.6 1.7 0.8 2.6 
Blood test – all* 118 1.5 1.5 1.1 2 
Skin infection, other 106 1.3 1.4 1 1.7 
Prescription – all* 101 1.3 1.3 0.8 1.8 
Asthma 100 1.2 1.3 1 1.7 
Repair/fixation – suture/cast/prosthetic device 
(apply/remove)* 
99 1.2 1.3 1 1.6 
Other preventive procedures/high risk medication* 86 1.1 1.1 0.7 1.5 
Burns/scalds 77 1.0 1.0 0.7 1.3 
Skin symptom/complaint, other 71 0.9 0.9 0.7 1.2 
Chest pain NOS 70 0.9 0.9 0.6 1.3 
Arthritis – all* 68 0.8 0.9 0.6 1.2 
Chronic obstructive pulmonary disease 65 0.8 0.9 0.6 1.1 
Subtotal 5,148 64.0 — — — 
Total problems involving practice nurse 8,041 100.0 105.6 104.4 106.8 
(a) Rate of nurse provision of treatment at encounter for selected problem per 100 total encounters in which a practice nurse or Aboriginal 
health worker was involved. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Table A4.3, <hdl.handle.net/2123/11882>).  
Note: LCL – lower confidence limit; UCL – upper confidence limit; PN/AHW – practice nurse/Aboriginal health worker; NOS – not otherwise 
specified 
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 10.5  Changes in other treatments over the  decade 
2004–05 to 2013–14 
An overview of changes in other treatments provided in general practice over the decade can 
be found in Chapter 10 of the companion report, A decade of Australian general practice activity 
2004–05 to 2013–14.1 A summary of the results is provided below. 
Clinical treatments 
There was a significant decrease in the rate at which clinical treatments were provided per 
100 problems managed when comparing 2004–05 and 2013–14, however the change over the 
decade was not linear. 
Following the introduction of PN and AHW Medicare item numbers in 2004, there was a 
sudden and significant decrease in the rate at which clinical treatments were provided 
between 2004–05 and 2005–06. From 2006–07 onwards, the rate remained steady, and in 
2013–14 clinical treatments were still provided at a significantly lower rate than 10 years 
earlier (23.8 clinical treatments per 100 problems managed in 2013–14). 
This pattern of change was reflected in the rate at which counselling/advice about 
nutrition/weight and exercise were provided. The rates of these clinical treatments 
significantly decreased in 2005–06, but have since been steady, remaining significantly lower 
in 2013–14 than 10 years earlier. Considering the rise in the prevalence of overweight and 
obesity among Australian general practice patients, it is hoped that the decrease since 
2005–06 reflects a shift of this role to PNs or other allied health professionals. 
There was no significant change over time in the rate at which problems were managed with 
clinical treatments. For every 100 GP–patient encounters in 2004–05, one or more clinical 
treatments were provided in the management of 34.4 problems. In 2013–14, clinical 
treatments were provided for 33.8 problems per 100 encounters. 
Procedural treatments 
There was a significant increase in the rate at which procedures were performed from  
2004–05 (10.6 per 100 problems) to 2013–14 (11.9 per 100 problems). The extrapolated effect 
of this change from 15.5 per 100 encounters in 2004–05 to 18.9 per 100 encounters in 2013–14, 
is that nationally in 2013–14 there were an estimated 10 million more procedures undertaken 
at GP–patient encounters than a decade earlier. 
The overall increase was reflected in increases in the rate of dressing/pressure/ 
compression/tamponade, local injection/infiltration, and INR tests (per 100 problems).  
There was also an increase in the likelihood of a procedure being undertaken in the 
management of an individual problem, rising from 14.3 per 100 encounters in 2004–05 to 17.7 
per 100 in 2013–14. This increase was reflected in significant increases in the rate at which 
one or more procedures were undertaken for the management of laceration/cut, general 
check-up, atrial fibrillation/flutter, vitamin/nutritional deficiency, skin symptom/complaint 
and depression. 
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Practice nurse/Aboriginal health worker activity  
As a proportion of all encounters, those involving a PN/AHW doubled from 4.2% in 2005–06 
to 9.0% in 2009–10, then remained steady in the 7–8% range to 2013–14. The proportion of 
problems managed with a PN/AHW involvement also rose from 2.8% in 2005–06 to 6.1% in 
2009–10, with no further change by 2013–14 (5.3%).  
In 2005–06, GPs recorded at least one PN/AHW Medicare item number at 39% of encounters 
with recorded PN/AHW activity. This increased to 46% by 2009–10, and then decreased to 
27% in 2011–12. After the change in practice nurse funding structure, a PN/AHW item 
number was claimed at only 4% of PN/AHW-involved encounters in 2012–13 and 5% in 
2013–14.  
The rate at which procedures (including tests) were undertaken by PNs/AHWs at  
GP–patient encounters more than doubled from 4.0 per 100 encounters in 2005–06 to 9.2 per 
100 in 2009–10, but then decreased in 2011–12 to 7.2 per 100 encounters, remaining steady  
thereafter.  
While their provision of clinical treatments (such as advice and health education) remained 
infrequent at GP–patient encounters, there was a significant increase over the study period, 
from 0.2 clinical treatments per 100 encounters in 2005–06 to 1.1 per 100 in 2013–14.  
The rate at which PNs/AHWs provided injections in association with GP–patient encounters 
did not change in 2013–14 when compared with the previous year, but remained at the far 
lower level of 34.0 per 100 PN/AHW-involved encounters, when compared with 2005–06 
(when it was 41.0 per 100). Check-ups by PNs/AHWs at GP–patient encounters doubled 
over the study period. INR blood testing frequency quadrupled, but most of this increase 
had occurred by 2010–11 with no further significant increase thereafter.  
In clinical treatments, PNs/AHWs carried out administrative procedures (excluding sickness 
certificates) at an ever increasing rate, rising from 0.7 per 100 PN/AHW-involved encounters 
in 2005–06 to 4.6 per 100 in 2013–14. Most of this growth occurred over the most recent 3 
years. Their provision of advice/education about nutrition and weight, medication, and 
advice about how to treat the health problem also increased significantly over the decade.  
There were significant increases in the rate at which PNs/AHWs were involved in 
management of check-ups, atrial fibrillation/flutter, diabetes, vitamin/nutritional deficiency, 
and hypertension. Many of these increases may have been stimulated by the introduction of 
MBS item 10997 for services provided to a person with a chronic disease, in 2007–08.  
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 11 Referrals and admissions 
A referral is defined as the process by which the responsibility for part, or all, of the care of a 
patient is temporarily transferred to another health care provider. GPs were instructed only 
to record new referrals at the encounter (that is, not to record continuations). For each 
encounter, GPs could record up to two referrals, and each referral was linked by the GP to 
the problem(s) for which the patient was referred. Referrals included those to medical 
specialists, allied health services, hospitals for admission, emergency departments, and those 
to other services (including those to outpatient clinics and to other GPs). 
Data on referrals and admissions are reported for each of the most recent BEACH years from 
2004–05 to 2013–14 in the 10-year report, A decade of Australian general practice activity 2004–05 
to 2013–14.1  
11.1 Number of referrals and admissions 
Table 11.1 provides a summary of referrals and admissions, and the rates per 100 encounters 
and per 100 problems managed. The patient was given at least one referral at 14.4% of all 
encounters, for 9.8% of all problems managed. 
There were 15,012 referrals made at a rate of 15.7 per 100 encounters, most often to medical 
specialists (9.5 per 100 encounters, 6.0 per 100 problems managed), followed by referrals to 
allied health services (4.9 per 100 encounters, 3.1 per 100 problems). Few patients were 
referred/admitted to hospital, or referred to the emergency department. 
Table 11.1: Summary of referrals and admissions 
Variable Number 
Rate per 100 
encounters 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Rate per 100 
problems 
(n = 151,675) 
95% 
LCL 
95% 
UCL 
At least one referral(a) 13,788 14.4 13.9 14.9 9.8 9.5 10.2 
Referrals  15,012 15.7 15.1 16.3 9.9 9.6 10.2 
 Medical specialist* 9,139 9.5 9.1 9.9 6.0 5.8 6.3 
 Allied health services* 4,744 4.9 4.7 5.2 3.1 3.0 3.3 
 Hospital* 382 0.4 0.3 0.5 0.3 0.2 0.3 
 Emergency department* 272 0.3 0.2 0.3 0.2 0.2 0.2 
 Other referrals* 360 0.4 0.3 0.4 0.2 0.2 0.3 
Total referrals 15,012 15.7 15.1 16.3 9.9 9.6 10.2 
(a) At least one referral was given in the management of 14,905 problems at the 13,788 encounters.  
* Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 4, Table A4.7, <hdl.handle.net/2123/11882>). 
Note: LCL – lower confidence limit; UCL – upper confidence limit. 
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 11.2 Most frequent referrals 
Table 11.2 shows the medical specialists and allied health service groups to whom GPs most 
often referred patients. Referrals to medical specialists were most often to orthopaedic 
surgeons (9.3% of specialist referrals), surgeons (8.1%), and cardiologists (7.9%). The top 10 
specialists accounted for 63.9% of specialist referrals and for 42.1% of all referrals. 
Referrals to allied health services were most often to physiotherapists (26.9% of allied health 
services referrals), psychologists (21.8%), podiatrists/chiropodists (11.1%), 
dietitians/nutritionists (7.9%) and dentists (2.8%). The top 10 allied health services accounted 
for 81.5% of allied health referrals and 27.9% of all referrals. 
Table 11.2: Most frequent referrals, by type 
Professional/organisation Number 
Per cent 
of all 
referrals  
Per cent of 
referral 
group 
Rate per 100 
encounters 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Rate per 100 
problems 
(n = 151,675) 
95% 
LCL 
95% 
UCL 
Medical specialist* 9,139 65.8 100.0 9.5 9.1 9.9 6.0 5.8 6.3 
 Orthopaedic surgeon  853 6.1 9.3 0.9 0.8 1.0 0.6 0.5 0.6 
 Surgeon 742 5.3 8.1 0.8 0.7 0.8 0.5 0.4 0.5 
 Cardiologist 718 5.2 7.9 0.7 0.7 0.8 0.5 0.4 0.5 
 Dermatologist 712 5.1 7.8 0.7 0.7 0.8 0.5 0.4 0.5 
 Ophthalmologist 667 4.8 7.3 0.7 0.6 0.8 0.4 0.4 0.5 
 Gastroenterologist 573 4.1 6.3 0.6 0.5 0.7 0.4 0.3 0.4 
 Ear, nose and throat 456 3.3 5.0 0.5 0.4 0.5 0.3 0.3 0.3 
 Gynaecologist  455 3.3 5.0 0.5 0.4 0.5 0.3 0.3 0.3 
 Urologist  381 2.7 4.2 0.4 0.3 0.4 0.3 0.2 0.3 
 Neurologist  284 2.0 3.1 0.3 0.3 0.3 0.2 0.2 0.2 
 Subtotal: top 10 medical  
 specialist referrals  5,842 42.1 63.9 — — — — — — 
Allied health services* 4,744 34.2 100.0 4.9 4.7 5.2 3.1 3.0 3.3 
 Physiotherapist  1,278 9.2 26.9 1.3 1.2 1.4 0.8 0.8 0.9 
 Psychologist  1,036 7.5 21.8 1.1 1.0 1.2 0.7 0.6 0.7 
 Podiatrist/chiropodist  528 3.8 11.1 0.6 0.5 0.6 0.3 0.3 0.4 
 Dietitian/nutritionist  374 2.7 7.9 0.4 0.3 0.5 0.2 0.2 0.3 
 Dentist  132 1.0 2.8 0.1 0.1 0.2 0.1 0.1 0.1 
 Optometrist  127 0.9 2.7 0.1 0.1 0.2 0.1 0.1 0.1 
 Audiologist 123 0.9 2.6 0.1 0.1 0.2 0.1 0.1 0.1 
 Exercise physiologist 104 0.7 2.2 0.1 0.1 0.1 0.1 0.0 0.1 
 Diabetes educator 93 0.7 2.0 0.1 0.1 0.1 0.1 0.0 0.1 
 Counsellor  73 0.5 1.5 0.1 0.1 0.1 0.0 0.0 0.1 
 Subtotal: top 10 allied  
 health referrals 3,868 27.9 81.5 — — — — — — 
Subtotal: all referrals listed 9,710 69.9 — — — — — — — 
Total allied health and 
medical specialist referrals 13,884 100.0 — 14.5 13.9 15.1 9.2 8.8 9.5 
* Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 4, Table A4.7, <hdl.handle.net/2123/11882>).  
Note: LCL – lower confidence limit; UCL – upper confidence limit.  
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 11.3  Problems most frequently referred to a 
specialist 
The GP could link a single referral to multiple problems being managed at the encounter. 
Therefore, there are more problem–referral links than referrals. Table 11.3 shows the most 
common problems referred to a medical specialist, in decreasing frequency order of 
problem-referral links. 
The 9,139 referrals to a medical specialist were provided in management of 9,350 problems. 
The 10 problems most often referred to a specialist accounted for only 18.7% of all problem–
referral links, reflecting the breadth of problems referred to specialists. Malignant skin 
neoplasm accounted for 2.8% of problem-referral links, osteoarthritis 2.8%, pregnancy 2.1% 
and diabetes 2.0% (Table 11.3). The far right column of Table 11.3 shows the likelihood of 
referral to a medical specialist when each problem is managed. Malignant skin neoplasm 
resulted in a specialist referral at almost 1 in 5 (19.8%) GP contacts with this problem. This 
was followed by pregnancy (18.2%) and ischaemic heart disease (16.2%).  
Table 11.3: The 10 problems most frequently referred to a medical specialist 
Problem managed 
Problem–referral links Rate per 100 
encounters 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Per cent of contacts 
with this problem(a) Number Per cent  
Malignant neoplasm, skin 266 2.8 0.3 0.2 0.3 19.8 
Osteoarthritis* 266 2.8 0.3 0.2 0.3 9.6 
Pregnancy* 197 2.1 0.2 0.2 0.2 18.2 
Diabetes – all* 187 2.0 0.2 0.2 0.2 4.6 
Ischaemic heart disease* 177 1.9 0.2 0.1 0.2 16.2 
Sleep disturbance 161 1.7 0.2 0.1 0.2 10.9 
Back complaint* 144 1.5 0.2 0.1 0.2 4.8 
Skin symptom/complaint, other 124 1.3 0.1 0.1 0.2 15.9 
Depression* 116 1.2 0.1 0.1 0.1 2.8 
Abnormal test results* 112 1.2 0.1 0.1 0.1 9.0 
Subtotal: top 10 problems referred to a 
medical specialist 1,752 18.7 — — — — 
Total problems referred to medical 
specialist  9,350 100.0 9.8 9.3 10.2 — 
(a) The proportion of GP contacts with this problem that was referred to a medical specialist. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Table A4.1 <hdl.handle.net/2123/11882>). 
Note: LCL – lower confidence limit; UCL – upper confidence limit. 
Table 11.4 shows the five problems accounting for the greatest proportion of referrals to each 
of the 10 most common medical specialty types. The top five problems may represent a small 
or large proportion of all problems referred to a particular specialty. For example, the top 
five problems accounted for 25.4% of all referrals to ear, nose, and throat (ENT) specialists 
(indicative of the broad range of conditions referred to them), but for 58.1% of all referrals to 
orthopaedic surgeons, consistent with a more defined range of clinical work.  
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Orthopaedic surgeon: The two problems accounting for the most referrals were 
osteoarthritis (26.9% of orthopaedic surgeon referrals) and acute internal knee damage 
(10.4%). Of the five problems most frequently referred to an orthopaedic surgeon, those most 
likely to be referred at each GP contact with that problem were acute internal knee damage 
(referred at 26.9% of contacts) and musculoskeletal injury (not otherwise specified) (8.6%).  
General/unspecified surgeon: The two problems accounting for the most referrals were 
other (not inguinal or diaphragmatic) abdominal hernia (7.8% of referrals) and inguinal 
hernia (6.1%). Of the five problems most frequently referred, those most likely to be referred 
were other abdominal hernia (referred at 41.6% of GP contacts) and inguinal hernia (40.7%).  
Cardiologist: The two problems accounting for the most referrals were ischaemic heart 
disease (21.4% of referrals) and atrial fibrillation/flutter (12.3%). Of the five problems most 
frequently referred, those most likely to be referred were ischaemic heart disease (referred at 
14.8% of GP contacts) and chest pain (not otherwise specified) (13.6%). 
Dermatologist: The two problems accounting for the most referrals were malignant 
neoplasm of skin (15.6% of referrals) and other skin symptom/complaint (11.3%). Of the five 
problems most frequently referred to a dermatologist, those most likely to be referred were 
acne (referred at 13.0% of GP contacts) and skin check-up (11.1%).  
Ophthalmologist: The two problems accounting for the most referrals were cataract (13.1%) 
and glaucoma (10.7%). Of the five problems most frequently referred to an ophthalmologist, 
those most likely to be referred were cataract (referred at 55.6% of GP contacts) and other 
visual disturbance (44.7%).  
Gastroenterologist: The two problems accounting for the most referrals were gastro-
oesophageal reflux disease (10.5% of referrals) and abdominal pain (6.8%). Of the five 
problems most frequently referred to a gastroenterologist, those most likely to be referred 
were rectal bleeding (referred at 27.0% of GP contacts) and digestive neoplasm (benign or 
uncertain) (23.8%).  
Ear, nose, and throat (ENT) specialist: The two problems accounting for the most referrals 
were acute/chronic sinusitis (6.3% of referrals) and tonsillitis (5.1%). Of the five problems 
most frequently referred to an ENT specialist, those most likely to be referred were voice 
symptom/complaint (referred at 62.6% of GP contacts) and nose bleed/epistaxis (20.5%).  
Gynaecologist: The two problems accounting for the most referrals were menstrual 
problems (13.1% of referrals) and ‘other’ female genital disease (11.5%). Of the five problems 
most frequently referred to a gynaecologist, those most likely to be referred were 
uterovaginal prolapse (referred at 36.7% of GP contacts) and female infertility/ 
subfertility (28.3%).  
Urologist: The two problems accounting for the most referrals were benign prostatic 
hypertrophy (12.6% of referrals) and abnormal test results (8.4%). Of the five problems most 
frequently referred, those most likely to be referred were benign prostatic hypertrophy 
(referred at 18.1% of GP contacts) and haematuria (16.4%).  
Neurologist: The two problems accounting for the most referrals were epilepsy (10.0% of 
referrals) and headache (9.0%). Of the five problems most frequently referred to a 
neurologist, those most likely to be referred at each GP contact with that problem were 
epilepsy (referred at 11.2% of GP contacts) and carpal tunnel syndrome (10.3%) (Table 11.4). 
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Table 11.4: The top problems most frequently referred, by type of medical specialist 
Specialist Problem managed Number 
Per cent of 
problems referred 
to each specialist 
Per cent of 
contacts with  
this problem(a) 
Orthopaedic surgeon Total 870 100.0 — 
 Osteoarthritis* 234 26.9 8.5 
 Acute internal knee damage  90 10.4 26.9 
 Injury musculoskeletal NOS 74 8.5 8.6 
 Bursitis/tendonitis/synovitis NOS 54 6.2 4.5 
 Fracture* 53 6.1 5.3 
 Subtotal: top five problems  505 58.1  — 
General/unspecified 
surgeon 
Total 755 100.0 — 
Abdominal hernia, other 59 7.8 41.6 
 Inguinal hernia 46 6.1 40.7 
 Malignant neoplasm, skin 37 4.9 2.8 
 Cholecystitis/cholelithiasis 33 4.4 22.0 
 Obesity (BMI > 30) 29 3.9 4.1 
 Subtotal: top five problems  204 27.1  — 
Cardiologist Total 757 100.0 — 
 Ischaemic Heart Disease* 162 21.4 14.8 
 Atrial fibrillation/flutter 93 12.3 6.4 
 Hypertension* 56 7.4 0.7 
 Chest pain NOS 47 6.2 13.6 
 Heart failure 37 4.9 6.5 
 Subtotal: top five problems 396 52.3  — 
Dermatologist Total 721 100.0 — 
 Malignant neoplasm, skin 113 15.6 8.4 
 Skin symptom/complaint, other 82 11.3 10.4 
 Skin check-up* 60 8.3 11.1 
 Skin disease, other 59 8.1 5.3 
 Acne 54 7.5 13.0 
 Subtotal: top five problems 366 50.8  — 
Ophthalmologist  Total 677 100.0 — 
 Cataract 89 13.1 55.6 
 Glaucoma 72 10.7 40.9 
 Diabetes – all* 67 9.9 1.7 
 Eye/adnexa disease, other 49 7.3 28.5 
 Visual disturbance, other 34 5.0 44.7 
 Subtotal: top five problems 311 46.0  — 
(continued) 
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Table 11.4 (continued): The top problems most frequently referred, by type of medical specialist 
Specialist Problem managed Number 
Per cent of 
problems referred 
to each specialist 
Per cent of 
contacts with this 
problem(a) 
Gastroenterologist Total 584 100.0 — 
 Gastro-oesophageal reflux disease* 62 10.5 2.5 
 Abdominal pain* 40 6.8 5.8 
 Benign/uncertain neoplasm, digestive 37 6.3 23.8 
 Rectal bleeding 33 5.6 27.0 
 Chronic enteritis/ulcerative colitis 29 4.9 17.7 
 Subtotal: top five problems 200 34.2  — 
Ear, nose, and throat 
(ENT) specialist 
Total 465 100.0 — 
Sinusitis acute/chronic 29 6.3 2.8 
 Tonsillitis* 24 5.1 3.6 
 Respiratory disease, other 23 4.9 10.6 
 Nose bleed/epistaxis 22 4.7 20.5 
 Voice symptom/complaint 21 4.5 62.6 
 Subtotal: top five problems 118 25.4  — 
Gynaecologist  Total 464 100.0 — 
 Menstrual problems* 61 13.1 10.2 
 Genital disease, other (female) 53 11.5 22.5 
 Abnormal test results* 30 6.5 2.4 
 Uterovaginal prolapse 28 6.1 36.7 
 Infertility/subfertility (female) 21 4.5 28.3 
 Subtotal: top five problems 193 41.7  — 
Urologist  Total 391 100.0 — 
 Benign prostatic hypertrophy 49 12.6 18.1 
 Abnormal test results* 33 8.4 2.6 
 Haematuria 30 7.6 16.4 
 Malignant neoplasm prostate 28 7.1 8.4 
 Urinary tract infection* 22 5.7 1.3 
 Subtotal: top five problems 162 41.4  — 
Neurologist Total 288 100.0 — 
 Epilepsy 29 10.0 11.2 
 Headache* 26 9.0 2.5 
 Carpal tunnel syndrome 19 6.8 10.3 
 Peripheral neuritis/neuropathy 19 6.7 6.7 
 Neurological disease, other 18 6.2 3.4 
 Subtotal: top five problems 111 38.6  — 
(a) The proportion of GP contacts with this problem that was referred to each type of medical specialist.  
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Table A4.1 <hdl.handle.net/2123/11882>). 
Note: NOS – not otherwise specified. 
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 11.4  Problems most frequently referred to allied 
health services and hospitals  
The 4,744 referrals to an allied health service were provided in the management of 4,943 
problems. The 10 most commonly referred problems accounted for 46.6% of all problem–
referral links. Depression was the problem accounting for the largest proportion of allied 
health referrals (11.0%), followed by diabetes (7.7%), anxiety (6.2%) and back complaints 
(6.1%). However, of the 10 most commonly referred problems, the most likely to be referred 
to an allied health service was anxiety, referred at 14.2% of all GP contacts with this problem 
(Table 11.5).  
Table 11.5: The 10 problems most frequently referred to allied health services 
Problem managed 
Problem–referral links Rate per 100 
encounters 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Per cent of 
contacts with 
this problem(a) Number Per cent 
Depression* 542 11.0 0.6 0.5 0.6 13.1 
Diabetes – all*  381 7.7 0.4 0.3 0.5 9.4 
Anxiety* 307 6.2 0.3 0.3 0.4 14.2 
Back complaint* 303 6.1 0.3 0.3 0.4 10.0 
Osteoarthritis* 196 4.0 0.2 0.2 0.2 7.1 
Sprain/Strain* 151 3.1 0.2 0.1 0.2 12.3 
Bursitis/tendonitis/synovitis NOS 114 2.3 0.1 0.1 0.1 9.5 
Administrative procedure NOS 113 2.3 0.1 0.1 0.2 9.3 
Acute stress reaction 100 2.0 0.1 0.1 0.1 13.5 
Obesity (BMI > 30) 97 2.0 0.1 0.1 0.1 13.7 
Subtotal: top 10 problems referred to AHS 2,304 46.6 — — — — 
Total problems referred to AHS 4,943 100.0 5.2 4.8 5.5 — 
(a) The proportion of GP contacts with this problem that was referred to allied health services. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Table A4.1, <hdl.handle.net/2123/11882>). 
Note: LCL – lower confidence limit; UCL – upper confidence limit; NOS – not otherwise specified; AHS – allied health service. 
The 382 referrals to a hospital were provided in the management of 390 problems.  
The 10 problems most frequently referred to hospital are shown in Table 11.6. Pregnancy 
accounted for the highest proportion (4.5%) of these referrals, but pneumonia was the 
problem most likely to be referred (4.4%).  
The 272 referrals to an emergency department were associated with the management of 
275 problems. The 10 problems most frequently referred to an emergency department are 
shown in Table 11.7. Fracture and appendicitis accounted for the equal highest proportion 
(6.1% each) of these referrals, but appendicitis was the most likely to be referred (44.1%).  
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 Table 11.6: The 10 problems most frequently referred to hospital 
Problem managed 
Problem–referral links Rate per 100 
encounters 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Per cent of 
contacts with 
this problem(a) Number Per cent 
Pregnancy* 17 4.5 0.02 0.01 0.03 1.6 
Fracture* 16 4.0 0.02 0.01 0.03 1.6 
Pneumonia 10 2.6 0.01 0.00 0.02 4.4 
Urinary tract infection* 10 2.5 0.01 0.00 0.02 0.6 
Acute bronchitis/bronchiolitis 10 2.5 0.01 0.00 0.02 0.5 
Chest pain NOS 9 2.3 0.01 0.00 0.02 2.5 
Heart failure 8 2.1 0.01 0.00 0.01 1.5 
Diabetes – all*  7 1.9 0.01 0.00 0.02 0.2 
Infectious disease, other/NOS 7 1.8 0.01 0.00 0.02 1.5 
Abdominal pain* 7 1.8 0.01 0.00 0.01 1.0 
Subtotal: top 10 problems referred for 
admission 101 26.0 — — — — 
Total problems referred to hospital 390 100.0 0.41 0.34 0.47 — 
(a) The proportion of GP contacts with this problem that was referred to hospital. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Table A4.1, <hdl.handle.net/2123/11882>). 
Note: LCL – lower confidence limit; UCL – upper confidence limit; NOS – not otherwise specified. 
Table 11.7: The 10 problems most frequently referred to an emergency department 
Problem managed 
Problem–referral links Rate per 100 
encounters 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Per cent of 
contacts with 
this problem(a) Number Per cent 
Fracture* 17 6.1 0.02 0.01 0.03 1.7 
Appendicitis 17 6.1 0.02 0.01 0.03 44.1 
Chest pain NOS 13 4.6 0.01 0.00 0.02 3.7 
Disease digestive system, other 10 3.5 0.01 0.00 0.02 3.0 
Anaemia* 8 2.8 0.01 0.00 0.02 1.3 
Abdominal pain* 8 2.7 0.01 0.00 0.02 1.1 
Hypertension* 7 2.4 0.01 0.00 0.01 0.1 
Ischaemic heart disease* 7 2.4 0.01 0.00 0.01 0.6 
Skin infection, other 6 2.1 0.01 0.00 0.01 1.6 
Pneumonia 6 2.0 0.01 0.00 0.01 2.5 
Subtotal: top 10 problems referred to 
emergency department 96 34.8 — — — — 
Total problems referred to emergency 
department 275 100.0 0.29 0.24 0.33 — 
(a) The proportion of GP contacts with this problem that was referred to an emergency department. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Table A4.1, <hdl.handle.net/2123/11882>). 
Note: LCL – lower confidence limit; UCL – upper confidence limit; NOS – not otherwise specified. 
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 11.5  Changes in referrals over the decade 2004–05 
to 2013–14 
An overview of changes in referrals over the decade can be found in Chapter 11 of the 
companion report, A decade of Australian general practice activity 2004–05 to 2013–14.1 In that 
report, changes over time are discussed in terms of change in the management of problems 
(that is, as a rate per 100 problems managed). This reflects change in how GPs are managing 
problems, and accounts for the significant increase in the number of problems managed per 
encounter over the decade.  
In summary, over the 10 years there was a significant increase in the proportion of problems 
that were referred: in 2004–05 at least one referral was made in the management of 7.9% of 
problems and this increased to 9.8% of problems managed in 2013–14.  
The overall rate of referral per 100 problems managed increased from 7.9 in 2004–05 to 9.9 in 
2013–14, and per 100 encounters from 11.5 to 15.7. This suggests that there were 9.7 million 
more referrals nationally in 2013–14 than a decade earlier.  
Referrals to medical specialists increased from 5.3 per 100 problems managed in 2004–05 to 
6.0 in 2013–14. There were marginally significant increases in the rate of referrals per 100 
problems to orthopaedic surgeons, cardiologists and gastroenterologists, and marginal 
decreases in referrals to surgeons and ophthalmologists.  
Referrals to allied health services increased from 1.9 per 100 problems managed in 2004–05 to 
3.1 in 2013–14. This was reflected in significant increases in referral rates per 100 problems to 
psychologists and podiatrists/chiropodists, and marginally significant increases in referral 
rates to physiotherapists and dietitians/nutritionists.  
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 12 Investigations 
The GP participants were asked to record (in free text) any pathology, imaging or other tests 
ordered or undertaken at the encounter, and to nominate the patient problem(s) associated 
with each test order placed. This allows the linkage of a test order to a single problem or 
multiple problems. Up to five orders for pathology, and two for imaging and other tests 
could be recorded at each encounter. A single test may have been ordered for the 
management of multiple problems, and multiple tests may have been used in the 
management of a single problem. 
A pathology test order may be for a single test (for example, Pap smear, HbA1c) or for a 
battery of tests (for example, lipids, full blood count). Where a battery of tests was ordered, 
the battery name was recorded rather than each individual test within the battery. GPs also 
recorded the body site for any imaging ordered (for example, x-ray chest, CT head). 
Data on investigations are reported for each year from 2004–05 to 2013–14 in the 10-year 
report, A decade of Australian general practice activity 2004–05 to 2013–14.1 
12.1 Number of investigations 
Table 12.1 shows the number of encounters and problems at which a pathology or imaging 
test was ordered. There were no pathology or imaging tests recorded at three-quarters 
(74.3%) of encounters. 
At least one pathology test order was recorded at 19.1% of encounters (for 13.9% of problems 
managed), and at least one imaging test was ordered at 9.3% of encounters (for 6.1% of 
problems managed).  
Table 12.1: Number of encounters and problems for which pathology or imaging was ordered 
Pathology/imaging test 
ordered 
Number of 
encounters  
Per cent of 
encounters 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Number of 
problems 
Per cent of 
problems 
(n = 151,675) 
95% 
LCL 
95% 
UCL 
Pathology and imaging ordered 2,577 2.7 2.5 2.9 1,831 1.2 1.1 1.3 
Pathology only ordered 15,705 16.4 15.9 16.9 19,233 12.7 12.3 13.1 
Imaging only ordered 6,361 6.6 6.4 6.9 7,491 4.9 4.7 5.1 
No pathology or imaging tests 
ordered 
71,236 74.3 73.6 75.0 123,120 81.2 80.7 81.7 
At least one pathology ordered 18,282 19.1 18.4 19.7 21,064 13.9 13.5 14.3 
At least one imaging ordered 8,939 9.3 9.0 9.7 9,322 6.1 5.9 6.4 
At least one other investigation 
ordered 
718 0.7 0.7 0.8 735 0.5 0.4 0.5 
At least one other investigation 
performed in the practice 
1,528 1.6 1.4 1.8 1,543 1.0 0.9 1.1 
At least one other investigation 
ordered or performed 
2,189 2.3 2.1 2.5 2,225 1.5 1.3 1.6 
Note: LCL – lower confidence limit; UCL – upper confidence limit. 
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 12.2 Pathology ordering 
A report on changes in pathology ordering by GPs from 1998 to 2001 was produced in 2003.82 
A review of GP pathology orders in the National Health Priority Areas and other selected 
problems between 2000 and 2008 is reported in General practice in Australia, health priorities 
and policies 1998 to 2008.13 A report Evidence-practice gap in pathology test ordering: a comparison 
of BEACH pathology data and recommended testing was produced by the FMRC for the 
Australian Government Quality Use of Pathology Program in June 2009.16 A PhD thesis 
Evaluation of pathology ordering by general practitioners in Australia was completed in 2013.14 
Readers may wish to consider those publications in conjunction with the information 
presented below.  
Nature of pathology orders at encounter 
The GPs recorded 47,035 orders for pathology tests/batteries of tests, at a rate of 49.1 per 
100 encounters or 31.0 per 100 problems managed. The pathology tests recorded were 
grouped according to the categories set out in Appendix 4, Table A4.8. The main pathology 
groups reflect those used in the Medicare Benefits Schedule (MBS).83 
The distribution of pathology tests by MBS group, and the most common tests within each 
group are presented in Table 12.2. Each group and individual test is expressed as a 
proportion of all pathology tests, as a proportion of the group, as a rate per 100 encounters 
and as a rate per 100 problems managed with 95% confidence limits. 
Tests classed as chemistry accounted for more than half the pathology test orders (58.4%), 
the most common being: lipid tests, for which there were 4.2 orders per 100 encounters and 
2.6 per 100 problems; multi-biochemical analysis (3.5; 2.2); thyroid function tests (3.1; 2.0); 
and electrolytes, urea and creatinine (3.0; 1.9). Haematology tests accounted for 17.4% of all 
pathology including the most frequently ordered individual pathology test, full blood count 
(FBC). FBC tests accounted for 13.8% of all pathology, there being 6.8 FBC orders per 100 
encounters and 4.3 per 100 problems managed. Microbiology accounted for 13.5% of 
pathology orders, with urine microscopy, culture and sensitivity being the most frequent test 
type in the group at 2.1 orders per 100 encounters and 1.3 per 100 problems managed. 
Table 12.2: Pathology orders by MBS pathology groups and most frequent individual test orders 
within group 
Pathology test ordered Number 
Per cent  
of all 
pathology  
Per cent  
of group 
Rate per 100 
encounters 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Rate per 100 
problems 
(n = 151,675) 
95% 
LCL 
95% 
UCL 
Chemistry*  27,462 58.4 100.0 28.6 27.3 30.0 18.1 17.4 18.8 
 Lipids* 4,011 8.5 14.6 4.2 3.9 4.4 2.6 2.5 2.8 
 Multi-biochemical analysis* 3,349 7.1 12.2 3.5 3.2 3.8 2.2 2.0 2.4 
 Thyroid function* 2,974 6.3 10.8 3.1 2.9 3.3 2.0 1.8 2.1 
 Electrolytes, urea and creatinine* 2,844 6.0 10.4 3.0 2.7 3.2 1.9 1.7 2.0 
 Glucose/glucose tolerance* 2,345 5.0 8.5 2.4 2.2 2.6 1.5 1.4 1.7 
 Liver function* 2,267 4.8 8.3 2.4 2.2 2.6 1.5 1.4 1.6 
 Ferritin* 1,529 3.3 5.6 1.6 1.5 1.7 1.0 0.9 1.1 
 HbA1c* 1,344 2.9 4.9 1.4 1.3 1.5 0.9 0.8 1.0 
 C reactive protein 997 2.1 3.6 1.0 0.9 1.1 0.7 0.6 0.7 
(continued) 
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Table 12.2 (continued): Pathology orders by MBS pathology groups and most frequent individual 
test orders within group 
Pathology test ordered Number 
Per cent  
of all 
pathology  
Per cent  
of group 
Rate per 100 
encounters 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Rate per 100 
problems 
(n = 151,675) 
95% 
LCL 
95% 
UCL 
 Chemistry; other*  971 2.1 3.5 1.0 0.9 1.1 0.6 0.6 0.7 
 Prostate specific antigen*  905 1.9 3.3 0.9 0.8 1.0 0.6 0.5 0.7 
 Hormone assay* 717 1.5 2.6 0.7 0.6 0.9 0.5 0.4 0.5 
 Vitamin D 697 1.5 2.5 0.7 0.6 0.8 0.5 0.4 0.5 
 Vitamin B12 667 1.4 2.4 0.7 0.6 0.8 0.4 0.4 0.5 
 Albumin/creatinine, urine* 547 1.2 2.0 0.6 0.5 0.6 0.4 0.3 0.4 
 Calcium/phosphate/magnesium* 309 0.7 1.1 0.3 0.3 0.4 0.2 0.2 0.2 
 Drug screen 288 0.6 1.1 0.3 0.1 0.5 0.2 0.1 0.3 
 Cardiac enzymes 245 0.5 0.9 0.3 0.2 0.3 0.2 0.1 0.2 
Haematology*  8,166 17.4 100.0 8.5 8.1 9.0 5.4 5.1 5.6 
 Full blood count 6,477 13.8 79.3 6.8 6.4 7.1 4.3 4.1 4.5 
 ESR 877 1.9 10.7 0.9 0.8 1.0 0.6 0.5 0.6 
 Coagulation*  631 1.3 7.7 0.7 0.6 0.8 0.4 0.4 0.5 
Microbiology*  6,345 13.5 100.0 6.6 6.2 7.0 4.2 4.0 4.4 
 Urine M,C&S* 2,016 4.3 31.8 2.1 2.0 2.2 1.3 1.2 1.4 
 Microbiology; other* 926 2.0 14.6 1.0 0.9 1.1 0.6 0.5 0.7 
 Hepatitis serology* 509 1.1 8.0 0.5 0.4 0.6 0.3 0.3 0.4 
 Faeces M,C&S* 462 1.0 7.3 0.5 0.4 0.6 0.3 0.3 0.4 
 Chlamydia* 375 0.8 5.9 0.4 0.3 0.5 0.2 0.2 0.3 
 Vaginal swab M,C&S* 326 0.7 5.1 0.3 0.3 0.4 0.2 0.2 0.2 
 Venereal disease* 285 0.6 4.5 0.3 0.2 0.3 0.2 0.2 0.2 
 HIV* 265 0.6 4.2 0.3 0.2 0.3 0.2 0.1 0.2 
 Skin swab M,C&S* 252 0.5 4.0 0.3 0.2 0.3 0.2 0.1 0.2 
 H Pylori* 226 0.5 3.6 0.2 0.2 0.3 0.1 0.1 0.2 
Cytopathology*  1,573 3.3 100.0 1.6 1.5 1.8 1.0 0.9 1.1 
 Pap smear*  1,544 3.3 98.2 1.6 1.4 1.8 1.0 0.9 1.1 
Immunology*  1,018 2.2 100.0 1.1 0.9 1.2 0.7 0.6 0.7 
 Immunology, other* 552 1.2 54.2 0.6 0.5 0.7 0.4 0.3 0.4 
Tissue pathology*  1,001 2.1 100.0 1.0 0.9 1.2 0.7 0.6 0.7 
 Histology; skin 895 1.9 89.4 0.9 0.8 1.1 0.6 0.5 0.7 
Other NEC*  972 2.1 100.0 1.0 0.8 1.2 0.6 0.5 0.8 
 Blood test  436 0.9 44.8 0.5 0.4 0.6 0.3 0.2 0.4 
 Other test NEC 306 0.6 31.4 0.3 0.2 0.4 0.2 0.1 0.3 
Simple tests*  252 0.5 100.0 0.3 0.2 0.3 0.2 0.1 0.2 
Infertility/pregnancy* 246 0.5 100.0 0.3 0.2 0.3 0.2 0.1 0.2 
Total pathology tests  47,035 100.0 — 49.1 47.1 51.0 31.0 30.0 32.1 
* Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 4, Table A4.8, <hdl.handle.net/2123/11882>). 
Note: LCL – lower confidence limit; UCL – upper confidence limit; ESR – erythrocyte sedimentation rate; M,C&S – microscopy, culture and 
sensitivity; HIV – human immunodeficiency virus; H Pylori – test for Helicobacter pylori infection; NEC – not elsewhere classified. 
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Problems for which pathology tests were ordered 
Table 12.3 describes the problems for which pathology was commonly ordered, in 
decreasing frequency order of problem–pathology combinations. Diabetes (accounting for 
7.8% of all problem–pathology combinations), general check-ups, hypertension, and 
weakness/tiredness were the most common problems for which pathology tests were 
ordered.  
The two columns on the far right show the proportion of each problem that resulted in a 
pathology order, and the rate of pathology tests/batteries of tests per 100 specified problems 
when at least one test was ordered. For example, 32.6% of contacts with diabetes resulted in 
pathology orders, and when pathology was ordered for diabetes, the GPs ordered an 
average of 290 tests/batteries of tests per 100 ‘tested’ diabetes contacts. In contrast, only 
11.5% of contacts with hypertension problems resulted in a pathology test, but the resulting 
test orders accounted for almost as many tests (5.7%) as did diabetes (7.8%). This is because 
in general practice, hypertension is managed far more frequently (8.7 per 100 encounters) 
than diabetes (4.2 per 100 encounters) (see Section 7.4). 
Table 12.3: The 10 problems for which pathology was most frequently ordered 
Problem managed 
Number of 
problems 
Number of 
problem–
pathology 
combinations(a) 
Per cent of 
problem–
pathology 
combinations(a) 
Per cent of 
problems with 
test(b) 
Rate of pathology 
orders per 100 
problems with 
pathology(c) 
Diabetes – all* 4,038 3,813 7.8 32.6 289.7 
General check-up* 2,925 2,993 6.1 28.9 354.1 
Hypertension* 8,297 2,778 5.7 11.5 291.1 
Weakness/tiredness 714 1,881 3.8 67.2 392.2 
Lipid disorder 2,953 1,869 3.8 27.1 233.3 
Female genital check-up/ 
Pap smear*  
1,597 1,505 3.1 78.2 120.6 
Abnormal test results* 1,241 1,222 2.5 55.6 177.1 
Urinary tract infection* 1,724 1,170 2.4 58.6 115.8 
Blood test NOS 338 1,048 2.1 83.3 372.6 
Pregnancy* 1,084 873 1.8 37.4 215.3 
Subtotal 24,910 19,154 39.2 — — 
Total problems 151,675 48,910 100.0 13.9 232.2 
(a) A test was counted more than once if it was ordered for the management of more than one problem at an encounter. There were 47,035 
pathology test orders and 48,910 problem–pathology combinations. 
(b) The percentage of total contacts with the problem that generated at least one order for pathology. 
(c) The rate of pathology orders placed per 100 problem contacts with at least one order for pathology. 
* Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 4, Table A4.1, <hdl.handle.net/2123/11882>). 
Note: NOS – not otherwise specified. 
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 12.3 Imaging ordering 
Readers wanting a more detailed study of imaging orders should consult the comprehensive 
report on imaging orders by GPs in Australia in 1999–00, by the FMRC using BEACH data, 
and published by the Australian Institute of Health and Welfare and the University of 
Sydney in 2001.84 A 2014 report, Evaluation of imaging ordering by general practitioners in 
Australia 2002–03 to 2011–12, describes changes in GPs’ imaging ordering over time and 
evaluates the alignment between guidelines and GP test ordering for selected problems.17 
This recent report was funded by a grant from the Diagnostic Imaging Quality Program, 
through the Australian Government Department of Health. Readers may wish to consider 
those reports in conjunction with the information presented below.  
Nature of imaging orders at encounter 
There were 10,460 imaging test orders recorded, at a rate of 10.9 per 100 encounters and 
6.9 per 100 problems managed.  
The distribution of imaging tests by MBS group, and the most common tests within each 
group are presented in Table 12.4. Each group and individual test is expressed as a 
percentage of all imaging tests, as a percentage of the group, as a rate per 100 encounters, 
and as a rate per 100 problems with 95% confidence limits. Diagnostic radiology accounted 
for 41.5% of all imaging test orders, and ultrasound accounted for 41.2%. 
Table 12.4: Imaging orders by MBS imaging groups and the most frequent imaging tests ordered 
within group 
Imaging test ordered Number 
Per cent of 
all imaging  
 Per cent 
of group 
Rate per 100 
encounters 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Rate per 100 
problems 
(n = 151,675) 
95% 
LCL 
95% 
UCL 
Diagnostic radiology* 4,338 41.5 100.0 4.5 4.3 4.7 2.9 2.7 3.0 
 X-ray; chest 863 8.3 19.9 0.9 0.8 1.0 0.6 0.5 0.6 
 X-ray; knee 446 4.3 10.3 0.5 0.4 0.5 0.3 0.3 0.3 
 Test; densitometry  309 3.0 7.1 0.3 0.3 0.4 0.2 0.2 0.2 
 Mammography; female 294 2.8 6.8 0.3 0.3 0.3 0.2 0.2 0.2 
 X-ray; shoulder 274 2.6 6.3 0.3 0.2 0.3 0.2 0.2 0.2 
 X-ray; foot/feet 249 2.4 5.7 0.3 0.2 0.3 0.2 0.1 0.2 
 X-ray; hip  246 2.3 5.7 0.3 0.2 0.3 0.2 0.1 0.2 
 X-ray; ankle 198 1.9 4.6 0.2 0.2 0.2 0.1 0.1 0.2 
 X-ray; wrist  154 1.5 3.6 0.2 0.1 0.2 0.1 0.1 0.1 
 X-ray; hand 150 1.4 3.5 0.2 0.1 0.2 0.1 0.1 0.1 
 X-ray; spine; lumbosacral 100 1.0 2.3 0.1 0.1 0.1 0.1 0.0 0.1 
 X-ray; spine; lumbar  98 0.9 2.3 0.1 0.1 0.1 0.1 0.0 0.1 
 X-ray; abdomen  96 0.9 2.2 0.1 0.1 0.1 0.1 0.0 0.1 
 X-ray; finger(s)/thumb 83 0.8 1.9 0.1 0.1 0.1 0.1 0.0 0.1 
 X-ray; spine; cervical 76 0.7 1.8 0.1 0.1 0.1 0.1 0.0 0.1 
 X-ray; spine; thoracic 65 0.6 1.5 0.1 0.0 0.1 0.0 0.0 0.1 
 X-ray; elbow  63 0.6 1.5 0.1 0.0 0.1 0.0 0.0 0.1 
(continued) 
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Table 12.4 (continued): Imaging orders by MBS imaging groups and the most frequent imaging 
tests ordered within group  
Imaging test ordered Number 
Per cent of 
all imaging  
 Per cent 
of group 
Rate per 100 
encounters 
(n = 95,879) 
95% 
LCL 
95% 
UCL 
Rate per 100 
problems 
(n = 151,675) 
95% 
LCL 
95% 
UCL 
Ultrasound* 4,308 41.2 100.0 4.5 4.3 4.7 2.8 2.7 3.0 
 Ultrasound; pelvis 578 5.5 13.4 0.6 0.5 0.7 0.4 0.3 0.4 
 Ultrasound; shoulder  518 4.9 12.0 0.5 0.5 0.6 0.3 0.3 0.4 
 Ultrasound; abdomen 432 4.1 10.0 0.5 0.4 0.5 0.3 0.3 0.3 
 Ultrasound; breast; female 315 3.0 7.3 0.3 0.3 0.4 0.2 0.2 0.2 
 Ultrasound; obstetric 254 2.4 5.9 0.3 0.2 0.3 0.2 0.1 0.2 
 Echocardiography 182 1.7 4.2 0.2 0.2 0.2 0.1 0.1 0.1 
 Ultrasound; hip  142 1.4 3.3 0.1 0.1 0.2 0.1 0.1 0.1 
 Test; Doppler 137 1.3 3.2 0.1 0.1 0.2 0.1 0.1 0.1 
 Ultrasound; foot/toe(s)  126 1.2 2.9 0.1 0.1 0.2 0.1 0.1 0.1 
 Ultrasound; kidney 119 1.1 2.8 0.1 0.1 0.2 0.1 0.1 0.1 
 Ultrasound; leg  117 1.1 9.2 0.1 0.1 0.1 0.1 0.1 0.1 
 Ultrasound; kidney/ureter/bladder 109 1.0 8.6 0.1 0.1 0.1 0.1 0.1 0.1 
 Ultrasound; thyroid 97 0.9 7.6 0.1 0.1 0.1 0.1 0.0 0.1 
 Ultrasound; neck 96 0.9 7.5 0.1 0.1 0.1 0.1 0.0 0.1 
 Ultrasound; abdomen upper 96 0.9 7.5 0.1 0.1 0.1 0.1 0.0 0.1 
 Test; doppler carotid 89 0.8 7.0 0.1 0.1 0.1 0.1 0.0 0.1 
 Ultrasound; scrotum 74 0.7 5.8 0.1 0.1 0.1 0.0 0.0 0.1 
 Ultrasound; knee 73 0.7 5.7 0.1 0.1 0.1 0.0 0.0 0.1 
 Ultrasound; hand/finger(s) 70 0.7 5.5 0.1 0.1 0.1 0.0 0.0 0.1 
 Ultrasound; groin 65 0.6 5.1 0.1 0.0 0.1 0.0 0.0 0.1 
 Ultrasound; renal tract 63 0.6 5.0 0.1 0.0 0.1 0.0 0.0 0.1 
 Ultrasound; wrist 63 0.6 5.0 0.1 0.0 0.1 0.0 0.0 0.1 
Computerised tomography* 1,272 12.2 100.0 1.3 1.2 1.4 0.8 0.8 0.9 
 CT scan; abdomen  201 1.9 15.8 0.2 0.2 0.2 0.1 0.1 0.2 
 CT scan; brain 170 1.6 13.4 0.2 0.1 0.2 0.1 0.1 0.1 
 CT scan; spine; lumbar 166 1.6 13.1 0.2 0.1 0.2 0.1 0.1 0.1 
 CT scan; chest  104 1.0 8.2 0.1 0.1 0.1 0.1 0.1 0.1 
 CT scan; head  96 0.9 7.5 0.1 0.1 0.1 0.1 0.0 0.1 
 CT scan; spine; lumbosacral  95 0.9 7.5 0.1 0.1 0.1 0.1 0.0 0.1 
 CT scan; sinus  81 0.8 6.4 0.1 0.1 0.1 0.1 0.0 0.1 
Magnetic resonance imaging* 417 4.0 100.0 0.4 0.4 0.5 0.3 0.2 0.3 
 MRI; knee 131 1.3 31.4 0.1 0.1 0.2 0.1 0.1 0.1 
 MRI; brain 61 0.6 14.6 0.1 0.0 0.1 0.0 0.0 0.1 
Nuclear medicine* 125 1.2 100.0 0.1 0.1 0.2 0.1 0.1 0.1 
 Scan; bone(s) 72 0.7 57.6 0.1 0.1 0.1 0.0 0.0 0.1 
Total imaging tests 10,460 100.0 — 10.9 10.5 11.4 6.9 6.6 7.2 
* Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 4, Table A4.9 <hdl.handle.net/2123/11882>). 
Note: LCL – lower confidence limit; UCL – upper confidence limit; CT – computerised tomography; MRI – magnetic resonance imaging. 
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Problems for which imaging tests were ordered 
Table 12.5 lists the problems for which imaging was commonly ordered, in decreasing 
frequency order of problem–imaging combinations. Osteoarthritis accounted for 5.1% of all 
orders, as did back complaint (5.1%), followed by bursitis/tendonitis/synovitis (3.8%) and 
fracture (3.5%).  
The two columns on the far right show the proportion of each problem that resulted in an 
imaging test, and the rate of imaging tests per 100 specified problems when at least one test 
was ordered. For example, 17.0% of contacts with osteoarthritis resulted in an imaging test, 
and 115.5 tests were ordered per 100 osteoarthritis tested contacts. 
Table 12.5: The 10 problems for which an imaging test was most frequently ordered 
Problem managed 
Number of 
problems 
Number of  
problem–imaging 
 combinations(a) 
Per cent of 
problem–imaging 
combinations 
Per cent  
of problems 
with test(b) 
Rate of imaging 
orders per 100 
problems with 
imaging(c) 
Osteoarthritis* 2,761 543 5.1 17.0 115.5 
Back complaint* 3,016 543 5.1 16.1 111.8 
Bursitis/tendonitis/synovitis NOS  1,206 403 3.8 28.9 115.8 
Fracture*  991 370 3.5 34.3 109.0 
Injury musculoskeletal NOS  861 338 3.2 33.4 117.4 
Pregnancy* 1,084 332 3.1 30.2 101.6 
Abdominal pain* 693 321 3.0 40.8 113.6 
Shoulder syndrome 614 319 3.0 41.4 125.7 
Sprain/strain* 1,228 304 2.9 20.4 121.4 
Breast lump/mass (female) 175 176 1.7 73.2 136.9 
Subtotal 12,629 3,650 34.5 — — 
Total problems 151,675 10,572 100.0 6.1 113.4 
(a) A test was counted more than once if it was ordered for the management of more than one problem at an encounter. There were 10,460 
imaging test orders and 10,572 problem–imaging combinations. 
(b) The percentage of total contacts with the problem that generated at least one order for imaging. 
(c) The rate of imaging orders placed per 100 tested problem contacts with at least one order for imaging. 
* Includes multiple ICPC-2 and ICPC-2 PLUS codes (see Appendix 4, Table A4.1 <hdl.handle.net/2123/11882>). 
Note: NOS – not otherwise specified. 
12.4 Other investigations 
Other investigations include diagnostic procedures ordered by the GP or undertaken by the 
GP or practice staff at the encounter. GPs ordered 753 other investigations during the 
study year, and GPs or practice staff undertook 1,606 other investigations. There were, in 
total, 2,359 other investigations either ordered or undertaken (Table 12.6). 
The first section of Table 12.6 lists the other investigations ordered by GPs. The second lists 
the other investigations undertaken in the practice by GPs or practice staff. The third section 
lists the total other investigations (either ordered or undertaken in the practice). Each 
investigation is expressed as a percentage of total other investigations ordered or 
undertaken, as a rate per 100 encounters, and as a rate per 100 problems, each with 
95% confidence limits. Electrical tracings were the most common group of other 
investigations ordered or undertaken, making up 49.4% of other investigations, followed by 
physical function test (28.1%). 
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Table 12.6: Other investigations ordered by GPs or performed in the practice 
 Investigations ordered by the GP  Investigations undertaken in the practice  All investigations (ordered or undertaken) 
Investigation  Number Per cent 
Rate per 100 
encounters 
(95% CI) 
(n = 95,879) 
Rate per 100 
problems 
(95% CI) 
(n = 151,675)  Number Per cent 
Rate per 100 
encounters 
(95% CI) 
(n = 95,879) 
Rate per 100 
problems 
(95% CI) 
(n = 151,675) 
 
Number Per cent 
Rate per 100 
encounters 
(95% CI) 
(n = 95,879) 
Rate per 100 
problems 
(95% CI) 
(n = 151,675) 
Electrical tracings* 419 55.7 0.44 (0.37–0.50) 
0.28 
(0.24–0.32) 
 746 46.4 0.78 
(0.66–0.90) 
0.49 
(0.42–0.57) 
 1,165 49.4 1.22 
(1.08–1.35) 
0.77 
(0.68–0.86) 
Diagnostic endoscopy* 181 24.0 0.19 (0.15–0.23) 
0.12 
(0.09–0.14) 
 18 1.1 0.02 
(0.01–0.03) 
0.01 
(0.01–0.02) 
 199 8.4 0.21 
(0.17–0.25) 
0.13 
(0.11–0.16) 
Physical function test*  142 18.9 0.15 (0.12–0.18) 
0.09 
(0.08–0.11) 
 522 32.5 0.54 
(0.46–0.62) 
0.34 
(0.29–0.39) 
 664 28.1 0.69 
(0.60–0.78) 
0.44 
(0.38–0.49) 
Other diagnostic procedures* 11 1.4 0.01 (0.00–0.02) 
0.01 
(0.00–0.01) 
 320 19.9 0.33 
(0.27–0.40) 
0.21 
(0.17–0.25) 
 331 14.0 0.35 
(0.28–0.41) 
0.22 
(0.18–0.26) 
Total other investigations  753 100.0 0.79 (0.70–0.87) 
0.50 
(0.44–0.55) 
 1,606 100.0 1.68 
(1.50–1.85) 
1.06 
(0.95–1.17) 
 2,359 100.0 2.46 
(2.25–2.67) 
1.56 
(1.43–1.68) 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see Appendix 4, Table A4.6 <hdl.handle.net/2123/11882>). 
Note: CI – confidence interval.  
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12.5  Changes in investigations over the decade 
2004–05 to 2013–14 
Data on investigations are reported for each year from 2004–05 to 2013–14 in Chapter 12 of 
the companion report, A decade of Australian general practice activity 2004–05 to 2013–14.1 In 
that report, changes over time are measured as change in the management of problems (that 
is, as a rate per 100 problems). This reflects change in how GPs are managing problems, and 
accounts for the significant increase in the number of problems managed per encounter over 
the decade. The major changes are highlighted below. 
• At least one pathology test was ordered for 12.2% of problems managed in 2004–05 
rising to 13.9% of problems in 2013–14. The number of pathology tests ordered increased 
from 25.2 tests (or batteries of tests) per 100 problems managed in 2004–05 to 31.0 per 100 
problems in 2013–14. The largest increase was in orders for chemical pathology, which 
increased from 14.0 per 100 problems in 2004–05 to 18.1 per 100 problems in 2013–14. 
Haematology increased at a slower rate, from 4.8 per 100 problems in 2004–05 to 5.4 in 
2013–14.  
• Between 2004–05 and 2013–14, the number of problems managed per 100 encounters 
rose from 145.5 to 158.2. Both the rise in the proportion of problems generating at least 
one pathology test and the rise in the number of problems managed at encounter 
contributed to an overall increase in the proportion of encounters involving a pathology 
test. This rose from 15.7% of encounters in 2004–05 to 19.1% in 2013–14. Combined with 
the increased attendance rate over the decade, this suggests that in 2013–14 one or more 
pathology tests were ordered at about 10 million more encounters nationally than in 
2004–05. 
• The rate of pathology tests ordered per 100 encounters increased from 36.7 per 100 
encounters in 2004–05 to 49.1 in 2013–14, which extrapolates to approximately 
29.5 million more tests (or batteries of tests) ordered nationally in 2013–14 than a decade 
earlier.  
• At least one imaging test was ordered for 5.2% of all problems managed in 2004–05, 
rising to 6.1% of all problems in 2013–14. The proportion of encounters generating 
imaging orders increased from 7.3% in 2004–05 to 9.3% in 2013–14. This resulted in an 
estimated 5.2 million more encounters at which imaging was ordered nationally in 
2013–14 than in 2004–05. 
• The number of imaging tests ordered increased from 5.7 tests per 100 problems managed 
in 2004–05 to 6.9 per 100 problems in 2013–14. Total imaging orders per 100 encounters 
increased significantly from 8.3 per 100 encounters in 2004–05 to 10.9 in 2013–14, 
suggesting that nationally there were 6.4 million more imaging orders in  
2013–14 than in 2004–05. 
 
111
  
13 Patient risk factors 
General practice is a useful intervention point for health promotion because the majority of 
the population visit a GP at least once per year. In 2013–14, 85.2% of Australians visited a GP 
at least once (personal communication, DoH, August 2014). GPs have substantial knowledge 
of population health, screening programs and other interventions. They are therefore in an 
ideal position to advise patients about the benefits of health screening, and to counsel 
individuals about their lifestyle choices.  
Since the beginning of the BEACH program (1998), a section at the bottom of each encounter 
form has been used to investigate aspects of patient health or healthcare delivery not covered 
by general practice consultation-based information. These additional substudies are referred 
to as SAND (Supplementary Analysis of Nominated Data). The SAND methods are 
described in Section 2.6.  
The patient risk factors collected in BEACH include body mass index (BMI) (calculated using 
self-reported height and weight), self-reported alcohol consumption and self-reported 
smoking status. These patient risk factors are investigated for a subsample of 40 of the 100 
patient encounters recorded by each GP. An example of the encounter form with the patient 
risk factor SAND questions is included as Appendix 1. The methods used in the risk factor 
substudies reported in this chapter are described in each section below. 
Unweighted (sample) data on patient risk factors measured in SAND are reported for each of 
the 10 most recent years, and risk factor prevalence after adjustment for attendance patterns 
by age–sex for each of the 7 most recent years are reported in the companion report, A decade 
of Australian general practice activity 2004–05 to 2013–14.1 
Abstracts of results and the research tools used in other SAND substudies from April 1998 to 
March 2014 have been published. Those conducted: 
• from April 1998 to March 1999 were published in Measures of health and health care delivery 
in general practice in Australia23 
• from April 1999 to July 2006 were published in Patient-based substudies from BEACH: 
abstracts and research tools 1999–200624 
• since August 2006 have been published in each general practice annual reports25-31 
• in the 2013–14 BEACH year are provided in Chapter 14 of this publication. 
13.1 Body mass index 
From the most recent publicly available Australian data, high body mass (BMI) was the third 
highest contributor to the total burden of disease in Australia in 2003, accounting for 7.5% of 
the total burden,85 an increase from 4.3% of the total burden and sixth rank in 1996.86 The 
Global Burden of Disease 2010 study compared burden of disease and injury attributable to 
67 risk factors in 21 regions. In Australasia (which includes Australia) ‘high body mass 
index’ was the leading risk factor for disease burden, and ‘physical inactivity and low 
physical activity’ was ranked as the fourth risk factor for disease burden. These Australasian 
rankings compare unfavourably with the global risk factor rankings, with ‘high body mass 
index’ ranking sixth and ‘physical inactivity and low physical activity’ ranking tenth.87 
In 2014, the Organisation for Economic Co-operation and Development (OECD) reported 
that Australia’s adult obesity rates (based on measured data) in 1989, 1995, 2007 and 2011 
were among the highest in the world (10.8%, 19.8%, 24.6% and 28.3% of adults respectively), 
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with Australia’s adult obesity rate fifth globally, behind the United States and Mexico and on 
par with New Zealand and Hungary (28.4% and 28.5% respectively).88  
In 2007 (or nearest year), Australia was fourth, with obesity rates 2% below that of New 
Zealand, but in the ensuing 5 years, Australia caught up to New Zealand (Australia 
increased by 4% to 28.3%, New Zealand increased by 2% to 28.4%).88 In a similar 5-year 
period, obesity rates in the United States increased by about 1% to 35.3%, and those in 
Mexico increased by 2.4% to 32.4%.88 
Australia’s obesity rate of 28.3% in 2011 is much higher than the average for the 16 OECD 
countries with recent measured data (22.7%). It has been suggested that the growing 
prevalence of obesity in Australia foreshadows increases in related health problems (such as 
diabetes and cardiovascular diseases) and escalating health care costs in future.89 
The Australian Health Survey (2011–12), using trained interviewer measured data, estimated 
that 35% of Australians aged 18 years and over were overweight (BMI 25–<30) and 28% were 
obese (BMI 30 or more). Men were more likely to be overweight (42%) than women (28%), 
but obesity rates were the same (28% among both men and women).90  
The Australian Health Survey also reported that 25% of children aged 2–17 years were 
classified as overweight or obese (18% overweight, 7% obese).90  
The Australian government has recognised the epidemic of overweight and obesity, and the 
impact on future health costs and negative health outcomes. New guidelines about the 
clinical management of overweight and obesity were released by the National Health and 
Medical Research Council in May 2013.91 
Method 
Patient BMI was investigated for a subsample of 40 of each GP’s 100 patient encounters. Each 
GP was instructed to ask the patient (or their carer in the case of children): 
• What is your height in centimetres (without shoes)? 
• What is your weight in kilograms (unclothed)? 
Metric conversion tables (from feet and inches; from stones and pounds) were provided to 
the GP. 
The BMI for an individual was calculated by dividing weight (kilograms) by height (metres) 
squared. The WHO recommendations92 for BMI groups were used. They specify that an 
adult (18 years and over) with a BMI: 
• less than 18.5 is underweight 
• greater than or equal to 18.5 and less than 25 is normal weight 
• greater than or equal to 25 and less than 30 is overweight 
• of 30 or more is obese. 
The reported height for adult patients was checked against sex-appropriate upper and lower 
height limits from the ABS.93 Adults whose self-reported height was outside the sex-
appropriate limits were excluded from the analysis. 
The standard BMI cut-offs described above are not appropriate in the case of children. 
Cole et al. (2000 & 2007) developed a method to calculate the age–sex-specific BMI cut-off 
levels for underweight, overweight and obesity specific to children aged 2–17 years.94,95 
There are four categories defined for childhood BMI: underweight, normal weight, 
overweight and obese. This method, based on international data from developed Western 
cultures, is applicable in the Australian setting.  
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The reported height of children was checked against age–sex-appropriate upper and lower 
height limits from the ABS and Centres for Disease Control.93,96 Children whose self-reported 
height was outside the age–sex-appropriate limits were excluded from the analysis. 
The BEACH data on BMI are presented separately for adults (aged 18 years and over) and 
children (aged 2–17 years).  
Results 
Body mass index of adults 
The sample size was 31,371 patients aged 18 years and over at encounters with 956 GPs. 
• Over half (62.7%) of these adults were overweight (34.9%) or obese (27.8%) (Table 13.1). 
• Just over one-third (35.1%) of adult patients had a BMI in the normal range, and 2.2% of 
were underweight. Underweight was more prevalent among females than males. 
• Males were more likely to be overweight or obese (69.3%, 95% CI: 68.2–70.3) than 
females (58.6%, 95% CI: 57.5–59.6) (results not tabulated). 
• Overweight/obesity was most prevalent among male patients aged 65–74 years (77.5%) 
and 45–64 years (76.0%) (Figure 13.1).  
• This pattern was also noted in female patients, with overweight/obesity most prevalent 
in those aged 65–74 years (69.4%) and 45–64 years (65.2%) (Figure 13.1). 
• Underweight was most prevalent among patients aged 18–24 years (6.7%, 95% CI:  
5.6–7.8) (results not tabulated).  
• Of young adults (aged 18–24 years), 7.5% of females and 4.6% of males were 
underweight, and among those aged 75 years and over, 3.9% of females and 1.6% of 
males were underweight (Figure 13.2). 
Our overall and sex-specific prevalence estimates of overweight/obesity among patients at 
general practice encounters (63% of adults, 69% of males and 59% of females are remarkably 
consistent with the ABS 2011–12 figures from the Australian Health Survey (based on 
measured BMI data), which reported that 63% of adults aged 18 and over (70% of men and 
56% of females) were overweight or obese.18  
Readers interested in the prevalence of the three WHO-defined levels of obesity will find 
more information and discussion in Chapter 7 of General practice in Australia, health priorities 
and policies 1998 to 2008.97  
Estimation of body mass index for the adult general practice patient population 
The BEACH study provides data about patient BMI from a sample of the patients attending 
general practice. As older people attend a GP more often than young adults, and females 
attend more often than males, they have a greater chance of being selected in the subsample. 
This leads to a greater proportion of older and female patients in the BEACH sample than in 
the total population who attend a GP at least once in a year. The 2013–14 BEACH sample 
was weighted to estimate the BMI of the GP–patient attending population (that is, the 
15.4 million adult patients who attended a GP at least once in 2013–14 (personal 
communication, DoH, August 2014), using the method described by Knox et al. (2008).20 This 
statistical adjustment had little effect on the resulting proportions. 
The estimates for the adult population who attended general practice at least once (after 
adjusting for age–sex attendance patterns) suggest that 26.9% of the adult patient population 
were obese, 34.6% were overweight, 36.3% were normal weight and 2.2% were underweight 
(Table 13.1).  
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Table 13.1: Patient body mass index (aged 18 years and over) 
 Male(a)  Female(a)  Total respondents 
BMI class 
Per cent in 
BEACH sample 
(95% CI) 
(n = 12,022) 
Per cent  
in patient 
population 
(95% CI)(b)  
Per cent in 
BEACH sample 
(95% CI) 
(n = 19,112) 
Per cent  
in patient 
population 
(95% CI)(b)  
Per cent in 
BEACH sample 
(95% CI) 
(n = 31,371) 
Per cent  
in patient 
population 
(95% CI)(b) 
Obese 27.2 
(26.2–28.2) 
26.2 
(25.1–27.4)  
28.1 
(27.2–29.0) 
27.5 
(26.6–28.5)  
27.8 
(27.0–28.5) 
26.9 
(26.1–27.8) 
Overweight 42.0 
(41.1–43.0) 
41.1 
(40.0–42.1)  
30.4 
(29.7–31.2) 
29.1 
(28.3–29.8)  
34.9 
(34.3–35.5) 
34.6 
(33.9–35.2) 
Normal 29.6 
(28.6–30.6) 
31.4 
(30.2–32.6)  
38.5 
(37.5–39.5) 
40.3 
(39.3–41.4)  
35.1 
(34.3–35.9) 
36.3 
(35.4–37.2) 
Underweight 1.1 
(0.9–1.3) 
1.3 
(1.0–1.5)  
2.9 
(2.7–3.2) 
3.1 
(2.7–3.4)  
2.2 
(2.0–2.4) 
2.2 
(2.0–2.4) 
(a) Patient sex was not recorded for 237 respondents. 
(b) Estimation of BMI among the total adult general practice patient population (that is, patients aged 18 years and over who attended a GP at 
least once in 2013–14). Source: Unpublished Medicare data, personal communication, DoH, August 2014 (n = 15.4 million). 
Note: BMI – body mass index; CI – confidence interval. 
 
 
 
 
Figure 13.1: Age–sex-specific rates of overweight/obesity among sampled adults, 2013–14 
(95% confidence intervals) 
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Figure 13.2: Age–sex-specific rates of underweight among sampled adults, 2013–14 (95% 
confidence intervals) 
 
Body mass index of children 
BMI was calculated for 2,536 patients aged 2–17 years at encounters with 836 GPs. 
• Just over one-quarter of children (28.3%, 95% CI: 26.3–30.3) were classed as overweight 
or obese, including 9.6% (95% CI: 8.3–10.8) obese and 18.7% (95% CI: 17.1–20.4) 
overweight (results not tabulated). 
• There was no difference in the prevalence of overweight/obesity among male (28.5%,  
95% CI: 25.8–31.2) and female children (28.2%, 95% CI: 25.6–30.7) (results not tabulated). 
• The age-specific rates of obesity followed similar patterns for both sexes 
(figures 13.3 and 13.4). 
Readers interested in further detail and discussion about overweight and obesity in children 
attending general practice will find more information in Cretikos et al. (2008) General practice 
management of overweight and obesity in children and adolescents in Australia.98 
 
18–24 25–44 45–64 65–74 75+
 Male 4.6 1.0 0.8 0.5 1.6
 Female 7.5 3.3 1.6 1.5 3.9
0
1
2
3
4
5
6
7
8
9
10
Per cent 
Age group (years) 
 
116
  
 
 
Figure 13.3: Age-specific rates of obesity, overweight, normal weight and underweight among 
sampled male children, 2013–14 
 
 
 
 
Figure 13.4: Age-specific rates of obesity, overweight, normal weight and underweight 
among sampled female children, 2013–14 
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13.2 Smoking (patients aged 18 years and over) 
Tobacco smoking is the leading cause of ill health, drug-related death and hospital 
separations in Australia.99 It is a major risk factor for coronary heart disease, stroke, 
peripheral vascular disease, several cancers, respiratory disorders and other diseases.100 The 
most recent publicly available Australian data identified smoking as the risk factor 
associated with the greatest disease burden, accounting for 7.8% of the total burden of 
disease in Australia in 2003,85 a decrease from 9.7% of total burden in 1996.86  
The Global Burden of Disease 2010 study has compared burden of disease and injury 
attributable to 67 risk factors in 21 regions. In Australasia (which includes Australia), 
‘tobacco smoking, including second hand smoke’ was ranked as the second most important 
risk factor for disease burden. These Australasian rankings are on par to the global risk factor 
rankings, with ‘tobacco smoking, including second hand smoke’ second globally.87  
In 2014, the OECD reported that Australia has been remarkably successful in reducing 
tobacco consumption by more than half, from 30.6% of adults in 1986 to 15.1% in 2010, now 
one of the lowest smoking rates in OECD countries at that time. 88 They suggested “much of 
this decline can be attributed to policies aimed at reducing tobacco consumption through 
public awareness campaigns, advertising bans and increased taxation”. In December 2012, 
Australia became the first (and currently only) country to require tobacco products to be sold 
in plain packaging.89 
According to the 2010 National Drug Strategy Household Survey (NDSHS), 15.1% of 
Australians aged 14 years and over smoked daily: 16.4% of males and 13.9% of females.101 
The 2011–12 Australian Health Survey reported that 16.1% of Australians aged 18 years and 
over were daily smokers: 18.1% of males and 14.1% of females.90 
Method 
GPs were instructed to ask adult patients (18 years and over): 
• What best describes your smoking status?  Smoke daily 
 Smoke occasionally 
 Previous smoker 
 Never smoked 
Results 
The smoking status of 32,166 adult patients was established at encounters with 955 GPs. 
Table 13.2 shows that: 
• 13.5% of sampled adult patients were daily smokers 
• significantly more male (16.7%) than female patients (11.6%) were daily smokers 
(Table 13.2) 
• only 2.3% of sampled adult patients were occasional smokers 
• more than one-quarter of sampled adults (28.6%) were previous smokers. 
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Table 13.2: Patient smoking status (aged 18 years and over) 
 Male(a)  Female(a)  Total respondents 
Smoking 
status 
Per cent in 
BEACH sample 
(95% CI) 
(n = 12,294) 
Per cent in 
patient 
population 
(95% CI)(b)  
Per cent in 
BEACH sample 
(95% CI) 
(n = 19,625) 
Per cent in 
patient 
population 
(95% CI)(b)  
Per cent in 
BEACH sample 
(95% CI) 
(n = 32,166) 
Per cent in 
patient 
population 
(95% CI)(b) 
Daily 16.7 
(15.7–17.8) 
20.9 
(19.6–22.2)  
11.6 
(10.9–12.3) 
13.4 
(12.6–14.2)  
13.5 
(12.9–14.2) 
16.9 
(15.9–17.8) 
Occasional 2.9 
(2.5–3.3) 
3.9 
(3.3–4.4)  
1.9 
(1.7–2.2) 
2.4 
(2.1–2.7)  
2.3 
(2.1–2.5) 
3.1 
(2.7–3.4) 
Previous 37.0 
(35.8–38.2) 
29.8 
(28.7–30.9)  
23.3 
(22.4–24.1) 
21.9 
(21.1–22.7)  
28.6 
(27.8–29.4) 
25.6 
(24.8–26.3) 
Never 43.4 
(42.1–44.7) 
45.4 
(44.0–46.9)  
63.2 
(62.2–64.2) 
62.3 
(61.2–63.4)  
55.6 
(54.6–56.6) 
54.5 
(53.4–55.6) 
(a) Patient sex was not recorded for 247 respondents. 
(b) Estimation of smoking status among the total adult general practice patient population (that is, patients aged 18 years and over who 
attended a GP at least once in 2013–14). Source: Unpublished Medicare data, personal communication, DoH, August 2014 
(n = 15.4 million). 
Note: CI – confidence interval. 
 
Daily smoking was least prevalent among older adults aged 65–74 and 75 years or more 
(8.0% and 3.3% respectively), and most prevalent among adult patients aged 25–44 years 
(19.8%) (results not tabulated). Over half (53.3%) of the male and 24.3% of the female patients 
aged 75 years and over were previous smokers, but only 3.7% of males and 3.0% of females 
in this age group were daily smokers (figures 13.5 and 13.6). 
 
 
 
Figure 13.5: Smoking status – male age-specific rates among sampled patients, 2013–14  
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Figure 13.6: Smoking status – female age-specific rates among sampled patients, 2013–14 
Estimation of smoking in the adult general practice patient population 
The BEACH study provides data about patient smoking habits from a sample of the patients 
attending general practice. As older people attend a GP more often than young adults, and 
females attend more often than males, they have a greater chance of being selected in the 
subsample. This leads to a greater proportion of older and female patients in the BEACH 
sample than in the total population who attend a GP at least once in a year. The 2013–14 
BEACH sample was weighted to estimate the smoking status of the GP–patient attending 
population (that is, the 15.4 million adult patients who attended a GP at least once in  
2013–14 [personal communication, DoH, August 2014]), using the method described by Knox 
et al. (2008).20  
After adjusting for age–sex attendance patterns, we estimated that 16.9% of the patient 
population aged 18 or more were daily smokers, 3.1% were occasional smokers, 25.6% were 
previous smokers and 54.5% had never smoked. Male patients in the total general practice 
population were significantly more likely to be daily (20.9%), occasional 3.9%) and previous 
smokers (29.8%), than females patients (13.4%, 2.4% and 21.9%, respectively) (Table 13.2).  
13.3  Alcohol consumption (patients aged 18 years 
and over) 
Among people aged 65 years and over, low to moderate consumption of alcohol has been 
found to have a preventive effect against selected causes of morbidity.102 Following a review 
of the evidence, the National Health and Medical Research Council (NHMRC) stated that at 
low levels of consumption, alcohol has some cardiovascular health benefits in certain age 
groups (middle-aged and older males, and women after menopause). Low levels of alcohol 
consumption raise high-density lipoprotein cholesterol and reduce plaque accumulations in 
arteries. Alcohol can also have a mild anti-coagulating effect. However, the authors of the 
review noted that the extent of cardiovascular risk reduction is uncertain, and the potential 
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cardiovascular benefits can be gained from other means, such as exercise or modifying the 
diet.103 From the most recent publicly available Australian data, in 2003, alcohol consumption 
accounted for 3.3% of the total burden of disease in Australia; however, after taking into 
account the benefit derived from low to moderate alcohol consumption, this fell to 2.3%.85 
The Global Burden of Disease 2010 study compared burden of disease and injury attributable 
to 67 risk factors in 21 regions. In Australasia (which includes Australia) ‘alcohol use’ was 
ranked as the ninth risk factor for disease burden, a lower ranking than in the global risk 
factor rankings, where ‘alcohol use’ ranked fifth.87 
The Australian Health Survey classified alcohol use for those aged 18 years or more based on 
the estimated average daily consumption of alcohol during the previous week. The results 
indicated that 11.7% drank at levels considered to be risky (13.4% of males and 10.1% of 
females), based on the 2001 NHMRC guidelines.18 Based on the NHMRC 2009 guidelines, 
19.5% of adults drank at levels exceeding the guidelines (29.1% of males and 10.1% of 
females).18 
The 2010 NDSHS found that 20.1% of people aged 14 years and over (29.0% of males and 
11.3% of females) drank at levels considered to put them at risk of harm from alcohol-related 
disease or injury over their lifetime. The NDSHS also found that 28.4% of people aged 14 
years or more (38.2% of males and 18.9% of females) drank (at least once in the previous 
month) in a pattern that placed them at risk of an alcohol-related injury from a single 
drinking occasion.101 These alcohol consumption risk levels were based on the NHMRC 2009 
guidelines.103 
For consistency over time, this report uses the definitions of alcohol-related risk developed 
by WHO (see ‘Method’ below).104 This differs from the definition in the NHMRC guidelines. 
Method 
To measure alcohol consumption, BEACH uses AUDIT-C,105 which is the first three items 
from the WHO Alcohol Use Disorders Identification Test (AUDIT),104 with scoring for an 
Australian setting.106 The AUDIT-C has demonstrated validity and internal consistency and 
performs as well as the full AUDIT tool.107 The three AUDIT-C tool is practical and valid in a 
primary care setting to assess ‘at-risk’ alcohol consumption (heavy drinking and/or active 
alcohol dependence).105 The scores for each question range from zero to four. A total (sum of 
all three questions) score of five or more for males, or four or more for females, suggests that 
the person’s drinking level is placing him or her at risk.106 
 
GPs were instructed to ask adult patients (18 years and over): 
• How often do you have a drink containing alcohol? Never 
 Monthly or less 
 Once a week/fortnight 
 2–3 times a week 
 4 times a week or more 
• How many standard drinks do you have on a typical day when you are drinking?   
 
 _______________ 
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• How often do you have six or more standard drinks on one occasion?  
 Never 
 Less than monthly 
 Monthly 
 Weekly 
 Daily or almost daily 
A standard drinks chart was provided to each GP to help the patient identify the number of 
standard drinks consumed. 
Results 
Patient self-reported alcohol consumption was recorded for 31,369 adult patients (18 years 
and over) at encounters with 956 GPs. 
• Just under one-quarter of sampled adults reported drinking alcohol at at-risk levels 
(23.0%) (Table 13.3). 
• At-risk drinking was more prevalent among male (27.6%) than female patients (20.1%) 
(Table 13.3). 
• At-risk drinking was most prevalent in those aged 18–24 years, particularly among men. 
In this age group almost half the males (43.8%) and one-third of females (30.4%) reported 
at-risk alcohol consumption (Figure 13.7). 
• The proportion of patients who were at-risk drinkers decreased with age among both 
males and females (Figure 13.7). 
These estimates are not directly comparable with the results from the 2011–12 Australian 
Health Survey18 or the 2010 NDSHS101. They all use different definitions for risky levels of 
alcohol consumption, and different adult populations (patients aged 18 years or more for 
BEACH, persons aged 15 or 18 years or more for the Australian Health Survey, and persons 
aged 14 years or more for the NDSHS).  
Readers interested in the relationship between morbidity managed and alcohol consumption 
will find more information in Proude et al. (2006) The relationship between self-reported alcohol 
intake and the morbidities managed by GPs in Australia.108 
Table 13.3: Patient alcohol consumption (aged 18 years and over) 
 Male  Female  Total respondents 
Alcohol 
consumption 
Per cent in 
BEACH sample 
(95% CI) 
(n = 12,079) 
Per cent in 
patient 
population 
(95% CI)(a)  
Per cent in 
BEACH sample 
(95% CI) 
(n = 19,290) 
Per cent in 
patient 
population 
(95% CI)(a)  
Per cent in 
BEACH sample 
(95% CI) 
(n = 31,369) 
Per cent in 
patient 
population 
(95% CI)(a) 
At-risk drinker 27.6 
(26.5–28.8) 
31.6 
(30.2–32.9)  
20.1 
(19.2–20.9) 
21.6 
(20.7–22.5)  
23.0 
(22.2–23.8) 
26.2 
(25.3–27.1) 
Responsible 
drinker 
48.8 
(47.6–50.5) 
46.5 
(45.2–47.8)  
40.8 
(39.8–41.9) 
41.9 
(40.7–43.0)  
43.9 
(43.0–44.8) 
44.0 
(43.0–45.0) 
Non-drinker 23.6 
(22.4–24.7) 
22.0 
(20.7–23.2)  
39.1 
(37.8–40.4) 
36.5 
(35.1–37.9)  
33.1 
(32.0–34.2) 
29.8 
(28.7–30.9) 
(a) Estimation of alcohol consumption among the total adult general practice patient population (that is, patients aged 18 years and over who 
attended a GP at least once in 2013–14). Source: Unpublished Medicare data, personal communication, DoH, August 2014 
(n = 15.4 million). 
Note: CI – confidence interval. 
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Figure 13.7: Age–sex-specific rates of at-risk alcohol consumption in sampled patients, 2013–14  
Estimation of alcohol consumption levels in the adult general practice patient 
population 
The BEACH study provides data about patient alcohol consumption from a sample of the 
patients attending general practice. As older people attend a GP more often than young 
adults, and females attend more often than males, they have a greater chance of being 
selected in the subsample. This leads to a greater proportion of older and female patients in 
the BEACH sample than in the total population who attend a GP at least once in a year. The 
2013–14 BEACH sample was weighted to estimate the prevalence of at-risk alcohol 
consumption among the GP–patient attending population (that is, the 15.4 million adult 
patients who attended a GP at least once in 2013–14 (personal communication, DoH, August 
2014), using the method described by Knox et al. (2008).20  
After adjusting for age–sex attendance patterns, we estimated that 26.2% of the patient 
population were at-risk drinkers, 44.0% were responsible drinkers and 29.8% were non-
drinkers. Males in the general practice attending population were significantly more likely to 
be at-risk drinkers (31.6%) than females (21.6%) (Table 13.3).  
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13.4 Risk factor profile of adult patients 
All patient risk factor questions (BMI, smoking and alcohol consumption) were asked of the 
same subsample of patients. This allows us to build a risk profile of this sample. For the 
purposes of this analysis, being overweight or obese, a daily smoker or an at-risk drinker 
were considered risk factors. A risk factor profile was prepared for the 30,250 adult patients 
from 954 GPs, for whom data were available in all three elements. (Table 13.4). 
• About half (53.0%) the sampled adult respondents had one risk factor. The most 
common was overweight (23.9% of adults) followed by obesity (19.6%). 
• Almost 1 in 5 patients (18.4%) had two risk factors, the most common combinations 
being: 
– overweight and at-risk alcohol consumption – 6.6% of patients 
– obesity and at-risk alcohol consumption – 4.5% of patients 
– overweight and daily smoking – 2.6% of patients. 
• A small group of patients (3.2%) had all three risk factors. 
Table 13.5 shows the number of risk factors by patient sex. 
• Females were significantly more likely to have no risk factors (29.1%) than males (19.6%). 
• Females were significantly less likely to have two or three risk factors (15.0% and 2.2% 
respectively) than males (23.9% and 4.7%). 
Estimation of the risk profile of the adult general practice patient population 
The 2013–14 BEACH sample was weighted to estimate the risk profile of the GP–patient 
attending population; that is, the 15.4 million adult patients who attended a GP at least once 
in 2013–14.  
After adjusting for age–sex attendance patterns we estimated that:  
• one-quarter of patients had no risk factors (24.5%) 
• half of the adult patients had one risk factor (50.6%), the most common being overweight 
(22.0% of adults) followed by obesity (17.7%) 
• 1 in 5 patients had two risk factors (20.8%), the most common combinations being 
overweight and at-risk alcohol consumption (7.1%), followed by obesity and at-risk 
alcohol consumption (4.7%)  
• 4.1% of patients who attend general practice had three risk factors (Table 13.4) 
• significantly more female than male patients had no risk factors (29.6% and 18.4% 
respectively). Male patients were also more likely to have two and three risk factors 
(26.6% and 5.8%) than females (15.9% and 2.7%) (Table 13.5). 
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Table 13.4: Risk factor profile of patients (aged 18 years and over) 
Number of risk factors  Number 
Per cent in 
BEACH sample  
(n = 30,250) 
95% 
LCL 
95% 
UCL 
Per cent in 
patient 
population(a) 
95% 
LCL 
95% 
UCL 
No risk factors 7,696 25.4 24.7 26.2 24.5 23.7 25.3 
One risk factor 16,025 53.0 52.3 53.7 50.6 49.8 51.3 
 Overweight only 7,236 23.9 23.3 24.5 22.0 21.4 22.7 
 Obese only 5,925 19.6 19.0 20.2 17.7 17.1 18.4 
 At-risk alcohol level only 1,953 6.5 6.1 6.9 7.2 6.7 7.7 
 Current daily smoker only 911 3.0 2.7 3.3 3.6 3.3 4.0 
Two risk factors 5,571 18.4 17.8 19.0 20.8 20.1 21.6 
 Overweight and at-risk alcohol level 1,988 6.6 6.2 6.9 7.1 6.6 7.5 
 Obese and at-risk alcohol level 1,365 4.5 4.2 4.8 4.7 4.4 5.0 
 Overweight and current daily smoker 795 2.6 2.4 2.9 3.1 2.8 3.4 
 Daily smoker and at-risk alcohol level 721 2.4 2.2 2.6 3.2 2.9 3.5 
 Obese and current daily smoker 702 2.3 2.1 2.5 2.7 2.5 3.0 
Three risk factors 958 3.2 2.9 3.4 4.1 3.8 4.5 
 Overweight and current daily smoker 
and at-risk alcohol level 
559 1.8 1.7 2.0 2.5 2.2 2.7 
 Obese and current daily smoker and 
at-risk alcohol level 
399 1.3 1.2 1.5 1.7 1.5 1.9 
(a) Estimation of risk factor profile among the total adult general practice patient population (that is, patients aged 18 years and over who 
attended a GP at least once in 2013–14). Source: Unpublished Medicare data, personal communication, DoH, August 2014 
(n = 15.4 million). 
Note: LCL – lower confidence limit; UCL – upper confidence limit. 
Table 13.5: Number of risk factors, by patient sex 
 Male  Female 
Number of risk factors 
Per cent in BEACH 
sample (95% CI) 
(n = 11,687) 
Per cent in patient 
population 
(95% CI)(a)  
Per cent in BEACH 
sample (95% CI) 
(n = 18,563) 
Per cent in patient 
population 
(95% CI)(a) 
No risk factors 19.6 
(18.7–20.4) 
18.4 
(17.5–19.4)  
29.1 
(28.2–30.1) 
29.6 
(28.6–30.6) 
One risk factor 51.9 
(50.8–52.9) 
49.1 
(48.0–50.3)  
53.7 
(52.8–54.5) 
51.8 
(50.9–52.7) 
Two risk factors 23.9 
(22.9–24.9) 
26.6 
(25.5–27.7)  
15.0 
(14.3–15.6) 
15.9 
(15.2–16.6) 
Three risk factors 4.7 
(4.2–5.1) 
5.8 
(5.3–6.4)  
2.2 
(2.0–2.5) 
2.7 
(2.4–3.0) 
(a) Estimation of risk factor profile among the total adult general practice patient population (that is, patients aged 18 years and over who 
attended a GP at least once in 2013–14). Source: Unpublished Medicare data, personal communication, DoH, August 2014 
(n = 15.4 million).  
Note: CI – confidence interval. 
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13.5  Changes in patient risk factors over the decade 
2004–05 to 2013–14 
To investigate changes over time in prevalence of these patient risk factors, results are 
reported from the BEACH sample data for each year from 2004–05 to 2013–14 in Chapter 13 
of the companion report, A decade of Australian general practice activity 2004–05 to 2013–14.1 
The major changes between 2004–05 and 2013–14 are summarised below. 
• The prevalence of obesity in adults attending general practice increased significantly, 
from 22.4% to 27.8%, an increase apparent in both male and female patients. In parallel, 
the prevalence of normal weight in adults attending general practice decreased 
significantly, from 40.3% to 35.1%. 
• The prevalence of overweight and obesity among sampled children aged 2–17 years did 
not differ significantly between 2004–05 and 2013–14 (around 10% and 18% respectively), 
this stable relationship noted for both male and female children.  
• There was a significant decrease in the prevalence of current daily smoking and 
occasional smoking among sampled adults aged 18 years and over attending general 
practice, from 18.0% and 3.7% respectively in 2004–05, to 13.5% and 2.3% in 2013–14. 
These decreases were apparent among both male and female patients. 
• Prevalence of at-risk levels of alcohol consumption among sampled adults declined from 
about 26% in 2004–05 to 23% in 2013–14. A corresponding increase in non-drinkers from 
about 29% in 2004–05 to 33% in 2013–14 was seen. The significant decrease in at-risk 
levels of alcohol consumption and increase in non-drinkers was apparent among both 
male and female patients. 
• There was a significant increase in the proportion of adults with one risk factor from 
48.8% in 2004–05, to 53.0% in 2013–14. The increase was noted for both male and female 
patients. About 1 in 5 adults had two risk factors in all reported years. There was a 
significant decrease in the proportion of patients with three risk factors from 4.0% to 
3.2%.  
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14 SAND abstracts and research tools 
Since BEACH began in April 1998, a section on the bottom of each encounter form has been 
used to investigate aspects of patient health or healthcare delivery not covered by general 
practice consultation-based information. These additional substudies are referred to as 
SAND (Supplementary Analysis of Nominated Data). The SAND methods are described in 
Section 2.6. All substudies were approved by the Human Ethics Committee of the University 
of Sydney. 
The Family Medicine Research Centre (FMRC) and most of the organisations supporting the 
BEACH program select topics for investigation in the SAND studies. In each BEACH year, 
up to 20 substudies can be conducted in addition to the study of patient risk behaviours (see 
Chapter 13). Topics can be repeated to increase the sample size and its statistical power. 
This chapter includes the abstracts and research tools for SAND substudies, most of which 
were conducted from April 2013 to March 2014. The subjects covered in the abstracts in this 
chapter are listed in Table 14.1, with the sample size for each topic. 
Table 14.1: SAND abstracts for 2013–14 and sample size for each  
Abstract 
number Subject 
Number of 
respondents  
Number  
of GPs 
211 Antiplatelet therapy in general practice patients 2,658 92 
212 The prevalence of common chronic conditions in patients at general practice encounters 2012–14 14,391 479 
213 Influenza and pneumococcal vaccination in general practice patients – 2013(a) 2,523 97 
214 COPD prevalence, severity and management in general practice patients 5,583 196 
215 Travel vaccination and prophylaxis in general practice patients – 2013 2,362 80 
216 Management of opioid-induced constipation in general practice patients 2,891 98 
217 Practice based continuity of care 7,799 269 
218 Management of hypertension in general practice patients – 2013 2,419 82 
219 Use of combination products in the management of hypertension in general practice patients 2,528 86 
220 Management of asthma and COPD in general practice patients in Australia – 2013  2,818 96 
221 Patient weight, perception and management(b) 5,199 204 
222 GP encounters in languages other than English and interpreter use 6,074 206 
Note: COPD – chronic obstructive pulmonary disease 
(a) Substudy limited to patients aged 15 years and over. 
(b) Substudy limited to patients aged 18 years and over. 
 
127
  
SAND abstract number 211: Antiplatelet therapy in general practice 
patients 
Organisation collaborating for this study: Merck Sharp and Dohme (Australia) Pty Ltd 
Issues: The proportion of general practice patients who had atherosclerotic disease or 
diabetes and the proportion of those who had coronary artery bypass graft (CABG) and/or 
percutaneous coronary intervention (PCI) and/or were taking antiplatelet drugs. Their 
original and current antiplatelet drugs and reason for change of drug, and expected duration 
of therapy. 
Sample: 2,658 patients from 92 GPs; data collection period: 14/08/2012 – 17/09/2012.  
Method: Detailed in the paper entitled SAND Method 2013–14 on this website: 
<sydney.edu.au/medicine/fmrc/publications/sand-abstracts>. 
Summary of results  
Of 2,648 patients who provided patient age, there were significantly more respondents aged 
<1 year (3.6%; 95% CI: 2.6–4.6 compared with 1.8%; 95% CI: 1.7–1.9) and 
1–4 years (6.5%; 95% CI: 4.8–8.3 compared with 4%; 95% CI: 4.2–4.7), than among patients at 
all 2011–12 BEACH encounters, and significantly fewer aged 65–74 years (9.3%; 95% CI: 
7.8–10.8 compared with 13.4%; 95% CI: 12.8–13.9). 
Patient sex was known for 2,646 respondents of whom 38.2% (95% CI: 34.9–41.5) were male, 
a significantly smaller proportion than among those at all BEACH encounters in 2011–12, 
where 43.5% (95% CI: 42.7–44.3) were male. 
Of the 2,658 respondents, 402 (15.1%, 95% CI: 12.3–18.0) reported having any atherosclerotic 
disease or diabetes with 99 (3.7% 95% CI: 2.4–5.1) having two or more conditions. Of the 
2,658 patients, 149 (5.6%, 95% CI: 3.8–7.4) had atherosclerotic disease; 60 (2.3%, 95% CI: 1.4–
3.1) had experienced a single myocardial infarction; 10 patients (0.4%, 95% CI: 0.2–0.6) had 
multiple myocardial infarctions; 86 (3.2%, 95% CI: 2.1–4.4) had a stroke or transient 
ischaemic attack (TIA); 40 (1.5%, 95% CI: 0.6–2.4) had peripheral vascular disease (PVD)/ 
peripheral arterial disease (PAD); and 187 (7.0%, 95% CI: 5.7–8.4) had diabetes. 
Of 402 patients with a listed condition, 378 responded to the procedure question, 82 (21.7%, 
95% CI: 15.8–27.6) reported at least one procedure and 4 (1.1%, 95% CI: 0.0–2.1) two or more. 
A CABG had been performed on 42 patients (11.1%); 6 (1.6%) had a PCI without stent; 15 
(4.0%) had undergone a PCI with stent; and 6.1% had undergone a PCI drug-eluting stent. 
Responses to medication questions were recorded for 387 of the 402 patients. Of these, 67.4% 
were currently taking at least one oral antiplatelet, and for 80.5% of these, their current 
regimen was that originally prescribed (i.e. had not been changed). 
Of the 261 patients currently taking an antiplatelet, 73.6% were taking aspirin; 19.2% were 
taking clopidogrel; 2.7% were taking aspirin and clopidogrel; 0.8% were taking prasugrel. 
Of 71 patients who had an antiplatelet medication changed or stopped, 63.4% were 
commenced on aspirin, 22.5% on aspirin plus clopidogrel, 5.6% on clopidogrel, and 8.5% on 
other medications.  
The reasons for change included ‘high bleeding risk’ (recorded for 19.7% of patients with 
medication changes); ‘more effective/additional therapy needed’ (for 36.6%); ‘treatment no 
longer needed’ (for 21.1%); and ‘adverse effect’ (for 9.9%). 
Expected duration of current antiplatelet treatment was reported for 247 patients. For 97.6% 
of these patients, the GP expected the treatment to be required for more than 12 months. 
The following page contains the recording form and instructions with which the data in this substudy were collected.  
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SAND abstract number 212: The prevalence of common chronic 
conditions in patients at general practice encounters 2012–14  
Organisation conducting this study: Family Medicine Research Centre 
Issues: The prevalence among patients at general practice encounters of: common chronic 
conditions; two or more chronic conditions; three or more chronic conditions; two or more 
chronic conditions classified to two or more different ICPC-2 chapters; three or more chronic 
conditions classified to 3+ different ICPC-2 chapters (complex multimorbidity). 
Sample: 14,391 patients from 479 GPs; data collection period: 27/11/2012 – 31/03/2014.  
Method: Detailed in the paper entitled SAND Method 2013–14 on this website: 
<sydney.edu.au/medicine/fmrc/publications/sand-abstracts>. This study combines the 
results from two SAND prevalence substudies. The chronic conditions measured were 
consistent across both these studies. 
Summary of results 
The sex distribution of patients in this sample (with female patients accounting for 60.3%) 
did not differ from that of all patients at unweighted 2013–14 BEACH encounters. The age 
distribution did not differ from patients at all unweighted 2013–14 BEACH encounters. 
The most prevalent chronic condition was hypertension, reported for one-quarter (26.3%) of 
patients sampled. The prevalence of other common chronic conditions were: osteoarthritis 
(23.4%); hyperlipidaemia (17.4%); depression (16.6%); anxiety (12.0%); gastro-oesophageal 
reflux disease (11.3%); chronic back pain (9.9%); type 2 diabetes (9.5%); asthma (8.8%); 
obesity (8.2%); ischaemic heart disease (7.5%); malignant neoplasms (5.9%); osteoporosis 
(5.9%); chronic obstructive pulmonary disease (4.6%); hypothyroidism (4.6%); atrial 
fibrillation (4.3%); insomnia (3.9%); other arthritis (3.0%); chronic renal failure (2.7%); 
congestive heart failure (2.6%); cerebrovascular accident (2.5%); dementia (2.3%); sleep 
apnoea (2.2%); peripheral vascular disease (1.6%); glaucoma (1.6%); rheumatoid arthritis 
(1.4%); type 1 diabetes (0.9%); and hyperthyroidism (0.6%). 
When chronic conditions were classified by ICPC-2 chapter (largely based on body systems), 
one-third of patients had at least one chronic musculoskeletal condition (33.0%). The 
prevalence of at least one chronic condition in other ICPC-2 chapters were: circulatory 
(32.2%); endocrine (31.1%); psychological (26.9%); respiratory (15.4%); digestive (15.1%); 
neurological (4.3%); male & female genital (4.1%); urinary (4.0%); skin (3.3%); general & 
unspecified (3.0%); eye (2.8%); blood & blood-forming organs (1.8%); ear (0.7%); pregnancy 
(0.1%) and social (0.1%). 
About half (52.0%, 95% CI: 50.1–54.0) the sampled patients at GP encounters had two or 
more chronic conditions. Over one-third (37.5%, 95% CI: 35.5–39.4) of patients had three or 
more chronic conditions. The proportion of patients with chronic conditions within two or 
more ICPC-2 chapters was 48.3% (95% CI: 46.3–50.3). The proportion of sampled patients 
with complex multimorbidity (chronic conditions classified to three or more ICPC-2 
chapters) was 30.3% (95% CI: 28.5–32.2). 
 
 
 
 
 
The following page contains the recording form and instructions with which the data in this substudy were collected.  
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SAND abstract number 213: Influenza and pneumococcal 
vaccination in general practice patients – 2013 
Organisation collaborating for this study: bioCSL (Australia) Pty Ltd 
Issues: The proportion of general practice patients with indications for influenza and 
pneumococcal vaccination; the proportion of patients who received an influenza/ 
pneumococcal vaccine; how the vaccine was supplied; reasons for not vaccinating against 
influenza/pneumococcal. The proportion of patients aware of the influenza/pneumococcal 
campaign; whether this campaign prompted patients to ask a GP about vaccination. 
Sample: 2,523 patients aged 15+ years from 97 GPs; data collection period: 26/03/2013 – 
30/04/2013. 
Method: Detailed in the paper entitled SAND Method 2013–14 on this website: 
<sydney.edu.au/medicine/fmrc/publications/sand-abstracts>.  
Summary of results  
The age and sex distributions of the 2,523 respondents aged 15 years and over did not differ 
from the age and sex distributions of all patients at 2012–13 BEACH encounters. 
Of 2,523 respondents, more than half had at least one risk factor for influenza (50.5%) or 
pneumococcal disease (55.1%). More than one-third (38.4%) of total respondents were at-risk 
due to being aged 65+ years, 13.4% had chronic heart disease, 11.3% had diabetes and 10.4% 
had chronic lung disease. Nearly 1 in 10 patients were at-risk due to tobacco smoking (9.2%), 
3.6% had chronic renal failure and 1.0% were pregnant.  
Influenza: Of 2,523 respondents, 29.0% had one risk factor and 14.5% had two. More than 
half of 2,499 respondents had received an influenza vaccination (55.7%), including 82.4% (n = 
1,036) of those with at least one risk factor. Influenza vaccination was free to 79.6% of 1,327 
patients, fully privately funded by 17.0% of patients and PBS subsidised for 3.5%. 
Of 140 at-risk patients not vaccinated, 64.3% objected to vaccination, for 18.6% the GP 
assessed the patient as not at-risk and 17.9% of patients did not agree they were at-risk. 
Pneumococcal infection: Of 2,523 respondents, 32.1% had one risk factor and 15.5% had two. 
One-third (33.9%) of 2,386 patients had received a pneumococcal vaccination. More than half 
with at least one risk factor had been vaccinated (57.9%, n = 770), while 37.4% had not been 
vaccinated. Of 766 patients who had been vaccinated, 96.1% of pneumococcal vaccines were 
free to the patient, 3.1% were PBS subsidised and 0.8% fully privately funded. For 45.6% of 
331 at-risk patients not vaccinated, the GP did not assess the patient at-risk of pneumococcal 
disease, 39.3% of patients objected to vaccination and 14.2% did not agree they were at-risk.  
Awareness: Nearly half (46.7%) of 2,328 respondents had seen a consumer awareness 
campaign about influenza and/or pneumococcal infection. For 31.3% of these patients, this 
prompted a discussion with the GP about vaccination (333 of 1,065 respondents).  
A consumer awareness campaign had been seen by more than half (54.6%) of the 185 
patients who had a risk factor for influenza and had not been vaccinated, and by 49.9% of the 
469 patients with a pneumococcal risk factor who had not been vaccinated. 
 
 
 
 
The following page contains the recording form and instructions with which the data in this substudy were collected. 
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SAND abstract number 214: COPD prevalence, severity and 
management in general practice patients  
Organisation collaborating for this study: Novartis Pharmaceuticals Australia Pty Ltd  
Issues: The proportion of patients with diagnosed COPD +/- asthma; severity of COPD; 
management of COPD.  
Sample: 5,583 patients from 196 GPs; data collection periods: 26/03/2013 – 30/04/2013; 
03/12/2013 – 20/01/2014.  
Method: Detailed in the paper entitled SAND Method 2012–13 on this website: 
<sydney.edu.au/medicine/fmrc/publications/sand-abstracts>.  
Method for this substudy: Severity of COPD assessed using GOLD guidelines (Rabe KF et 
al. 2007, Am J Respir Crit Care Med 176(6):532-55). LABA – long-acting beta agonist; LAMA – 
long-acting muscarinic agent; ICS – inhaled corticosteroid. 
Summary of results  
The initial question about diagnosed COPD +/- asthma was completed by 5,583 patients. 
Age was known for 5,551 and sex for 5,541 patients. The age and sex distributions did not 
differ from those of patients at all BEACH encounters in 2012–13.  
Of 5,583 respondents, 297 (5.3%, 95% CI: 4.5–6.1) had diagnosed COPD. Of these, half  
(n = 148) had COPD with asthma and half (n = 149) had COPD without asthma. A further 
532 (9.5%) had asthma without COPD. 
There was no significant difference between the proportions of male and female patients 
with diagnosed COPD (6.4% males and 4.5% females). Age-specific rates showed that COPD 
increased with patient age – only five patients aged <45 years had COPD; 4.5% of those aged 
45–64; 9.7% of those aged 65–74 and 12.6% of patients aged 75 years or older. 
For 289 COPD respondents, GPs reported that 37.7% had mild COPD; 40.8% moderate 
COPD; 17.3% severe COPD and 4.2% had very severe COPD.  
Of 287 respondents with COPD, 21 patients (7.3%) were taking LAMA + LABA; 108 patients 
(37.6%) took LAMA + LABA/ICS; 54 patients (18.8%) took LAMA without LABA or 
LABA/ICS, and 104 (36.2%) did not take LAMA.  
Regimen information was available for 120 of the 129 patients taking LAMA + LABA or 
LAMA + LABA/ICS. Of these, 34 patients (28.3%) had taken both agents since diagnosis and 
71.7% had taken one agent initially with the other added later. Of the 20 patients taking 
LAMA + LABA, six had taken both agents since diagnosis and 14 had taken one initially 
with the other added later. Of 100 patients taking LAMA + LABA/ICS, 28 had taken both 
since initial diagnosis and 72 had taken one agent initially with the second added later.  
Severity and LAMA medication status was known for 279 patients. Of these, LAMA was 
taken by 44.6% of patients with mild COPD; 70.5% of patients with moderate COPD; 87.8% 
of patients with severe COPD; and 91.7% of patients with very severe COPD.  
Primary use for the combination treatment was recorded for 127 of the 129 patients taking 
LAMA + LABA (or LABA/ICS). For 24.4% of patients, the primary reason was ‘breathing 
problems’; for 11.0% ‘managing exacerbations’ was the primary reason, and both reasons 
were reported for 64.6%. 
 
 
The following page contains the recording form and instructions with which the data in this substudy were collected. 
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SAND abstract number 215: Travel vaccination and prophylaxis in 
general practice patients – 2013  
Organisation collaborating for this study: bioCSL (Australia) Pty Ltd  
Issues: The proportion of patients who travelled overseas in the previous 2 years; countries 
visited; travel advice sought; vaccination and prophylaxis status; discussion of risk of disease 
with the GP; and reasons for non-vaccination.  
Sample: 2,362 patients from 80 GPs; data collection period: 01/05/2013 – 03/06/2013.  
Method: Detailed in the paper entitled SAND Method 2012–13 on this website: 
<sydney.edu.au/medicine/fmrc/publications/sand-abstracts>. 
Summary of results  
The initial question about travel overseas in the previous 2 years was completed by 2,362 
patients. Age was known for 2,347 and sex for 2,347 patients. The age and sex distributions 
did not differ from those of patients at all BEACH encounters in 2011–12.  
Of 2,362 respondents, 476 (20.2%, 95% CI: 17.1–23.2) had travelled overseas in the previous 
2 years. A smaller proportion of patients aged < 15 years and aged 75 + had travelled 
overseas.  
All following results relate only to the most recent overseas trip.  
Of 473 travellers, 76.7% had visited one country, 14.8% two countries, and 8.5% three or 
more countries. The ‘main’ destinations most frequently visited were New Zealand (NZ) 
(14%), United States of America (USA) (10%) and Thailand (9%).  
Of the 473 travellers, 287 (60.7%, 95% CI: 55.5–65.9) had travelled to one or more ‘at-risk’ 
destinations: 58.4% (of 473) to countries with a risk for hepatitis B, 55.4% for typhoid, 53.1% 
for hepatitis A, 45.0% for rabies, 6.1% for malaria and 2.1% for yellow fever.  
Of 453 respondents (who each reported nil, one or more sources of advice): 64.0% had not 
sought travel advice before travel; 30.0% had sought advice from a GP; 3.3% from a travel 
clinic; and 2.9% from the internet. Of the 277 respondents who had travelled to at-risk 
destinations, 52.3% had not sought advice and 39.7% had sought advice from a GP.  
For each of six infectious diseases we investigated the patient’s pre-travel vaccination status 
and discussion of infection risk. The following results should be interpreted with caution, as 
the number of respondents and the proportion of completed questions varied considerably.  
Of 185 respondents visiting at least one at-risk country, only 7.0% had been fully 
vaccinated/given prophylaxis for all relevant diseases (out of the six diseases listed below). 
The proportion of respondent travellers who were fully vaccinated (or malaria prophylaxis) 
for each specified disease prior to travel was: 53.8% of 160 respondents travelling to a 
hepatitis A risk destination; 51.2% of 164 respondents for a typhoid risk destination; 37.5% of 
160 for hepatitis B; 52.2% of 23 for malaria; 77.8% of 9 for yellow fever; and 5.2% of 116 
respondents travelling to a rabies risk destination. For each of these diseases, the proportion 
of respondent travellers who were both ‘at-risk’ and ‘had not discussed the risk’ was 14.8%, 
14.9%, 12.7%, 14.9%, 11.6% and 16.4% respectively.  
Of 57 ‘not fully-vaccinated’ respondents visiting an at-risk country, the reason for lack of full 
protection was ‘Patient refusal’ for 31.6% and ‘Did not consult GP/doctor ‘for 26.3%.  
 
 
The following page contains the recording form and instructions with which the data in this substudy were collected. 
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SAND abstract number 216: Management of opioid-induced 
constipation in general practice patients 
Organisation collaborating for this study: AstraZeneca Pty Ltd (Australia) 
Issues: Proportion of patients consulting a GP who have taken an opioid for chronic non-
cancer pain; type(s) of opioids taken; duration of opioid use. Proportion of these patients 
who experienced opioid-induced constipation requiring laxative treatment; first, second and 
third line laxative treatment; proportion who needed rescue therapy; type(s) of rescue 
therapy used; number of times rescue therapy was used in the previous 12 months. 
Sample: 2,891 patients from 98 GPs; data collection period: 04/06/2013 – 15/07/2013 
Method: Detailed in the paper entitled SAND Method 2013–14 on this website: 
<sydney.edu.au/medicine/fmrc/publications/sand-abstracts>.  
Methods for this substudy: An information card on types of medication used for 
constipation was supplied to participating GPs. 
Summary of results 
The sex distribution of respondents in this sample did not differ from patients at all 2012–13 
encounters. There were fewer patients aged 25–44 years and more patients aged 75 and over 
in this sample, compared with patients in these age groups at all 2012–13 BEACH 
encounters. 
Of the 2,891 respondents, 340 (11.8%) had taken opioid medication in the previous 12 months 
for non-cancer pain: 72 (2.5%) patients had taken opioids for less than 4 weeks (accounting 
for 21.2% of patients who had taken an opioid) and 268 (9.3%) had taken them for 4 weeks or 
more (78.8% of those who took an opioid). 
Opioid use in young patients was rare. A significantly smaller proportion of patients aged 
25–44 years had taken an opioid compared with those aged 75 years or older, but there was 
no significant difference in the likelihood between patients aged 45–64, 65–74 and 75 years or 
older. Likelihood also did not differ between the sexes. 
Of 268 patients who had taken an opioid for 4 weeks or more, 77.2% had taken one opioid 
and 19.0% had taken two. A total of 330 opioids were recorded: 71.2% were natural opium 
alkaloids, 14.2% were oripavine derivatives, and 6.4% were 'other opioids'. Oxycodone was 
the most common type of opioid (accounting for 40.9% of those recorded), followed by 
paracetamol/codeine 30mg (14.8%), and buprenorphine (14.2%). Duration of use was known 
for 307 opioids listed, and most (63.5%) had been taken for 7 months or more. 
Among 264 respondents, 118 (44.7%) had used a laxative for opioid-induced constipation. Of 
116 respondents, 59.5% only required first line treatment, 35.3% needed second line 
treatment, and 5.2% needed third line treatment. As first line treatment, 39.7% (of those 
taking a laxative) took an osmotic laxative, 34.5% took a softener/stimulant, 31.9% took a 
bulk laxative, 9.5% took a stimulant laxative, and 1.7% ate prunes. As second line treatment, 
19.8% (of those taking a laxative) took a softener/stimulant, 13.8% took an osmotic laxative, 
7.8% took a stimulant laxative, and 3.4% took a bulk laxative. 
Among 116 respondents, 7.8% had needed rescue therapy for constipation in the previous 12 
months: six had an enema or manual evacuation administered at home (three patients had it 
once, and one patient had it 3 times), one patient visited the hospital for an enema or manual 
evacuation (4 times), and two recorded 'other' rescue therapy. 
 
The following page contains the recording form and instructions with which the data in this substudy were collected. 
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 SAND abstract number 217: Practice based continuity of care 
Organisation collaborating for this study: Family Medicine Research Centre 
Issues: Proportion of patients, and proportion of those with chronic disease, who have a 
regular general practice (‘that they usually visit’); relationship between having/not having a 
regular practice, and attendance frequency. Extent of, and reasons for, multiple practice 
usage among those with a regular practice. 
Sample: 7,799 patients from 269 GPs; data collection: 04/06/2013–23/09/2013 
Method: Detailed in the paper entitled SAND Method 2013–14 on this website: 
<http://sydney.edu.au/medicine/fmrc/publications/sand-abstracts>. 
Summary of results 
The sex-distribution of the responding patients did not differ from that of patients at all 
BEACH encounters in 2012–13, but this sample had a smaller proportion of patients aged  
25–44 years (19.8%, 95% CI: 18.2–21.4) than average (22.5%, 95% CI: 21.8–23.2). 
Of the 7,799 respondents, 96.0 (95% CI: 95.2–96.8) said they had a regular practice, 88.1% 
‘this’ practice and 7.8% another practice. Adjusted for attendance rates, we estimated 94.4% 
(95% CI: 93.3–95.5) of the attending population and 80.3% (95% CI: 79.1–81.4) of the total 
population have a regular practice. Likelihood of having a regular practice did not differ 
between the sexes, was least likely among babies <1 year (92.2%), and most likely among 
those aged 65 years or more (98.6%).  
Of 7,762 (99.5%) patients for whom presence/absence of diagnosed chronic condition(s) was 
reported, 70.6% (95% CI: 68.5–72.8) had one or more diagnosed chronic condition(s) and this 
proportion applied in both sexes. Likelihood increased step-wise with age, from 11.1% of 
babies (< 1 year), to 98.5% of those aged 75 years and over. 
Of the 5,482 respondents who had one or more diagnosed chronic condition(s), 97.7% (95% 
CI: 97.1–98.3) had a regular practice and 2.3% did not. Among those with no chronic 
conditions (n = 2,280), a significantly smaller proportion, but still the vast majority (91.8%, 
95% CI: 89.9–93.7) had a regular practice (80.7% ‘this’ practice and 11.1% another practice).  
For 7,702 patients reporting number of GP visits (including the recorded encounter) in the 
previous 12 months, the mean was 9.2 (95% CI: 8.8–9.6), range 1–115 visits. Those with a 
regular practice had averaged 9.4 (8.9–9.8) visits, double the average of those without (mean 
4.7, 95% CI: 3.7–5.8). Respondents with 1+ chronic conditions visited an average 10.8 times 
(95% CI: 10.3–11.3), double the rate of those with none (mean 5.2 visits, 95% CI: 4.9–5.5). This 
suggests the higher attendance rate among those with a regular practice is largely due to the 
high prevalence of one or more chronic conditions in this group. 
Of the 7,485 patients with a regular practice, 7,386 responded to the question on visits to 
other practices. Of these, 78.4% (95% CI: 76.4.0–80.4) had not attended any other practice and 
the remaining 21.6% (n = 1,597) had attended an average of 1.3 (95% CI: 1.3–1.4) practices 
other than their regular practice over the previous 12 months.  
Main reasons for other practice visits were: difficulties getting appointment at regular 
practice (26%): convenience of location (e.g. work, home) (26%); travelling (12.4%); 
emergency (12.0%), use for specific problem (9.5%). 
 
 
 
The following page contains the recording form and instructions with which the data in this substudy were collected.
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SAND abstract number 218: Management of hypertension in 
general practice patients – 2013 
Organisation collaborating for this study: Merck Sharp and Dohme (Australia) Pty Ltd 
Issues: Diagnosed prevalence of hypertension among patients consulting a GP; 
medication(s) taken for hypertension; use of combination products; comorbidities; current 
blood pressure (BP); level of BP control; reasons for uncontrolled BP; next step in the 
management plan for patients with uncontrolled BP. 
Sample: 2,419 patients from 82 GPs; data collection period: 16/07/2013 – 19/08/2013. 
Method: Detailed in the paper entitled SAND Method 2013–14 on this website: 
<sydney.edu.au/medicine/fmrc/publications/sand-abstracts>. 
Summary of results 
The age and sex distributions of patients in this sample did not differ from those of patients 
at all 2012–13 BEACH encounters. 
Of the 2,419 respondents, 735 (30.4%) had diagnosed hypertension and there was no 
significant difference in prevalence between the sexes. The prevalence rose significantly by 
age group from 15–24 (1.0%), 25–44 (7.2%), 45–64 (32.6%), to the highest among patients aged 
65 years or older (63.0%). 
Among 730 respondents with hypertension, 691 (94.7%) were currently taking at least one 
anti-hypertensive medication. Of these, almost half (47.2%) were taking a single anti-
hypertensive product, one-quarter (25.8%) were taking two or more agents not as a 
combination product, and the remaining quarter (27.1%) were taking combination products. 
An angiotensin II receptor antagonist (ATRA) was the most frequently listed anti-
hypertensive medication type (29.0%), followed by angiotensin-converting-enzyme (ACE) 
inhibitor (27.1%), and calcium channel blocker (CCB) (25.8%).  
Among 688 respondents with hypertension, 575 (83.6%) had at least one comorbidity: 54.5% 
having dyslipidaemia; 28.1% diabetes; 23.0% coronary heart disease; 8.0% cerebral vascular 
disease; 7.8% chronic kidney disease; 6.3% peripheral vascular disease; and 2.0% proteinuria. 
A family history of coronary artery disease was reported for 21.5% of respondents. 
Current BP was recorded for 705 patients with hypertension. According to the National 
Heart Foundation BP categories, 45.0% of patients had high-normal BP, and 32.6% had 
isolated systolic hypertension (ISP) on that day. 
Of 695 respondents with hypertension, 491 (70.6%) were considered by the GP to have well 
controlled BP, however most of them had either high-normal BP (61.4%) or ISP (26.4%) on 
that day. Of the 204 (29.4%) patients considered to have uncontrolled BP, the main reason 
reported by 32.3% was that the current medication was not efficacious, and 14.4% reported 
patient non-compliance. 
No change in management was planned for 27.0% of the 204 patients with uncontrolled BP. 
Dose titration was the next step for 20.6%; 6.9% planned to add a CCB, 3.9% planned to add 
an ATRA, 2.9% planned to add a beta blocker, 2.5% planned to add a diuretic, and another 
2.5% planned to add an ACE inhibitor as the next step in the management plan. 
 
 
 
The following page contains the recording form and instructions with which the data in this substudy were collected. 
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SAND abstract number 219: Use of combination products in the 
management of hypertension in general practice patients 
Organisation collaborating for this study: Merck Sharp and Dohme (Australia) Pty Ltd 
Issues: Diagnosed prevalence of hypertension among patients consulting a GP; level of 
blood pressure (BP) control for patients with hypertension; reasons for uncontrolled BP; 
medications taken for hypertension; use of combination products; reasons for not using a 
combination product; difference in BP control between patients taking single product and 
combination product. 
Sample: 2,528 patients from 86 GPs; data collection period: 20/08/2013 – 23/09/2013. 
Method: Detailed in the paper entitled SAND Method 2013–14 on this website: 
<sydney.edu.au/medicine/fmrc/publications/sand-abstracts>. 
Summary of results 
The initial question about hypertension status was answered by 2,528 patients. Sex was 
known for 2,518 patients, and age was known for 2,517 patients. The sex distribution did not 
differ from patients at all 2012–13 BEACH encounters, but there were fewer patients aged 
15–24 years in this sample (6.6%, 95% CI: 5.4–7.8 compared with 8.3%, 95% CI: 7.9–8.7). 
Of the 2,528 respondents, 760 patients (30.1%) had diagnosed hypertension and there was no 
significant difference in prevalence between the sexes. The prevalence rose significantly by 
age group from 15–24 (1.8%), 25–44 (7.4%), 45–64 (31.6%), to the highest among patients aged 
65 years or older (61.7%). 
Among 750 respondents with hypertension, 85.6% were considered to have 'well controlled' 
BP, 13.7% had BP that was ‘too high’, and for 0.7% it was 'too low'. Of 102 patients 
considered to have uncontrolled BP, the main reason reported for 52.9% of patients was that 
the current medication was not efficacious, patient non-compliance for 10.8%, and alternative 
medications were unsuitable for 3.9% of patients. 
At least one anti-hypertensive was recorded for 732 patients (97.5%). The majority (59.0%) 
were taking one anti-hypertensive, 28.5% were taking two, 7.9% were taking three, and 2.1% 
were taking four. An angiotensin II receptor antagonist (ATRA) was the most frequently 
listed anti-hypertensive medication (32.9%). 
Combination anti-hypertensive products were taken by 178 (24.3%) of the 732 patients taking 
anti-hypertensives. More than half had taken it for more than 2 years (58.1% of 167 
respondents). The most common reasons for prescribing a combination product were to 
improve BP control (67.3%), simplify treatment (37.5%) and/or improve compliance (16.1%). 
Almost three-quarters (73.8%, n = 554) of patients taking anti-hypertensives were not taking 
a combination product: 342 patients (46.8% of 730 respondents taking an anti-hypertensive) 
were taking a single anti-hypertensive agent, and 210 (28.8%) were taking two or more anti-
hypertensive agents not in a combination product. Good current BP control was the reason 
for not using a combination product for 81.8% of 417 respondents. 
Patients using a single anti-hypertensive agent were more likely to have well controlled BP 
(92.4%; 95% CI: 89.5–95.2) than those taking two or more products not in a combination 
product (83.1%; 95% CI: 77.0–89.2) or those using a combination product (79.8%; 95% CI: 
73.5–86.0). 
 
 
The following page contains the recording form and instructions with which the data in this substudy were collected. 
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SAND abstract number 220: Management of asthma and COPD in 
general practice patients in Australia – 2013 
Organisation collaborating for this study: AstraZeneca Pty Ltd (Australia) 
Issues: The prevalence among patients seeing a general practitioner (GP) of asthma and/or 
chronic obstructive pulmonary disease (COPD); presence of selected characteristics of 
asthma/COPD; medications taken for asthma/COPD; use of eformoterol + budesonide for 
prevention and as a reliever; frequency of short acting beta agonist (SABA) use; use of 
spacers; level of asthma/COPD control. 
Sample: 2,818 patients from 96 GPs; data collection period: 20/10/2013 – 02/12/2013. 
Method: Detailed in the paper entitled SAND Method 2013–14 on this website: 
<sydney.edu.au/medicine/fmrc/publications/sand-abstracts>.  
Summary of results  
The age and sex distributions of the 2,818 respondents did not differ from the age and sex 
distributions of all patients at 2012–13 BEACH encounters. 
Of 2,818 respondents, 478 (17.0%) had diagnosed asthma and/or COPD: 364 (12.9%) had 
asthma alone; 95 (3.4%) COPD alone; and 19 (0.7%) both asthma and COPD. More than one-
third (35.1%) of patients with asthma and/or COPD were aged 65 years or over.  
Of 437 respondents with asthma/COPD, 58.6% described it as ‘intermittent’ and 28.8% as 
‘persistent’. One in five patients (19.2%) reported their asthma/COPD flared up in winter, 
15.3% indicated flare-ups in spring, and 12.1% reported exercise induced asthma/COPD. 
There were 389 patients (84.0% of 463 respondents) taking at least one medication for the 
management of asthma/COPD, with 664 medications listed. SABA accounted for 45.9% of 
these medications, followed by salmeterol + fluticasone (19.3%), anticholinergics (11.6%) and 
eformoterol + budesonide (11.3% of medications). 
Of 75 patients taking eformoterol + budesonide, 50.7%(n = 40) were taking this medication 
for prevention alone, and 46.7% (n = 35) for both prevention and as a reliever (SMART 
dosing).  
There were 296 patients (63.9% of 463 patients with asthma/COPD) taking at least one 
SABA, with 287 patients (62.0%) taking one SABA and nine patients (1.9%) taking two. Of 
246 patients for whom frequency of SABA use over the previous 4 weeks was reported, 
32.1% had not used a SABA over the previous 4 weeks, 30.1% had used a SABA two or fewer 
times per week, 15.9% had used it more than twice a week, but less than daily, and 19.1% 
had used it daily. 
At least one preventer medication was used by 249 patients (53.8% of 463 respondents). Of 
244 of these respondents, one in five (20.5%) used a spacer. Of 297 patients using reliever 
medication, 29.2% of 284 respondents were using a spacer with their reliever. 
Of 478 asthma/COPD patients: 24.1% had used reliever medication(s) more than twice a 
week in the previous 4 weeks; 22.2% had daytime symptoms due to asthma/COPD in the 
past 4 weeks and 12.6% had night-time waking/symptoms; 17.4% had limitations of 
activities due to asthma/COPD in the previous 4 weeks; 16.5% had taken an oral 
corticosteroid in the previous 12 months; and 7.3% had visited an accident and emergency 
department or been admitted to a hospital for asthma/COPD in the previous 12 months. 
 
 
The following page contains the recording form and instructions with which the data in this substudy were collected.  
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SAND abstract number 221: Patient weight, perception and 
management 
Organisation collaborating for this study: Family Medicine Research Centre 
Issues: Prevalence of overweight in patients aged 18 years or older; proportion of patients 
who considered themselves overweight; proportion considered overweight by the GP; 
relationship between patient body mass index (BMI) and weight perception; methods used 
by patients and GPs to manage overweight in the previous 12 months.  
Sample: 5,199 patients aged 18 years or older from 204 GPs; data collection period: 
29/10/2013 – 02/12/2013, and 21/01/2014 – 24/02/2014. 
Method: Detailed in the paper entitled SAND Method 2013–14 on this website: 
<sydney.edu.au/medicine/fmrc/publications/sand-abstracts>. 
Methods for this substudy: Patient-reported height and weight was used to calculate BMI 
and World Health Organisation recommendations for BMI groups were used 
<http://apps.who.int/bmi/index.jsp?introPage=intro_3.html>. 
Summary of results 
Patient-reported height and weight was recorded for 5,199 adult patients. Age was known 
for all patients, and sex was known for 5,178. The age and sex distributions of respondents in 
this sample did not differ from those of adult patients at all 2012–13 BEACH encounters. 
Of sampled patients, 2.3% were underweight, 37.8% normal weight, and 59.9% overweight/ 
obese (BMI ≥25.0), including: 23.7% obese and 4.7% morbidly obese. Overweight/obesity 
was most prevalent among 65–74 year olds (69.1%) and 45–64 year olds (66.8%). Males were 
significantly more likely than females to be overweight (BMI 25.0<30.0) (37.1% compared 
with 28.3%), but female patients were more likely to be morbidly obese (5.8% compared with 
2.9%). 
Of 5,161 respondents, 2,426 (47.6%) perceived themselves to be overweight. When patient 
self-perception and BMI were compared 26.8% of overweight/obese patients did not 
consider themselves overweight. The vast majority of obese (90.8%) and morbidly obese 
(99.2%) patients had correct perceptions about their weight, however 43.9% of overweight 
patients (BMI 25.0<30.0) did not consider themselves overweight.  
Of 2,236 patients who correctly identified themselves as overweight, 80.8% had taken steps 
to manage their weight in the previous 12 months. The most common method used was 
diet/meal plan (68.2%), followed by exercise (61.4%), seeking GP advice (17.2%) and weight 
loss program (8.1%). Multiple responses were allowed. 
Of 5,066 patients, 49.2% were considered overweight/obese by the GP. When GP perception 
and patient BMI were compared, 20.1% of overweight/obese patients were not considered 
overweight/obese by the GP. In the previous 12 months, the GP had provided weight 
management to two-thirds (66.4%) of patients they considered overweight/obese. The most 
common method was diet advice (62.1%), followed by exercise advice (55.8%) and referral to 
another health professional (11.7%). 
When perceptions and patient BMI were compared, overweight/obesity was correctly 
identified by both patient and GP for 69.2% of patients. About 1 in 6 (16.0%) 
overweight/obese patients were not considered overweight/obese by either the patient or 
the GP. The gap between perceptions and BMI needs to be addressed to encourage early 
intervention and prevention of disease associated with overweight and obesity. 
The following page contains the recording form and instructions with which the data in this substudy were collected
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SAND abstract number 222: GP encounters in languages other than 
English and interpreter use 
Organisations collaborating for this study: Family Medicine Research Centre and GPs from 
the Doutta Galla Community Health Centre.  
Issues: The proportion of general practice patients who speak a language other than English 
in the home; the languages spoken; the extent to which encounters with patients from non-
English-speaking backgrounds (NESB) were conducted in languages other than English; and 
use of interpreter services. 
Sample: 6,074 patients from 206 GPs; data collection period: 03/12/2013 – 20/01/2014; 
25/02/2014 – 31/03/2014. 
Method: Detailed in the paper entitled SAND Method 2013–14 on this website: 
<sydney.edu.au/medicine/fmrc/publications/sand-abstracts>.  
Summary of results  
The age distribution of respondents in this sample revealed a smaller proportion of patients 
aged 15–24 (6.9%, 95% CI: 6.0–7.8) and 25–44 years (21.4%, 95% CI: 19.5–23.4), and a 
significantly larger proportion of patients aged 75+ years (19.5%, 95% CI: 17.4–21.6) 
compared with patients at all BEACH encounters in 2012–13: 15–24 years (8.3%, 95% CI:  
7.9–8.7); 25–44 years (22.5%, 95% CI: 21.8–23.2); and 75+ years 16.2% (95% CI: 15.4–17.0). 
There was no difference in the sex distribution. 
Of 6,074 respondents, 986 (16.2%, 95% CI: 13.2–19.3) reported that a language other than 
English was spoken at home. Patients indicated more than 80 different languages were 
spoken at home. The most common were: Greek (14.9% of NESB patients), Italian (13.8%), 
Cantonese (7.7%), and Spanish (6.0%). 
One-in-three (32.3%) encounters with NESB patients (n = 946 respondents) involved 
communication, between the patient (or their carer) and the GP, in a language other than 
English. At 82.3% of these, multilingual GPs spoke the patient’s language, and for 17.7% a 
family/friend acted as interpreter. A professional interpreter was only used at 1.0% of these 
encounters. Languages spoken by NESB patients at encounters with multilingual GPs were 
most commonly Greek (31.9% of patients at these encounters), Cantonese (15.9%) and 
Spanish (10.8%). 
At encounters conducted in languages other than English where a professional interpreter 
was not used (n = 291 respondents), GPs were asked whether they believed the quality of the 
consultation would have been improved if a professional had been used. GPs indicated that 
they believed quality would have been improved for 8.6% of these encounters, for 2.4% they 
were unsure of improvement, and that quality would not be improved for 89.0%. 
There were 796 encounters with NESB patients where an interpreter of any kind (including a 
family member, friend or a professional interpreter) was not used. For the vast majority 
(96.4%) of these, the GP or patient felt it was not needed (e.g. the patient was fluent in 
English or the GP was multilingual). Other reasons given included: that the patient was in a 
nursing home (1.9%); that a family/friend was unavailable to interpret today (0.8%). GP lack 
of awareness of interpreting services, and unavailability of these, were reasons rarely given. 
 
 
 
The following page contains the recording form and instructions with which the data in this substudy were collected 
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 Abbreviations 
ABS Australian Bureau of Statistics 
ACE angiotensin-converting enzyme  
ACRRM Australian College of Rural and Remote Medicine 
AF Atrial fibrillation 
AHS allied health service 
AHW Aboriginal health worker 
ASGC Australian Standard Geographical Classification 
ATC Anatomical Therapeutic Chemical (classification) 
BEACH Bettering the Evaluation and Care of Health 
BMI body mass index 
CAPS Coding Atlas for Pharmaceutical Substances 
CI confidence interval (in this report 95% CI is used) 
CKD chronic kidney disease 
COPD chronic obstructive pulmonary disease 
CT computerised tomography 
DoH Australian Government Department of Health 
DoHA Australian Government Department of Health and Ageing 
DVA Australian Government Department of Veterans’ Affairs 
ENT Ear, nose and throat 
FMRC Family Medicine Research Centre 
FTE full-time equivalent 
GFR glomerular filtration rate 
GP general practitioner 
HbA1c haemoglobin, type A1c 
ICPC International Classification of Primary Care 
ICPC-2 International Classification of Primary Care – Version 2 
ICPC-2 PLUS a terminology classified according to ICPC-2 
INR international normalised ratio 
LABA long-acting beta agonist 
LCL lower confidence limit 
MBS Medicare Benefits Schedule 
M,C&S microscopy, culture and sensitivity 
NDSHS National Drug Strategy Household Survey 
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NESB non-English-speaking background 
NHMRC National Health and Medical Research Council 
NLC Nocturnal leg cramp 
OTC over-the-counter (medications advised for over-the-counter purchase) 
PBS Pharmaceutical Benefits Scheme 
PN Practice nurse 
RACGP Royal Australian College of General Practitioners 
RFE reason for encounter 
RRMA Rural, Remote and Metropolitan Area classification 
SABA short-acting beta agonist 
SAND Supplementary Analysis of Nominated Data 
SAS Statistical Analysis System 
UCL upper confidence limit 
URTI upper respiratory tract infection  
WHO World Health Organization 
Wonca World Organization of Family Doctors 
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 Symbols 
— not applicable 
< less than 
> more than 
NEC not elsewhere classified 
n number 
NOS not otherwise specified 
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 Glossary 
A1 Medicare items: see MBS/DVA items: A1 Medicare items. 
Aboriginal: The patient identifies himself or herself as an Aboriginal person. 
Activity level: The number of general practice A1 Medicare items claimed during the previous 
3 months by a participating GP. 
Allied health services: Clinical and other specialised health services provided in the 
management of patients by allied and other health professionals including physiotherapists, 
occupational therapists, dietitians, dentists and pharmacists. 
Chapters (ICPC-2): The main divisions within ICPC-2. There are 17 chapters primarily 
representing the body systems. 
Chronic problem: See Diagnosis/problem: Chronic problem. 
Commonwealth concession card: An entitlement card provided by the Australian Government, 
which entitles the holder to reduced-cost medicines under the Pharmaceutical Benefits 
Scheme and some other concessions from state and local government authorities. 
Complaint: A symptom or disorder expressed by the patient when seeking care. 
Component (ICPC-2): In ICPC-2 there are seven components that act as a second axis across all 
chapters. 
Co-located health service: a health service (e.g. physiotherapist, psychologist etc.) located in the 
practice building or within 50 metres of the practice building, available on a daily or regular 
basis. 
Co-operative after-hours arrangements: the normal after-hours arrangements for patient care 
provision is undertaken in co-operation with another practice(s). 
Consultation: See Encounter. 
Diagnosis/problem: A statement of the provider’s understanding of a health problem 
presented by a patient, family or community. GPs are instructed to record at the most 
specific level possible from the information available at the time. It may be limited to the 
level of symptoms. 
• New problem: The first presentation of a problem, including the first presentation of a 
recurrence of a previously resolved problem, but excluding the presentation of a 
problem first assessed by another provider. 
• Old problem: A previously assessed problem that requires ongoing care, including 
follow-up for a problem or an initial presentation of a problem previously assessed by 
another provider. 
• Chronic problem: A medical condition characterised by a combination of the following 
characteristics: duration that has lasted or is expected to last 6 months or more, a pattern 
of recurrence or deterioration, a poor prognosis, and consequences or sequelae that 
impact on an individual’s quality of life. (Source: O’Halloran J, Miller GC, Britt H 2004. 
Defining chronic conditions for primary care with ICPC-2. Fam Pract 21(4):381–6).  
• Work-related problem: Irrespective of the source of payment for the encounter, it is likely 
in the GP’s view that the problem has resulted from work-related activity or workplace 
exposure, or that a pre-existing condition has been significantly exacerbated by work 
activity or workplace exposure. 
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Encounter (enc): Any professional interchange between a patient and a GP. 
• Indirect: Encounter where there is no face-to-face meeting between the patient and the GP 
but a service is provided (for example, prescription, referral). 
• Direct: Encounter where there is a face-to-face meeting of the patient and the GP. 
Direct encounters can be further divided into: 
– MBS/DVA-claimable: Encounters for which GPs have recorded at least one MBS item 
number as claimable, where the conditions of use of the item require that the patient 
be present at the encounter.  
– Workers compensation: Encounters paid by workers compensation insurance. 
– Other paid: Encounters paid from another source (for example, state). 
Full-time equivalent (FTE): A GP working 35–45 hours per week. 
General practitioner (GP): A medical practitioner who provides primary comprehensive and 
continuing care to patients and their families within the community (Royal Australian 
College of General Practitioners). 
Generic medication: See Medication: Generic. 
GP consultation service items: Includes GP services provided under the MBS professional 
services category including MBS items classed as A1, A2, A5, A6, A7, A14, A17, A18, A19, 
A20, A22 and selected items provided by GPs classified in A11, A15 and A27. 
GP consultation service items: See MBS/DVA items: GP consultation service items.  
MBS/DVA items: MBS item numbers recorded as claimable for activities undertaken by GPs 
and staff under the supervision of GPs. In BEACH, an MBS item number may be funded by 
Medicare or by the Department of Veterans’ Affairs (DVA). 
• A1 Medicare items: Medicare item numbers 1, 2, 3, 4, 13, 19, 20, 23, 24, 25, 33, 35, 36, 37, 38, 
40, 43, 44, 47, 48, 50, 51, 601, 602. 
• GP consultation service items: Includes GP services provided under the MBS professional 
services category including MBS items classed as A1, A2, A5, A6, A7, A14, A17, A18, 
A19, A20, A22 and selected items provided by GPs classified in A11, A15 and A27. 
• MBS/DVA item categories: (Note: item numbers recorded in BEACH in earlier years 
which are no longer valid are mapped to the current MBS groups) 
– Surgery consultations: Identified by any of the following item numbers: short 3, 52, 
5000, 5200; standard 23, 53, 5020, 5203; long 36, 54, 2143, 5040; prolonged 44, 57, 2195, 
5060, 5208. 
– Residential aged care facility: Identified by any of the following item numbers: 20, 35, 
43, 51, 92, 93, 95, 96, 5010, 5028, 5049, 5067, 5260, 5263, 5265, 5267. 
– Home or institution visits (excluding residential aged care facilities): Identified by any of 
the following item numbers: 4, 19, 24, 33, 37, 40, 47, 50, 58, 59, 60, 65, 87, 89, 90, 91, 
503, 507, 5003, 5023, 5043, 5063, 5220, 5223, 5227, 5228. 
– GP mental health care: Identified by any of the following item numbers: 2700, 2701, 
2702, 2704, 2705, 2710, 2712, 2713, 2715, 2717, 2721, 2723, 2725. 
– Chronic disease management items: Identified by any of the following item numbers: 
720, 721, 722, 723, 724, 725, 726, 727, 729, 730, 731, 732. 
– Health assessments: Identified by any of the following item numbers: 700, 702, 703, 
704, 705, 706, 707, 708, 709, 710, 712, 713, 714, 715, 717, 718, 719. 
– Case conferences: Identified by any of the following item numbers: 139, 734, 735, 736, 
738, 739, 740, 742, 743, 744, 747, 750, 762, 765, 771, 773, 775, 778. 
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– Attendances associated with Practice Incentives Program payments: Identified by any of 
the following item numbers: 2497, 2501, 2503, 2504, 2506, 2507, 2509, 2517, 2518, 2521, 
2522, 2525, 2526, 2546, 2547, 2552, 2553, 2558, 2559, 2574, 2575, 2577, 2598, 2600, 2603, 
2606, 2610, 2613, 2616, 2620, 2622, 2624, 2631, 2633, 2635, 2664, 2666, 2668, 2673, 2675, 
2677, 2704, 2705. 
– Practice nurse/Aboriginal health worker/allied health worker services: Identified by any of 
the following item numbers: 711, 10950, 10951, 10960, 10966, 10970, 10986, 10987, 
10988, 10989, 10993, 10994, 10995, 10996, 10997, 10998, 10999, 16400, 82210. 
– Acupuncture: Identified by any of the following item numbers: 173, 193, 195, 197, 199. 
– Diagnostic procedures and investigations: Identified by item numbers: 11000–12533. 
– Therapeutic procedures: Identified by item numbers: 13206–23042 (excluding 16400). 
– Surgical operations: Identified by item numbers: 30001–52036. 
– Diagnostic imaging services: Identified by item numbers: 55037–63000. 
– Pathology services: Identified by item numbers: 65120–74991. 
Medication: Includes medication that is prescribed, provided by the GP at the encounter or 
advised for over-the-counter purchase. 
• Generic: The generic name of a medication is its non-proprietary name, which describes 
the pharmaceutical substance(s) or active pharmaceutical ingredient(s). 
• GP-supplied: The medication is provided directly to the patient by the GP at the 
encounter. 
• Over-the-counter (OTC): Medication that the GP advises the patient to purchase OTC (a 
prescription is not required for the patient to obtain an OTC medication). 
• Prescribed: Medications that are prescribed by the GP (that is, does not include 
medications that were GP-supplied or advised for over-the-counter purchase). 
Medication status: 
• New: The medication prescribed/provided at the encounter/advised is being used for 
the management of the problem for the first time. 
• Continued: The medication prescribed/provided at the encounter/advised is a 
continuation or repeat of previous therapy for this problem. 
• Old: See Continued. 
Morbidity: Any departure, subjective or objective, from a state of physiological wellbeing. 
In this sense, sickness, illness and morbid conditions are synonymous. 
Patient status: The status of the patient to the practice. 
• New patient: The patient has not been seen before in the practice. 
• Patient seen previously: The patient has attended the practice before. 
Problem managed: See Diagnosis/problem. 
Provider: A person to whom a patient has access when contacting the healthcare system. 
Reasons for encounter (RFEs): The subjective reasons given by the patient for seeing or 
contacting the general practitioner. These can be expressed in terms of symptoms, diagnoses 
or the need for a service. 
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Recognised GP: A medical practitioner who is: 
• vocationally recognised under Section 3F of the Health Insurance Act, or 
• a holder of the Fellowship of the Royal Australian College of General Practitioners who 
participates in, and meets the requirements for, quality assurance and continuing 
medical education as defined in the Royal Australian College of General Practitioners 
(RACGP) Quality Assurance and Continuing Medical Education Program, or 
• undertaking an approved placement in general practice as part of a training program for 
general practice leading to the award of the Fellowship of the Royal Australian College 
of General Practitioners, or undertaking an approved placement in general practice as 
part of some other training program recognised by the RACGP as being of equivalent 
standard. (Source: Commonwealth Department of Health and Aged Care 2001. Medicare 
Benefits Schedule book. Canberra: DHAC).  
Referral: The process by which the responsibility for part, or all, of the care of a patient is 
temporarily transferred to another health care provider. Only new referrals to specialists and 
allied health services, and for hospital and residential aged care facility admissions arising at 
a recorded encounter, are included. Continuation referrals are not included. Multiple 
referrals can be recorded at any one encounter. 
Repatriation Health Card: An entitlement card provided by the Department of Veterans’ 
Affairs that entitles the holder to access a range of repatriation health care benefits, including 
access to prescription and other medications under the Pharmaceutical Benefits Scheme. 
Rubric: The title of an individual code in ICPC-2. 
Significant: This term is used to refer to a statistically significant result. Statistical significance 
is measured at the 95% confidence level in this report.  
Torres Strait Islander: The patient identifies himself or herself as a Torres Strait Islander 
person. 
Work-related problem: See Diagnosis/problem. 
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 Appendices 
Appendix 1: Example of a 2013–14 recording form
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 Appendix 2: GP characteristics questionnaire,   
2013–14 
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 Appendix 3: Patient information card, 2013–14 
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 Appendix 4: Code groups from ICPC-2 and 
 ICPC-2 PLUS 
Available at: <purl.library.usyd.edu.au/sup/9781743324219>, see ‘Electronic editions and 
downloads’. 
Table A4.1:  Code groups from ICPC-2 and ICPC-2 PLUS – reasons for encounter  
and problems managed 
Table A4.2: Code groups from ICPC-2 and ICPC-2 PLUS – chronic problems 
Table A4.3: Code groups from ICPC-2 and ICPC-2 PLUS – problems managed by  
practice nurses 
Table A4.4: Code groups from ICPC-2 and ICPC-2 PLUS – clinical treatments 
Table A4.5: Code groups from ICPC-2 and ICPC-2 PLUS – procedures 
Table A4.6: Code groups from ICPC-2 and ICPC-2 PLUS – clinical measurements 
Table A4.7: Code groups from ICPC-2 and ICPC-2 PLUS – referrals 
Table A4.8:  Code groups from ICPC-2 and ICPC-2 PLUS – pathology test orders  
(MBS groups) 
Table A4.9:  Code groups from ICPC-2 and ICPC-2 PLUS – imaging test orders  
(MBS groups) 
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This book provides a summary of results from the 16th 
year of the BEACH program, a continuous national 
study of general practice activity in Australia.
From April 2013 to March 2014, 959 general 
practitioners recorded details of 95,900 GP–patient 
encounters, at which patients presented 148,880 
reasons for encounter and 151,675 problems were 
managed. For an ‘average’ 100 problems managed, 
GPs recorded: 65 medications (including 53 prescribed, 
7 supplied to the patient and 6 advised for over-the-
counter purchase); 12 procedures; 24 clinical treatments 
(advice and counselling); 6 referrals to specialists and 3 
to allied health services; orders for 31 pathology tests 
and 7 imaging tests. 
A subsample study of more than 31,000 patients 
suggests prevalence of measured risk factors in the adult 
(18 years and over) population who attended general 
practice at least once in 2013–14 were: obesity—27%; 
overweight—35%; daily smoking—17%; at-risk 
alcohol consumption—26%. One in four people in 
the attending population had at least two of these 
risk factors.
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